Ligand ID: QPS Drugbank ID: DB00284(Acarbose) Indication:For treatment and management of diabetes type II (used in combination therapy as a second or third line agent) |
DrReposER ID / Desc. | Hit PDBID |
Hit Macromolecule |
Res. Matches |
View | Interface | RMSD | Seq. Identity (%) |
HETATM | Dock | |
---|---|---|---|---|---|---|---|---|---|---|
![]() | 2X2I_A_QPSA1060_1 (ALPHA-1,4-GLUCANLYASE ISOZYME 1) | 1qz8 | POLYPROTEIN 1AB (SARSr-CoV) | 5 / 12 | PHE A 56SER A 13ASN A 27GLY A 17ALA A 54 | 1.44A | 8.69 | None | ||
![]() | 2X2I_B_QPSB1060_1 (ALPHA-1,4-GLUCANLYASE ISOZYME 1) | 1qz8 | POLYPROTEIN 1AB (SARSr-CoV) | 5 / 10 | PHE A 56SER A 13ASN A 27GLY A 17ALA A 54 | 1.42A | 8.69 | None | ||
![]() | 6GNF_C_QPSC602_1 (-) | 1uj1 | 3C-LIKE PROTEINASE (SARSr-CoV) | 5 / 10 | GLY B 143LEU B 141TYR B 126SER B 10HIS B 163 | 1.65A | 21.21 | None | ||
![]() | 6GNF_C_QPSC602_2 (-) | 1uk4 | 3C-LIKE PROTEINASE (SARSr-CoV) | 5 / 12 | HIS B 163ASN B 133GLN B 192PRO B 184GLY B 195 | 1.75A | 21.21 | ATO B2006 ( 4.6A)NoneNoneNoneNone | ||
![]() | 6GNF_A_QPSA602_1 (-) | 1uk4 | 3C-LIKE PROTEINASE (SARSr-CoV) | 5 / 12 | HIS B 163ASN B 133GLN B 192PRO B 184GLY B 195 | 1.74A | 21.21 | ATO B2006 ( 4.6A)NoneNoneNoneNone | ||
![]() | 2X2I_B_QPSB1060_1 (ALPHA-1,4-GLUCANLYASE ISOZYME 1) | 1wof | 3C-LIKE PROTEINASE (SARSr-CoV) | 5 / 10 | PHE A 140SER A 139SER B 1GLY A 124ALA A 116 | 1.79A | 15.47 | None | ||
![]() | 6GNG_B_QPSB601_1 (-) | 1wof | 3C-LIKE PROTEINASE (SARSr-CoV) | 5 / 12 | VAL A 157TYR A 182TYR A 161VAL A 13CYH A 16 | 1.78A | 18.97 | None | ||
![]() | 6GNG_B_QPSB601_2 (-) | 1wof | 3C-LIKE PROTEINASE (SARSr-CoV) | 5 / 12 | GLU B 166GLY B 170GLY A -1GLY B 183HIS B 163 | 1.53A | 18.97 | I12 B2145 (-3.7A)NoneNoneNoneI12 B2145 (-4.0A) | ||
![]() | 6GNG_B_QPSB601_3 (-) | 1wyy | E2 GLYCOPROTEIN (SARSr-CoV) | 3 / 3 | ASP B1165ASP B 932ASN A1175 | 0.71A | 12.68 | None | ||
![]() | 2X2I_D_QPSD1060_1 (ALPHA-1,4-GLUCANLYASE ISOZYME 1) | 1x7q | BETA-2-MICROGLOBULINHLA, A-11 (Homosapiens) | 5 / 10 | VAL B 85SER A 92SER A 13GLY A 120GLN B 2 | 1.54A | 7.19 | None | ||
![]() | 2X2I_B_QPSB1060_1 (ALPHA-1,4-GLUCANLYASE ISOZYME 1) | 1x7q | BETA-2-MICROGLOBULINHLA, A-11 (Homosapiens) | 5 / 10 | VAL B 85SER A 92SER A 13GLY A 120GLN B 2 | 1.58A | 7.19 | None | ||
![]() | 1DED_A_QPSA1001_1 (CYCLODEXTRINGLUCANOTRANSFERASE) | 1z1j | 3C-LIKE PROTEINASE (SARSr-CoV) | 5 / 12 | LEU B1272ALA B1234GLU B1240ASP B1289ARG B1131 | 1.61A | 19.01 | None | ||
![]() | 6GNG_B_QPSB601_3 (-) | 1zv8 | E2 GLYCOPROTEIN (SARSr-CoV) | 3 / 3 | ASP E 32ASP D 17ASN D 25 | 1.05A | 9.30 | None | ||
![]() | 2X2I_A_QPSA1060_1 (ALPHA-1,4-GLUCANLYASE ISOZYME 1) | 2acf | REPLICASEPOLYPROTEIN 1AB (SARS-COVTor2) | 5 / 12 | PHE B 314SER B 310SER B 321VAL B 277GLY B 261 | 1.52A | 10.03 | GOL B1004 (-4.5A)NoneNoneNoneNone | ||
![]() | 2X2I_D_QPSD1060_1 (ALPHA-1,4-GLUCANLYASE ISOZYME 1) | 2acf | REPLICASEPOLYPROTEIN 1AB (SARS-COVTor2) | 5 / 10 | PHE B 314SER B 310SER B 321VAL B 277GLY B 261 | 1.53A | 10.03 | GOL B1004 (-4.5A)NoneNoneNoneNone | ||
![]() | 6GNG_B_QPSB601_2 (-) | 2acf | REPLICASEPOLYPROTEIN 1AB (SARS-COVTor2) | 5 / 12 | GLY C 229GLY C 228HIS C 276ASN C 236PRO C 214 | 1.56A | 15.68 | GOL C1009 (-4.0A)GOL C1009 (-3.4A)NoneNoneNone | ||
![]() | 2X2I_D_QPSD1060_1 (ALPHA-1,4-GLUCANLYASE ISOZYME 1) | 2ahm | REPLICASEPOLYPROTEIN 1AB,HEAVY CHAINREPLICASEPOLYPROTEIN 1AB,LIGHT CHAIN (SARSr-CoV) | 5 / 10 | VAL C 21PHE G 97SER C 62GLY C 69GLN G 93 | 1.76A | 6.07 | None | ||
![]() | 2X2I_B_QPSB1060_1 (ALPHA-1,4-GLUCANLYASE ISOZYME 1) | 2ahm | REPLICASEPOLYPROTEIN 1AB,HEAVY CHAINREPLICASEPOLYPROTEIN 1AB,LIGHT CHAIN (SARSr-CoV) | 5 / 10 | VAL C 21PHE G 97SER C 62GLY C 69GLN G 93 | 1.78A | 6.07 | None | ||
![]() | 6GNF_C_QPSC602_2 (-) | 2ajf | ACE2SPIKE PROTEIN (Homosapiens;SARSr-CoV) | 5 / 12 | VAL B 93ASP F 393ASP B 30ASN B 33ARG B 393 | 1.80A | 22.10 | None | ||
![]() | 6GNG_B_QPSB601_3 (-) | 2ajf | ACE2SPIKE PROTEIN (Homosapiens;SARSr-CoV) | 3 / 3 | ASP E 393ASP A 30ASN A 90 | 1.17A | 13.07 | NoneNoneNAG A1090 (-1.7A) | ||
![]() | 1DED_B_QPSB1501_1 (CYCLODEXTRINGLUCANOTRANSFERASE) | 2ajf | ACE2 (Homosapiens) | 5 / 12 | TYR B 183LEU B 179ARG B 460ALA B 501PHE B 504 | 1.15A | 22.19 | None | ||
![]() | 2X2I_D_QPSD1060_1 (ALPHA-1,4-GLUCANLYASE ISOZYME 1) | 2ajf | ACE2 (Homosapiens) | 5 / 10 | VAL B 343SER B 47SER B 43ASN B 63VAL B 59 | 1.66A | 20.00 | None | ||
![]() | 6GNF_A_QPSA602_2 (-) | 2ajf | ACE2SPIKE PROTEIN (Homosapiens;SARSr-CoV) | 5 / 9 | THR F 487GLY F 488GLY F 490VAL F 394GLU B 37 | 1.63A | 15.49 | None | ||
![]() | 2X2I_A_QPSA1060_1 (ALPHA-1,4-GLUCANLYASE ISOZYME 1) | 2ajf | ACE2 (Homosapiens) | 5 / 12 | VAL B 506SER B 128THR B 129VAL B 172GLY B 173 | 1.43A | 20.00 | None | ||
![]() | 6GNG_B_QPSB601_1 (-) | 2ajf | ACE2 (Homosapiens) | 5 / 12 | THR A 519VAL A 404THR A 453HIS A 378GLY A 395 | 1.74A | 20.39 | NoneNoneNone ZN A 901 (-3.3A)None | ||
![]() | 6GNG_B_QPSB601_2 (-) | 2bx3 | MAIN PROTEINASE (SARS-COVSin2774) | 5 / 12 | GLY A 143LEU A 141GLY A 15PRO A 99PRO A 39 | 1.44A | 18.78 | None | ||
![]() | 6GNG_A_QPSA601_1 (-) | 2cjr | NUCLEOCAPSID PROTEIN (SARS-COVTW1) | 5 / 12 | THR B 333GLY A 336THR B 330GLY B 329ASN B 286 | 1.45A | 11.60 | None | ||
![]() | 6GNG_A_QPSA601_2 (-) | 2cjr | NUCLEOCAPSID PROTEIN (SARS-COVTW1) | 5 / 12 | GLY C 276TYR B 269ARG C 277PRO C 280GLY C 285 | 1.52A | 11.60 | None | ||
![]() | 1DED_B_QPSB1501_1 (CYCLODEXTRINGLUCANOTRANSFERASE) | 2cjr | NUCLEOCAPSID PROTEIN (SARS-COVTW1) | 5 / 12 | HIS C 301TYR C 299PHE C 364HIS C 357ASP C 289 | 1.65A | 11.97 | None | ||
![]() | 6GNF_C_QPSC602_2 (-) | 2dd8 | IGG HEAVY CHAINSPIKE GLYCOPROTEIN (Homosapiens;SARSr-CoV) | 5 / 12 | VAL S 337ASP H 95ASN S 409ARG S 395GLY S 403 | 1.70A | 16.54 | None | ||
![]() | 6GNG_A_QPSA601_1 (-) | 2dd8 | IGG LIGHT CHAIN (Homosapiens) | 6 / 12 | THR L 6GLY L 24LEU L 5VAL L 33ASN L 26ASN L 66 | 1.63A | 16.64 | None | ||
![]() | 1DED_A_QPSA1001_1 (CYCLODEXTRINGLUCANOTRANSFERASE) | 2dd8 | IGG LIGHT CHAIN (Homosapiens) | 5 / 12 | TYR L 193LEU L 118ALA L 209HIS L 190ASP L 152 | 1.63A | 16.25 | None | ||
![]() | 6GNF_A_QPSA602_1 (-) | 2dd8 | IGG HEAVY CHAINSPIKE GLYCOPROTEIN (Homosapiens;SARSr-CoV) | 5 / 12 | VAL S 337ASP H 95ASN S 409ARG S 395GLY S 403 | 1.75A | 16.54 | None | ||
![]() | 1DED_B_QPSB1501_1 (CYCLODEXTRINGLUCANOTRANSFERASE) | 2dd8 | IGG LIGHT CHAIN (Homosapiens) | 5 / 12 | TYR L 193LEU L 118ALA L 209HIS L 190ASP L 152 | 1.68A | 16.25 | None | ||
![]() | 6GNG_A_QPSA601_1 (-) | 2duc | REPLICASEPOLYPROTEIN 1AB (SARSr-CoV) | 5 / 12 | GLY B 124VAL A 303ASP A 153ASN A 151GLN A 127 | 1.48A | 18.78 | None | ||
![]() | 6GNG_B_QPSB601_2 (-) | 2fav | REPLICASEPOLYPROTEIN 1AB(PP1AB) (ORF1AB) (SARSr-CoV) | 5 / 12 | GLY C 48GLY C 47HIS C 95ASN C 55PRO C 33 | 1.57A | 15.41 | None | ||
![]() | 2X2I_D_QPSD1060_1 (ALPHA-1,4-GLUCANLYASE ISOZYME 1) | 2fav | REPLICASEPOLYPROTEIN 1AB(PP1AB) (ORF1AB) (SARSr-CoV) | 5 / 10 | PHE C 133SER C 129SER C 140VAL C 96GLY C 80 | 1.57A | 9.87 | None | ||
![]() | 1DED_A_QPSA1001_1 (CYCLODEXTRINGLUCANOTRANSFERASE) | 2fe8 | REPLICASEPOLYPROTEIN 1AB (SARSr-CoV) | 5 / 12 | LEU C 81LEU C 59ALA C 69GLU C 68HIS C 18 | 1.22A | 18.99 | None | ||
![]() | 6GNG_B_QPSB601_2 (-) | 2fe8 | REPLICASEPOLYPROTEIN 1AB (SARSr-CoV) | 5 / 12 | GLY C 100GLY C 101LEU C 102GLY C 257HIS C 276 | 1.58A | 17.93 | None | ||
![]() | 6GNG_B_QPSB601_3 (-) | 2g9t | ORF1A POLYPROTEIN (SARSr-CoV) | 3 / 3 | ASP B 106ASP B 29ASN K 40 | 1.23A | 13.84 | None | ||
![]() | 6GNG_B_QPSB601_2 (-) | 2ga6 | ORF1A POLYPROTEIN (SARSr-CoV) | 5 / 12 | GLU I 66GLY M 50HIS I 48GLU M 60PRO M 107 | 1.63A | 13.84 | None | ||
![]() | 6GNG_A_QPSA601_2 (-) | 2ga6 | ORF1A POLYPROTEIN (SARSr-CoV) | 5 / 12 | GLU N 66PRO J 37GLU I 60PRO I 59GLY I 50 | 1.60A | 13.84 | None | ||
![]() | 6GNG_B_QPSB601_1 (-) | 2ga6 | ORF1A POLYPROTEIN (SARSr-CoV) | 5 / 12 | THR J 101VAL J 97THR N 39PRO M 59GLY J 52 | 1.69A | 13.84 | None | ||
![]() | 2X2I_B_QPSB1060_1 (ALPHA-1,4-GLUCANLYASE ISOZYME 1) | 2ga6 | ORF1A POLYPROTEIN (SARSr-CoV) | 5 / 10 | VAL T 116PHE T 110SER T 67ASN T 62GLY T 127 | 1.79A | 9.79 | None | ||
![]() | 4BQF_A_QPSA951_1 (ALPHA-GLUCANPHOSPHORYLASE 2,CYTOSOLIC) | 2gdt | NSP1 (EC 3.4.22.-) P65 HOMOLOGLEADER PROTEIN (SARSr) | 4 / 6 | GLY A 116ARG A 32GLU A 76ARG A 113 | 1.21A | 9.07 | None | ||
![]() | 6GNG_A_QPSA601_2 (-) | 2gdt | NSP1 (EC 3.4.22.-) P65 HOMOLOGLEADER PROTEIN (SARSr) | 5 / 12 | GLU A 76HIS A 2PRO A 98ARG A 32GLY A 116 | 1.48A | 14.44 | None | ||
![]() | 2X2I_B_QPSB1060_1 (ALPHA-1,4-GLUCANLYASE ISOZYME 1) | 2ghw | ANTI-SCFV ANTIBODY,80R (Homosapiens) | 5 / 10 | PHE B 29SER B 30SER B 31GLY B 26ALA B 24 | 1.40A | 13.22 | None | ||
![]() | 6GNG_B_QPSB601_3 (-) | 2ghw | ANTI-SCFV ANTIBODY,80R (Homosapiens) | 3 / 3 | ASP D 182ASP D 99ASN D 57 | 1.22A | 16.61 | None | ||
![]() | 1DED_A_QPSA1001_1 (CYCLODEXTRINGLUCANOTRANSFERASE) | 2ghw | ANTI-SCFV ANTIBODY,80R (Homosapiens) | 5 / 12 | LEU B 179LEU B 205ASP B 214GLU B 213ASP B 192 | 1.67A | 17.49 | None | ||
![]() | 2X2I_A_QPSA1060_1 (ALPHA-1,4-GLUCANLYASE ISOZYME 1) | 2ghw | ANTI-SCFV ANTIBODY,80R (Homosapiens) | 5 / 12 | PHE B 29SER B 30SER B 31GLY B 26ALA B 24 | 1.31A | 13.22 | None | ||
![]() | 2X2I_B_QPSB1050_2 (ALPHA-1,4-GLUCANLYASE ISOZYME 1) | 2ghw | ANTI-SCFV ANTIBODY,80RSPIKE GLYCOPROTEIN (Homosapiens;SARSr-CoV) | 4 / 6 | PHE C 483TYR C 481ARG D 223THR C 431 | 1.79A | 11.12 | None | ||
![]() | 6GNG_A_QPSA601_1 (-) | 2ghw | ANTI-SCFV ANTIBODY,80R (Homosapiens) | 5 / 12 | GLY D 148LEU D 210VAL D 238ASP D 192ASP D 214 | 1.50A | 16.61 | None | ||
![]() | 2XFF_A_QPSA600_1 (BETA-AMYLASE) | 2ghw | ANTI-SCFV ANTIBODY,80RSPIKE GLYCOPROTEIN (Homosapiens;SARSr-CoV) | 5 / 12 | TYR B 103GLN B 222SER B 101HIS B 35THR A 487 | 1.74A | 18.54 | None | ||
![]() | 1DED_B_QPSB1501_1 (CYCLODEXTRINGLUCANOTRANSFERASE) | 2gib | NUCLEOCAPSID PROTEIN (SARSr-CoV) | 5 / 12 | HIS B 301TYR B 299PHE B 364HIS B 357ASP B 289 | 1.72A | 10.23 | None | ||
![]() | 6GNF_A_QPSA602_1 (-) | 2gri | NSP3 (SARSr-CoV) | 5 / 12 | VAL A 62ASP A 93ASN A 37ARG A 23GLU A 38 | 1.54A | 13.21 | None | ||
![]() | 6GNG_B_QPSB601_2 (-) | 2gt8 | 3C-LIKE PROTEINASE (SARSr-CoV) | 5 / 12 | GLY A 143LEU A 141GLY A 15PRO A 99PRO A 39 | 1.52A | 18.44 | None | ||
![]() | 2X2I_A_QPSA1050_2 (ALPHA-1,4-GLUCANLYASE ISOZYME 1) | 2h85 | PUTATIVE ORF1ABPOLYPROTEIN (SARSr-CoV) | 4 / 6 | VAL A 5TRP A 58TRP A 86THR A 83 | 1.66A | 15.48 | None | ||
![]() | 6GNF_C_QPSC602_2 (-) | 2idy | NSP3 (SARSr-CoV) | 5 / 12 | VAL A 62ASP A 93ASN A 37ARG A 23GLU A 38 | 1.61A | 13.21 | None | ||
![]() | 1DED_A_QPSA1001_1 (CYCLODEXTRINGLUCANOTRANSFERASE) | 2k87 | NSP3 OF REPLICASEPOLYPROTEIN 1A (SARSr) | 5 / 12 | HIS A 69LEU A 58LEU A 80ASP A 66ARG A 68 | 1.46A | 12.25 | None | ||
![]() | 2X2I_C_QPSC1050_2 (ALPHA-1,4-GLUCANLYASE ISOZYME 1) | 2k87 | NSP3 OF REPLICASEPOLYPROTEIN 1A (SARSr-CoV) | 4 / 5 | LEU A 105PHE A 98ARG A 106TRP A 103 | 1.62A | 7.30 | None | ||
![]() | 6GNG_A_QPSA601_2 (-) | 2kqv | NSP3 (SARSr-CoV) | 5 / 12 | GLU A 20HIS A 17VAL A 82GLU A 79PRO A 80 | 1.61A | 16.47 | None | ||
![]() | 2X2I_B_QPSB1060_1 (ALPHA-1,4-GLUCANLYASE ISOZYME 1) | 2ofz | NUCLEOCAPSID PROTEIN (SARS-COVTor2) | 5 / 10 | THR A 136VAL A 73ASN A 141GLY A 138GLN A 84 | 1.72A | 9.02 | None | ||
![]() | 2X2I_D_QPSD1060_1 (ALPHA-1,4-GLUCANLYASE ISOZYME 1) | 2ofz | NUCLEOCAPSID PROTEIN (SARS-COVTor2) | 5 / 10 | THR A 136VAL A 73ASN A 141GLY A 138GLN A 84 | 1.66A | 9.02 | None | ||
![]() | 2X2I_B_QPSB1060_1 (ALPHA-1,4-GLUCANLYASE ISOZYME 1) | 2ozk | URIDYLATE-SPECIFICENDORIBONUCLEASE (SARSr-CoV) | 5 / 10 | PHE C 123SER C 117GLY C 100ALA C 81GLN C 130 | 1.42A | 15.98 | None | ||
![]() | 2X2I_A_QPSA1060_1 (ALPHA-1,4-GLUCANLYASE ISOZYME 1) | 2ozk | URIDYLATE-SPECIFICENDORIBONUCLEASE (SARSr-CoV) | 5 / 12 | PHE C 123SER C 117GLY C 100ALA C 81GLN C 130 | 1.42A | 15.98 | None | ||
![]() | 6GNG_B_QPSB601_2 (-) | 2q6g | REPLICASEPOLYPROTEIN 1AB (SARS-COVBJ01) | 5 / 12 | GLU A 14GLY A 124LEU A 115GLY A 71ASN A 28 | 1.53A | 18.95 | None | ||
![]() | 6GNF_C_QPSC602_2 (-) | 2qc2 | 3C-LIKE PROTEINASE (-) | 5 / 12 | HIS B 163ASN B 133GLN B 192PRO B 184GLY B 195 | 1.79A | 21.39 | None | ||
![]() | 6GNF_A_QPSA602_1 (-) | 2qc2 | 3C-LIKE PROTEINASE (-) | 5 / 12 | HIS B 163ASN B 133GLN B 192PRO B 184GLY B 195 | 1.78A | 21.39 | None | ||
![]() | 6GNG_A_QPSA601_1 (-) | 2rhb | URIDYLATE-SPECIFICENDORIBONUCLEASE (SARSr-CoV) | 5 / 12 | THR E 120GLY E 140LEU E 122ASP F 36HIS E 95 | 1.39A | 21.07 | None | ||
![]() | 2X2I_A_QPSA1050_2 (ALPHA-1,4-GLUCANLYASE ISOZYME 1) | 2rhb | URIDYLATE-SPECIFICENDORIBONUCLEASE (SARSr-CoV) | 4 / 6 | VAL B 5TRP B 58TRP B 86THR B 83 | 1.75A | 15.86 | None | ||
![]() | 2X2I_D_QPSD1060_1 (ALPHA-1,4-GLUCANLYASE ISOZYME 1) | 2rhb | URIDYLATE-SPECIFICENDORIBONUCLEASE (SARSr-CoV) | 5 / 10 | THR A 33VAL A 10SER C 273ASN C 73GLY A 37 | 1.69A | 15.86 | None | ||
![]() | 6GNG_B_QPSB601_2 (-) | 2vj1 | MAIN PROTEINASE (SARSr-CoV) | 5 / 12 | GLY B 143LEU B 141GLY B 15PRO B 99PRO B 39 | 1.54A | 19.81 | XP1 B1304 (-3.8A)NoneNoneNoneNone | ||
![]() | 6GNG_A_QPSA601_2 (-) | 2xyv | NSP10PUTATIVE 2'-O-METHYLTRANSFERASE (SARSr-CoV) | 5 / 12 | TRP A 88PRO A 62GLU B 60PRO B 59GLY B 50 | 1.77A | 18.56 | None | ||
![]() | 6GNG_A_QPSA601_1 (-) | 2z3c | REPLICASEPOLYPROTEIN 1AB(PP1AB) (SARSr-CoV;syntheticconstruct) | 5 / 12 | LEU B 310VAL B 308THR A 24GLY A 23ASP A 187 | 1.45A | 2.86 | Z3E B 309 ( 4.1A)Z3E B 309 ( 2.8A)NoneNoneNone | ||
![]() | 6GNG_B_QPSB601_2 (-) | 3atw | 3C-LIKE PROTEINASE (SARSr-CoV) | 5 / 12 | GLY A 146GLY A 29LEU A 30GLY A 138PRO A 122 | 1.54A | 18.44 | None | ||
![]() | 6GNG_B_QPSB601_1 (-) | 3aw1 | 3C-LIKE PROTEINASE (SARSr-CoV) | 5 / 12 | VAL B 157TYR B 182TYR B 161VAL B 13CYH B 16 | 1.76A | 18.44 | None | ||
![]() | 6GNF_C_QPSC602_2 (-) | 3d0g | ACE2SPIKE GLYCOPROTEIN (Pagumalarvata;Homosapiens;SARSr-CoV) | 5 / 12 | VAL E 388ASP E 393GLN A 37GLU A 38GLY E 482 | 1.79A | 15.52 | None | ||
![]() | 6GNF_A_QPSA602_1 (-) | 3d0g | ACE2SPIKE GLYCOPROTEIN (Pagumalarvata;Homosapiens;SARSr-CoV) | 5 / 12 | VAL E 388ASP E 393GLN A 37GLU A 38GLY E 482 | 1.76A | 15.52 | None | ||
![]() | 1DED_A_QPSA1001_1 (CYCLODEXTRINGLUCANOTRANSFERASE) | 3d0g | ACE2 (Pagumalarvata;Homosapiens;SARSr-CoV) | 5 / 12 | LEU B 418LEU B 423ASP B 292ASP B 367ASP B 368 | 1.52A | 21.80 | None | ||
![]() | 4BQF_B_QPSB951_1 (ALPHA-GLUCANPHOSPHORYLASE 2,CYTOSOLIC) | 3d0g | ACE2 (Pagumalarvata;Homosapiens;SARSr-CoV) | 4 / 8 | MET B 123GLU B 181GLU B 182ARG B 115 | 1.68A | 21.82 | None | ||
![]() | 6GNG_B_QPSB601_1 (-) | 3d0h | ACE2 (Pagumalarvata;Homosapiens;SARSr-CoV) | 5 / 12 | VAL B 404TRP B 349HIS B 401GLU B 398GLY B 399 | 1.74A | 20.24 | None | ||
![]() | 6GNG_A_QPSA601_2 (-) | 3d0h | ACE2 (Pagumalarvata;Homosapiens;SARSr-CoV) | 5 / 12 | GLU B 375TRP B 349HIS B 401GLU B 398GLY B 399 | 1.72A | 20.24 | ZN B 901 (-3.3A)NoneNoneNoneNone | ||
![]() | 1DED_B_QPSB1501_1 (CYCLODEXTRINGLUCANOTRANSFERASE) | 3d0h | ACE2 (Pagumalarvata;Homosapiens;SARSr-CoV) | 5 / 12 | TYR A 183LEU A 179ARG A 460ALA A 501PHE A 504 | 1.09A | 21.80 | None | ||
![]() | 2X2I_A_QPSA1060_1 (ALPHA-1,4-GLUCANLYASE ISOZYME 1) | 3d0h | ACE2 (Pagumalarvata;Homosapiens;SARSr-CoV) | 5 / 12 | VAL B 506SER B 128THR B 129VAL B 172GLY B 173 | 1.42A | 19.75 | None | ||
![]() | 2X2I_A_QPSA1050_2 (ALPHA-1,4-GLUCANLYASE ISOZYME 1) | 3d0i | ACE2 (Pagumalarvata;Homosapiens;SARSr-CoV) | 4 / 6 | TRP B 349MET B 332TRP B 48THR B 55 | 1.68A | 19.75 | None | ||
![]() | 6GNG_B_QPSB601_3 (-) | 3d0i | ACE2 (Pagumalarvata;Homosapiens;SARSr-CoV) | 3 / 3 | ASP B 509ASP B 206ASN B 210 | 1.08A | 20.24 | None | ||
![]() | 6GNG_B_QPSB601_2 (-) | 3d62 | 3C-LIKE PROTEINASE (SARSr-CoV) | 5 / 12 | GLU A 166GLY A 124HIS A 163ASN A 142PRO A 122 | 1.55A | 19.11 | None | ||
![]() | 6GNG_B_QPSB601_1 (-) | 3d62 | 3C-LIKE PROTEINASE (SARSr-CoV) | 5 / 12 | VAL A 157TYR A 182TYR A 161VAL A 13CYH A 16 | 1.78A | 19.11 | None | ||
![]() | 6GNG_B_QPSB601_2 (-) | 3e91 | 3C-LIKE PROTEINASE (SARSr-CoV) | 5 / 12 | GLU B 14GLY B 124LEU B 115GLY B 71ASN B 28 | 1.57A | 19.12 | None | ||
![]() | 6GNG_B_QPSB601_1 (-) | 3eaj | 3C-LIKE PROTEINASE (SARSr-CoV) | 5 / 12 | VAL A 157TYR A 182TYR A 161VAL A 13CYH A 16 | 1.75A | 19.29 | None | ||
![]() | 6GNG_B_QPSB601_2 (-) | 3eaj | 3C-LIKE PROTEINASE (SARSr-CoV) | 5 / 12 | GLY B 251GLY A 179HIS A 134GLU A 178PRO B 293 | 1.43A | 19.29 | None | ||
![]() | 2X2I_B_QPSB1060_1 (ALPHA-1,4-GLUCANLYASE ISOZYME 1) | 3ee7 | REPLICASEPOLYPROTEIN 1A (SARSr-CoV) | 5 / 10 | PHE C 56SER C 13ASN C 27GLY C 17ALA C 54 | 1.38A | 8.39 | None | ||
![]() | 2X2I_A_QPSA1060_1 (ALPHA-1,4-GLUCANLYASE ISOZYME 1) | 3ee7 | REPLICASEPOLYPROTEIN 1A (SARSr-CoV) | 5 / 12 | PHE C 56SER C 13ASN C 27GLY C 17ALA C 54 | 1.39A | 8.39 | None | ||
![]() | 6GNG_B_QPSB601_2 (-) | 3f9f | 3C-LIKE PROTEINASE (SARSr-CoV) | 5 / 12 | GLY B 2GLY B 283LEU B 282GLY A 124ARG B 4 | 1.58A | 18.64 | None | ||
![]() | 6GNG_B_QPSB601_2 (-) | 3f9g | 3C-LIKE PROTEINASE (SARSr-CoV) | 5 / 12 | GLY A 2GLY A 283LEU A 282GLY B 124ARG A 4 | 1.20A | 18.27 | None | ||
![]() | 2X2I_B_QPSB1060_1 (ALPHA-1,4-GLUCANLYASE ISOZYME 1) | 3fzd | 3C-LIKE PROTEINASE (SARSr-CoV) | 5 / 10 | THR A 26SER A 123GLY A 146ALA A 28GLN A 19 | 1.70A | 14.85 | None | ||
![]() | 6GNF_A_QPSA602_1 (-) | 3fzd | 3C-LIKE PROTEINASE (SARSr-CoV) | 5 / 12 | ASP A 153ASN A 151PHE A 8GLN A 127GLY A 109 | 1.66A | 20.99 | None | ||
![]() | 4BQF_B_QPSB951_1 (ALPHA-GLUCANPHOSPHORYLASE 2,CYTOSOLIC) | 3i6g | HLA, A-2MEMBRANE PROTEIN (Homosapiens) | 4 / 8 | ARG D 131ARG D 157GLU A 166LYS C 0 | 1.66A | 15.49 | None | ||
![]() | 1DED_A_QPSA1001_2 (CYCLODEXTRINGLUCANOTRANSFERASE) | 3i6k | HLA, A-2 (Homosapiens) | 5 / 9 | TYR E 27HIS E 3ASP E 102ARG E 181PHE E 208 | 1.80A | 16.93 | None | ||
![]() | 2X2I_B_QPSB1060_1 (ALPHA-1,4-GLUCANLYASE ISOZYME 1) | 3i6k | BETA-2-MICROGLOBULINHLA, A-2 (Homosapiens) | 5 / 10 | THR A 94PHE B 56SER B 57GLY A 120GLN A 96 | 1.66A | 15.32 | None | ||
![]() | 6GNG_A_QPSA601_1 (-) | 3i6k | HLA, A-2 (Homosapiens) | 5 / 12 | THR E 80GLY E 79LEU E 78THR E 142GLN E 87 | 1.47A | 17.75 | None | ||
![]() | 2X2I_A_QPSA1050_2 (ALPHA-1,4-GLUCANLYASE ISOZYME 1) | 3i6k | BETA-2-MICROGLOBULINHLA, A-2 (Homosapiens) | 4 / 6 | VAL A 194MET B 99ARG A 202THR A 228 | 1.57A | 15.32 | None | ||
![]() | 2X2I_B_QPSB1060_1 (ALPHA-1,4-GLUCANLYASE ISOZYME 1) | 3i6l | BETA-2-MICROGLOBULINHLA, A-24 (Homosapiens) | 5 / 10 | VAL E 85SER D 92SER D 13GLY D 120GLN E 2 | 1.56A | 7.13 | None | ||
![]() | 2X2I_D_QPSD1060_1 (ALPHA-1,4-GLUCANLYASE ISOZYME 1) | 3i6l | BETA-2-MICROGLOBULINHLA, A-24 (Homosapiens) | 5 / 10 | VAL E 85SER D 92SER D 13GLY D 120GLN E 2 | 1.51A | 7.13 | None | ||
![]() | 6GNG_B_QPSB601_1 (-) | 3iwm | 3C-LIKE PROTEINASE (SARSr-CoV) | 5 / 12 | VAL D 157TYR D 182TYR D 161VAL D 13CYH D 16 | 1.73A | 18.78 | None | ||
![]() | 2X2I_B_QPSB1060_1 (ALPHA-1,4-GLUCANLYASE ISOZYME 1) | 3m3t | 3C-LIKE PROTEINASE (SARSr-CoV) | 5 / 10 | THR A 190VAL A 186PHE A 185ALA A 193GLN A 192 | 1.61A | 15.28 | None | ||
![]() | 6GNG_B_QPSB601_2 (-) | 3m3v | 3C-LIKE PROTEINASE (SARSr-CoV) | 5 / 12 | GLY B 2GLY A 124HIS A 163ASN A 142PRO A 122 | 1.55A | 18.97 | None | ||
![]() | 2X2I_B_QPSB1050_1 (ALPHA-1,4-GLUCANLYASE ISOZYME 1) | 3mj5 | REPLICASEPOLYPROTEIN 1A (SARSr-CoV) | 5 / 12 | VAL B 117ASN B 263ASP B 303MET B 244HIS B 172 | 1.65A | 14.95 | None | ||
![]() | 2X2I_C_QPSC1050_1 (ALPHA-1,4-GLUCANLYASE ISOZYME 1) | 3mj5 | REPLICASEPOLYPROTEIN 1A (SARSr-CoV) | 5 / 12 | VAL B 117ASN B 263ASP B 303MET B 244HIS B 172 | 1.71A | 14.95 | None | ||
![]() | 2X2I_D_QPSD1050_1 (ALPHA-1,4-GLUCANLYASE ISOZYME 1) | 3mj5 | REPLICASEPOLYPROTEIN 1A (SARSr-CoV) | 5 / 12 | VAL B 117ASN B 263ASP B 303MET B 244HIS B 172 | 1.71A | 14.95 | None | ||
![]() | 6GNG_B_QPSB601_1 (-) | 3mj5 | REPLICASEPOLYPROTEIN 1A (SARSr-CoV) | 5 / 12 | THR B 275TRP B 94PRO B 97CYH A 227GLY A 228 | 1.65A | 18.27 | NoneNoneNone ZN A 901 (-2.4A)None | ||
![]() | 6GNG_B_QPSB601_3 (-) | 3sci | ACE2SPIKE GLYCOPROTEIN (Homosapiens;SARSr-CoV) | 3 / 3 | ASP E 393ASP A 30ASN A 90 | 1.27A | 14.85 | None | ||
![]() | 6GNG_A_QPSA601_2 (-) | 3sci | ACE2 (Homosapiens) | 5 / 12 | GLU B 398GLY B 205PRO B 500ARG B 204GLU B 197 | 1.62A | 20.18 | None | ||
![]() | 4BQF_B_QPSB951_1 (ALPHA-GLUCANPHOSPHORYLASE 2,CYTOSOLIC) | 3sci | ACE2 (Homosapiens) | 4 / 8 | MET A 123GLU A 181GLU A 182ARG A 115 | 1.60A | 22.24 | None | ||
![]() | 6GNF_A_QPSA602_2 (-) | 3sci | ACE2SPIKE GLYCOPROTEIN (Homosapiens;SARSr-CoV) | 5 / 9 | THR E 487GLY E 488GLY E 490VAL E 394GLU A 37 | 1.56A | 17.83 | None | ||
![]() | 2X2I_A_QPSA1060_1 (ALPHA-1,4-GLUCANLYASE ISOZYME 1) | 3sci | ACE2 (Homosapiens) | 5 / 12 | VAL B 506SER B 128THR B 129VAL B 172GLY B 173 | 1.45A | 19.27 | None | ||
![]() | 2X2I_A_QPSA1050_2 (ALPHA-1,4-GLUCANLYASE ISOZYME 1) | 3scj | ACE2 (Homosapiens) | 4 / 6 | TRP A 349MET A 332TRP A 48THR A 55 | 1.78A | 19.27 | None | ||
![]() | 6GNF_A_QPSA602_2 (-) | 3scj | ACE2SPIKE GLYCOPROTEIN (Homosapiens;SARSr-CoV) | 5 / 9 | THR E 487GLY E 488GLY E 490VAL E 394GLU A 37 | 1.66A | 14.92 | None | ||
![]() | 2X2I_A_QPSA1050_1 (ALPHA-1,4-GLUCANLYASE ISOZYME 1) | 3sck | ACE2 (Pagumalarvata;Homosapiens;SARSr-CoV) | 5 / 12 | ASP B 367LEU B 370ASN B 290TYR B 279ASP B 292 | 1.79A | 19.01 | None | ||
![]() | 2X2I_A_QPSA1050_2 (ALPHA-1,4-GLUCANLYASE ISOZYME 1) | 3sck | ACE2 (Pagumalarvata;Homosapiens;SARSr-CoV) | 4 / 6 | TRP B 349MET B 332TRP B 48THR B 55 | 1.69A | 19.01 | None | ||
![]() | 6GNG_A_QPSA601_2 (-) | 3sck | ACE2 (Pagumalarvata;Homosapiens;SARSr-CoV) | 5 / 12 | GLU A 467GLY A 466TRP A 461PRO A 451VAL A 184 | 1.74A | 20.03 | None | ||
![]() | 1DED_B_QPSB1501_1 (CYCLODEXTRINGLUCANOTRANSFERASE) | 3sck | ACE2 (Pagumalarvata;Homosapiens;SARSr-CoV) | 5 / 12 | TYR B 183LEU B 179ARG B 460ALA B 501PHE B 504 | 1.09A | 21.62 | None | ||
![]() | 6GNG_B_QPSB601_3 (-) | 3sck | ACE2 (Pagumalarvata;Homosapiens;SARSr-CoV) | 3 / 3 | ASP A 509ASP A 206ASN A 210 | 1.10A | 20.03 | None | ||
![]() | 1DED_A_QPSA1001_1 (CYCLODEXTRINGLUCANOTRANSFERASE) | 3sck | ACE2 (Pagumalarvata;Homosapiens;SARSr-CoV) | 5 / 12 | LEU A 418LEU A 423ASP A 292ASP A 367ASP A 368 | 1.57A | 21.62 | None | ||
![]() | 6GNG_B_QPSB601_1 (-) | 3sck | ACE2 (Pagumalarvata;Homosapiens;SARSr-CoV) | 5 / 12 | THR A 282HIS A 241PRO A 590VAL A 485GLY A 272 | 1.74A | 20.03 | None | ||
![]() | 2X2I_A_QPSA1060_1 (ALPHA-1,4-GLUCANLYASE ISOZYME 1) | 3scl | ACE2 (Pagumalarvata;Homosapiens;SARSr-CoV) | 5 / 12 | VAL B 506SER B 128THR B 129VAL B 172GLY B 173 | 1.45A | 19.01 | None | ||
![]() | 4BQF_B_QPSB951_1 (ALPHA-GLUCANPHOSPHORYLASE 2,CYTOSOLIC) | 3scl | ACE2 (Pagumalarvata;Homosapiens;SARSr-CoV) | 4 / 8 | TRP A 473GLU A 182GLU A 181ARG A 177 | 1.71A | 21.54 | None | ||
![]() | 6GNF_C_QPSC602_2 (-) | 3sna | 3C-LIKE PROTEINASE (SARSr-CoV) | 5 / 12 | HIS A 163ASN A 133GLN A 192PRO A 184GLY A 195 | 1.70A | 20.80 | ECC H 5 ( 4.1A)NoneNoneNoneNone | ||
![]() | 6GNF_A_QPSA602_1 (-) | 3sna | 3C-LIKE PROTEINASE (SARSr-CoV) | 5 / 12 | HIS A 163ASN A 133GLN A 192PRO A 184GLY A 195 | 1.69A | 20.80 | ECC H 5 ( 4.1A)NoneNoneNoneNone | ||
![]() | 6GNG_B_QPSB601_1 (-) | 3sna | 3C-LIKE PROTEINASE (SARSr-CoV) | 5 / 12 | VAL A 157TYR A 182TYR A 161VAL A 13CYH A 16 | 1.76A | 18.41 | None | ||
![]() | 2XFF_A_QPSA600_1 (BETA-AMYLASE) | 4hi3 | 3C-LIKE PROTEINASE (SARSr-CoV) | 5 / 12 | ALA B 298TYR A 118PHE A 140SER A 123GLY A 124 | 1.60A | 19.67 | None | ||
![]() | 1DED_A_QPSA1001_1 (CYCLODEXTRINGLUCANOTRANSFERASE) | 4m0w | REPLICASEPOLYPROTEIN 1A (SARSr-CoV) | 5 / 12 | LEU A 81LEU A 59ALA A 69GLU A 68HIS A 18 | 1.39A | 18.95 | NoneNoneNoneNoneGOL A 405 (-3.9A) | ||
![]() | 6GNG_B_QPSB601_2 (-) | 4ovz | PAPAIN-LIKEPROTEINASE (SARS-COVUrbani) | 5 / 12 | GLY B 100GLY B 101LEU B 102GLY B 257HIS B 276 | 1.63A | 18.27 | None | ||
![]() | 6GNG_A_QPSA601_1 (-) | 4ow0 | PAPAIN-LIKE PROTEASE (SARS-COVUrbani) | 5 / 12 | THR A 201GLY A 202THR A 198ASN A 178GLN A 238 | 1.46A | 18.27 | NoneNoneGOL A 904 ( 3.4A)DMS A 905 (-3.1A)None | ||
![]() | 1DED_A_QPSA1001_1 (CYCLODEXTRINGLUCANOTRANSFERASE) | 4ow0 | PAPAIN-LIKE PROTEASE (SARS-COVUrbani) | 5 / 12 | LEU A 81LEU A 59ALA A 69GLU A 68HIS A 18 | 1.22A | 18.97 | None | ||
![]() | 6GNG_B_QPSB601_3 (-) | 4rna | PAPAIN-LIKE PROTEASE (Humanbetacoronavirus2cEMC/2012) | 3 / 3 | ASP A 144ASP A 121ASN A 267 | 1.25A | 20.23 | None | ||
![]() | 6GNF_A_QPSA602_1 (-) | 4tww | 3C-LIKE PROTEINASE (SARSr-CoV) | 5 / 12 | HIS B 163ASN B 133GLN B 192PRO B 184GLY B 195 | 1.74A | 21.25 | 3A7 B 401 (-4.0A)NoneNoneNoneNone | ||
![]() | 6GNF_C_QPSC602_2 (-) | 4tww | 3C-LIKE PROTEINASE (SARSr-CoV) | 5 / 12 | HIS B 163ASN B 133GLN B 192PRO B 184GLY B 195 | 1.75A | 21.25 | 3A7 B 401 (-4.0A)NoneNoneNoneNone | ||
![]() | 6GNG_B_QPSB601_3 (-) | 5c8s | GUANINE-N7METHYLTRANSFERASE (SARSr-CoV) | 3 / 3 | ASP D 415ASP D 390ASN D 438 | 0.94A | 21.49 | None | ||
![]() | 6GNF_C_QPSC602_2 (-) | 5c8s | NSP10 (SARSr-CoV) | 5 / 12 | VAL A 97ARG A 78GLU A 6PRO A 107GLY A 109 | 1.69A | 14.36 | None | ||
![]() | 2X2I_B_QPSB1050_1 (ALPHA-1,4-GLUCANLYASE ISOZYME 1) | 5c8s | GUANINE-N7METHYLTRANSFERASE (SARSr-CoV) | 5 / 12 | VAL B 91ASP B 273PHE B 146HIS B 148HIS B 95 | 1.79A | 19.90 | None | ||
![]() | 2X2I_D_QPSD1050_1 (ALPHA-1,4-GLUCANLYASE ISOZYME 1) | 5c8s | GUANINE-N7METHYLTRANSFERASE (SARSr-CoV) | 5 / 12 | VAL B 91ASP B 273PHE B 146HIS B 148HIS B 95 | 1.72A | 19.90 | None | ||
![]() | 6GNF_C_QPSC602_1 (-) | 5c8t | GUANINE-N7METHYLTRANSFERASE (SARSr-CoV) | 5 / 10 | GLY D 416SER D 507HIS D 427PHE D 401VAL D 282 | 1.78A | 21.61 | None | ||
![]() | 6GNF_C_QPSC602_2 (-) | 5c8t | GUANINE-N7METHYLTRANSFERASE (SARSr-CoV) | 5 / 12 | ASP D 358ASN D 334GLN D 354PRO D 355GLY D 333 | 1.79A | 21.61 | NoneSAM D 605 ( 4.7A)NoneNoneSAM D 605 (-3.6A) | ||
![]() | 6GNG_B_QPSB601_3 (-) | 5c8t | GUANINE-N7METHYLTRANSFERASE (SARSr-CoV) | 3 / 3 | ASP D 415ASP D 390ASN D 438 | 0.91A | 21.49 | None | ||
![]() | 6GNG_A_QPSA601_1 (-) | 5c8t | NSP10 (SARSr-CoV) | 5 / 12 | LEU C 14VAL C 13GLY C 2HIS C 80ASN C 40 | 1.27A | 12.27 | None | ||
![]() | 2X2I_D_QPSD1050_1 (ALPHA-1,4-GLUCANLYASE ISOZYME 1) | 5c8t | GUANINE-N7METHYLTRANSFERASE (SARSr-CoV) | 5 / 12 | VAL B 91ASP B 273PHE B 146HIS B 148HIS B 95 | 1.76A | 19.90 | None | ||
![]() | 6GNG_A_QPSA601_2 (-) | 5c8t | GUANINE-N7METHYLTRANSFERASE (SARSr-CoV) | 5 / 12 | GLU B 191GLY B 189TYR B 197PRO B 158GLY B 59 | 1.55A | 21.49 | MG B 604 (-2.2A)NoneNoneNoneNone | ||
![]() | 2X2I_A_QPSA1060_1 (ALPHA-1,4-GLUCANLYASE ISOZYME 1) | 5c8u | NSP10 (SARSr-CoV) | 5 / 12 | THR C 111VAL C 97PHE C 68THR C 102GLY C 109 | 1.42A | 8.91 | None | ||
![]() | 2X2I_B_QPSB1060_1 (ALPHA-1,4-GLUCANLYASE ISOZYME 1) | 5c8u | GUANINE-N7METHYLTRANSFERASE (SARSr-CoV) | 5 / 10 | THR D 113VAL D 115SER D 194GLY D 88ALA D 274 | 1.71A | 19.90 | None | ||
![]() | 6GNG_B_QPSB601_2 (-) | 5c8u | GUANINE-N7METHYLTRANSFERASENSP10 (SARSr-CoV) | 5 / 12 | GLY D 6LEU D 7HIS C 80ASN C 10PRO D 20 | 1.51A | 21.49 | None | ||
![]() | 6GNG_B_QPSB601_2 (-) | 5c8u | NSP10 (SARSr-CoV) | 5 / 12 | GLY A 69GLY A 70LEU A 92GLY A 50PRO A 107 | 1.57A | 12.27 | None | ||
![]() | 6GNG_B_QPSB601_1 (-) | 5e6j | POLYUBIQUITIN-BREPLICASEPOLYPROTEIN 1AB (SARSr-CoV;syntheticconstruct) | 5 / 12 | THR A 10VAL A 42THR F 12HIS A 51GLY A 39 | 1.72A | 18.09 | None | ||
![]() | 1DED_A_QPSA1001_1 (CYCLODEXTRINGLUCANOTRANSFERASE) | 5e6j | REPLICASEPOLYPROTEIN 1AB (SARSr-CoV) | 5 / 12 | LEU D 81LEU D 59ALA D 69GLU D 68HIS D 18 | 1.37A | 18.83 | None | ||
![]() | 2X2I_D_QPSD1060_1 (ALPHA-1,4-GLUCANLYASE ISOZYME 1) | 5e6j | REPLICASEPOLYPROTEIN 1AB (SARSr-CoV) | 5 / 10 | THR A 278SER A 115VAL A 99GLY A 100GLN A 123 | 1.68A | 14.85 | None | ||
![]() | 6GNG_A_QPSA601_2 (-) | 5nfy | POLYPROTEIN 1AB (SARS-COVFrankfurt1) | 5 / 12 | GLU A 191GLY A 189TYR A 197PRO A 158GLY A 59 | 1.51A | 22.41 | None | ||
![]() | 6GNG_A_QPSA601_1 (-) | 5nfy | POLYPROTEIN 1AB (SARS-COVFrankfurt1) | 5 / 12 | THR A 428GLY A 417LEU A 419VAL A 282GLY A 505 | 1.50A | 22.41 | None | ||
![]() | 6GNG_A_QPSA601_1 (-) | 5nfy | POLYPROTEIN 1AB (SARS-COVFrankfurt1) | 5 / 12 | LEU N 14VAL N 13GLY N 2HIS N 80ASN N 40 | 1.28A | 13.47 | None | ||
![]() | 2X2I_B_QPSB1060_1 (ALPHA-1,4-GLUCANLYASE ISOZYME 1) | 5nfy | POLYPROTEIN 1AB (SARS-COVFrankfurt1) | 5 / 10 | THR M 111PHE M 68SER M 67ASN M 62ALA M 104 | 1.64A | 8.89 | None | ||
![]() | 6GNF_C_QPSC602_2 (-) | 5nfy | POLYPROTEIN 1AB (SARS-COVFrankfurt1) | 5 / 12 | VAL M 97ARG M 78GLU M 6PRO M 107GLY M 109 | 1.78A | 14.50 | None | ||
![]() | 6GNG_B_QPSB601_1 (-) | 5r7z | 3C-LIKE PROTEINASE (SARS-CoV-2) | 5 / 12 | VAL A 157TYR A 182TYR A 161VAL A 13CYH A 16 | 1.76A | 18.86 | None | ||
![]() | 6GNG_B_QPSB601_1 (-) | 5rfc | 3C-LIKE PROTEINASE (SARS-CoV-2) | 5 / 12 | VAL A 157TYR A 182TYR A 161VAL A 13CYH A 16 | 1.77A | 13.74 | None | ||
![]() | 6GNG_A_QPSA601_1 (-) | 5rfc | 3C-LIKE PROTEINASE (SARS-CoV-2) | 5 / 12 | GLY A 143LEU A 27VAL A 20GLY A 170HIS A 41 | 1.56A | 13.74 | None | ||
![]() | 6GNG_A_QPSA601_2 (-) | 5tl6 | REPLICASEPOLYPROTEIN 1ABUBIQUITIN-LIKEPROTEIN ISG15 (Homosapiens;SARSr-CoV) | 5 / 12 | GLU C 115GLY C 91TYR C 96PRO C 81PRO D 224 | 1.76A | 7.68 | None | ||
![]() | 1DED_A_QPSA1001_1 (CYCLODEXTRINGLUCANOTRANSFERASE) | 5tl6 | REPLICASEPOLYPROTEIN 1AB (SARSr-CoV) | 5 / 12 | LEU B 81LEU B 59ALA B 69GLU B 68HIS B 18 | 1.19A | 18.97 | None | ||
![]() | 6GNG_B_QPSB601_2 (-) | 5tl7 | REPLICASEPOLYPROTEIN 1ABUBIQUITIN-LIKEPROTEIN ISG15 (Musmusculus;SARSr-CoV) | 5 / 12 | GLY B 164GLY A 154LEU B 163GLY B 39ASN B 111 | 1.59A | 18.60 | NoneAYE A 155 ( 2.4A)AYE A 155 ( 4.3A)NoneNone | ||
![]() | 6GNG_B_QPSB601_2 (-) | 5tl7 | REPLICASEPOLYPROTEIN 1ABUBIQUITIN-LIKEPROTEIN ISG15 (Musmusculus;SARSr-CoV) | 5 / 12 | GLY C 136LEU C 135GLY C 126GLU D 204PRO C 142 | 1.36A | 8.17 | None | ||
![]() | 2X2I_A_QPSA1060_1 (ALPHA-1,4-GLUCANLYASE ISOZYME 1) | 5wrg | SPIKE GLYCOPROTEIN (SARSr-CoV) | 5 / 12 | VAL A 581THR A 678GLY A 653ALA A 633GLN A 599 | 1.48A | 21.88 | None | ||
![]() | 6GNG_A_QPSA601_1 (-) | 5wrg | SPIKE GLYCOPROTEIN (SARSr-CoV) | 5 / 12 | GLY C 634VAL C 628THR A 841GLY A 839ASP A 719 | 1.34A | 19.90 | None | ||
![]() | 6GNG_B_QPSB601_3 (-) | 5wrg | SPIKE GLYCOPROTEIN (SARSr-CoV) | 3 / 3 | ASP C 454ASP C 407ASN A 357 | 1.10A | 19.90 | None | ||
![]() | 6GNG_B_QPSB601_1 (-) | 5x4r | S PROTEIN (MERS-CoV) | 5 / 12 | THR A 289VAL A 153THR A 259PRO A 320VAL A 109 | 1.40A | 18.34 | None | ||
![]() | 2XFF_A_QPSA600_1 (BETA-AMYLASE) | 5x4r | S PROTEIN (MERS-CoV) | 5 / 12 | ALA A 92ARG A 307SER A 302HIS A 298THR A 209 | 1.58A | 21.24 | None | ||
![]() | 6GNG_A_QPSA601_2 (-) | 5x4s | SPIKE GLYCOPROTEIN (SARSr-CoV) | 5 / 12 | GLU A 184GLY A 199TYR A 88TYR A 41PRO A 259 | 1.80A | 18.65 | None | ||
![]() | 2X2I_D_QPSD1060_1 (ALPHA-1,4-GLUCANLYASE ISOZYME 1) | 5x58 | SPIKE GLYCOPROTEIN (SARS-COVBJ01) | 5 / 10 | THR B 92VAL B 205SER B 211SER B 36VAL B 66 | 1.73A | 22.92 | None | ||
![]() | 6GNG_B_QPSB601_3 (-) | 5x58 | SPIKE GLYCOPROTEIN (SARS-COVBJ01) | 3 / 3 | ASP B 85ASP A 415ASN B 951 | 1.01A | 18.81 | None | ||
![]() | 6GNG_B_QPSB601_2 (-) | 5x59 | S PROTEIN (MERS-CoV) | 5 / 12 | GLY C 613GLY A 61ASN C 637PRO A 59GLN C 636 | 1.46A | 18.23 | None | ||
![]() | 2XFF_A_QPSA600_1 (BETA-AMYLASE) | 5x59 | S PROTEIN (MERS-CoV) | 5 / 12 | ALA B 92ARG B 307SER B 302HIS B 298THR B 209 | 1.57A | 17.33 | None | ||
![]() | 2X2I_B_QPSB1060_1 (ALPHA-1,4-GLUCANLYASE ISOZYME 1) | 5x5b | SPIKE GLYCOPROTEIN (SARS-COVBJ01) | 5 / 10 | VAL A1015PHE A1034SER A 798GLY A 862ALA A 864 | 1.64A | 22.92 | None | ||
![]() | 6GNF_C_QPSC602_2 (-) | 5x5b | SPIKE GLYCOPROTEIN (SARS-COVBJ01) | 5 / 12 | VAL A 958ASP C 554ASN A 838ASN A 960GLY A 726 | 1.78A | 19.12 | None | ||
![]() | 6GNG_B_QPSB601_1 (-) | 5x5b | SPIKE GLYCOPROTEIN (SARS-COVBJ01) | 5 / 12 | THR C 616VAL C 606THR A 729VAL C 601GLY C 580 | 1.64A | 18.81 | None | ||
![]() | 6GNF_A_QPSA602_1 (-) | 5x5b | SPIKE GLYCOPROTEIN (SARS-COVBJ01) | 5 / 12 | VAL A 958ASP C 554ASN A 838ASN A 960GLY A 726 | 1.79A | 19.12 | None | ||
![]() | 6GNG_A_QPSA601_1 (-) | 5x5b | SPIKE GLYCOPROTEIN (SARS-COVBJ01) | 5 / 12 | GLY A 634VAL A 628THR B 841GLY B 839ASP B 719 | 1.40A | 18.81 | None | ||
![]() | 6GNG_B_QPSB601_2 (-) | 5x5b | SPIKE GLYCOPROTEIN (SARS-COVBJ01) | 5 / 12 | GLY C 580GLY C 579GLY C 298PRO C 586PRO C 617 | 1.54A | 18.81 | None | ||
![]() | 6GNG_A_QPSA601_2 (-) | 5x5b | SPIKE GLYCOPROTEIN (SARS-COVBJ01) | 5 / 12 | GLU C 970GLY B 368VAL B 420PRO B 399GLY B 418 | 1.79A | 18.81 | None | ||
![]() | 2X2I_A_QPSA1060_1 (ALPHA-1,4-GLUCANLYASE ISOZYME 1) | 5x5b | SPIKE GLYCOPROTEIN (SARS-COVBJ01) | 5 / 12 | VAL B 328SER B 500ASN B 381VAL B 510ALA B 350 | 1.38A | 22.92 | None | ||
![]() | 6GNF_C_QPSC602_2 (-) | 5x5c | S PROTEIN (MERS-CoV) | 5 / 12 | VAL B 50ASP B 664HIS B 348ASN B 342GLY B 79 | 1.67A | 17.01 | None | ||
![]() | 6GNG_A_QPSA601_1 (-) | 5x5c | S PROTEIN (MERS-CoV) | 6 / 12 | GLY B 613LEU B 651VAL B 616GLY B 578ASP B 580ASN B 637 | 1.73A | 18.23 | None | ||
![]() | 6GNF_A_QPSA602_1 (-) | 5x5c | S PROTEIN (MERS-CoV) | 5 / 12 | VAL B 50ASP B 664HIS B 348ASN B 342GLY B 79 | 1.67A | 17.01 | None | ||
![]() | 6GNG_B_QPSB601_1 (-) | 5x5f | S PROTEIN (MERS-CoV) | 5 / 12 | THR C 289VAL C 153THR C 259PRO C 320VAL C 109 | 1.41A | 18.23 | None | ||
![]() | 2X2I_B_QPSB1060_1 (ALPHA-1,4-GLUCANLYASE ISOZYME 1) | 5xlr | SPIKE GLYCOPROTEIN (SARSr-CoV) | 5 / 10 | THR B 559VAL B 562SER B 516ASN B 528GLY B 534 | 1.58A | 21.88 | THR B 559 ( 0.8A)VAL B 562 ( 0.6A)SER B 516 ( 0.0A)ASN B 528 ( 0.6A)GLY B 534 ( 0.0A) | ||
![]() | 6GNG_A_QPSA601_2 (-) | 5xlr | SPIKE GLYCOPROTEIN (SARSr-CoV) | 5 / 12 | GLU B 184GLY B 199TYR B 88TYR B 41PRO B 259 | 1.78A | 19.90 | GLU B 184 ( 0.5A)GLY B 199 ( 0.0A)TYR B 88 ( 1.3A)TYR B 41 ( 1.3A)PRO B 259 ( 1.1A) | ||
![]() | 6GNF_A_QPSA602_1 (-) | 5xlr | SPIKE GLYCOPROTEIN (SARSr-CoV) | 5 / 12 | VAL C 496ASN C 424GLN C 492PRO C 493GLY C 391 | 1.78A | 19.87 | VAL C 496 ( 0.6A)ASN C 424 ( 0.6A)GLN C 492 ( 0.6A)PRO C 493 ( 1.1A)GLY C 391 ( 0.0A) | ||
![]() | 6GNF_C_QPSC602_2 (-) | 5xlr | SPIKE GLYCOPROTEIN (SARSr-CoV) | 5 / 12 | VAL C 496ASN C 424GLN C 492PRO C 493GLY C 391 | 1.79A | 19.87 | VAL C 496 ( 0.6A)ASN C 424 ( 0.6A)GLN C 492 ( 0.6A)PRO C 493 ( 1.1A)GLY C 391 ( 0.0A) | ||
![]() | 2X2I_B_QPSB1050_1 (ALPHA-1,4-GLUCANLYASE ISOZYME 1) | 5y3q | REPLICASEPOLYPROTEIN 1A (SARSr-CoV) | 5 / 12 | VAL A 117ASN A 263ASP A 303MET A 244HIS A 172 | 1.69A | 14.85 | None NA A 404 (-2.6A)NoneNoneNone | ||
![]() | 2X2I_A_QPSA1060_1 (ALPHA-1,4-GLUCANLYASE ISOZYME 1) | 5zvm | PAN-COV INHIBITORYPEPTIDE EK1SPIKE GLYCOPROTEIN (SARSr-CoV;syntheticconstruct) | 5 / 12 | THR A 943ASN a 12VAL a 13ALA A 938GLN A 939 | 1.20A | 6.86 | None | ||
![]() | 2X2I_B_QPSB1060_1 (ALPHA-1,4-GLUCANLYASE ISOZYME 1) | 5zvm | PAN-COV INHIBITORYPEPTIDE EK1SPIKE GLYCOPROTEIN (SARSr-CoV;syntheticconstruct) | 5 / 10 | THR A 943PHE a 15ASN a 12ALA A 938GLN A 939 | 1.69A | 6.86 | None | ||
![]() | 6GNG_A_QPSA601_2 (-) | 6acc | SPIKE GLYCOPROTEIN (SARSr-CoV) | 5 / 12 | GLY B 225TYR C 410ARG C 342PRO C 450GLY B 192 | 1.57A | 19.90 | None | ||
![]() | 2X2I_A_QPSA1050_1 (ALPHA-1,4-GLUCANLYASE ISOZYME 1) | 6acg | SPIKE GLYCOPROTEIN (SARSr-CoV) | 5 / 12 | ASP B 57LEU B 257TYR B 195ASP B 191PHE B 83 | 1.48A | 21.88 | None | ||
![]() | 6GNG_B_QPSB601_1 (-) | 6acg | ACE2 (Homosapiens) | 5 / 12 | THR D 282HIS D 241PRO D 590VAL D 485GLY D 272 | 1.73A | 20.18 | None | ||
![]() | 4BQF_B_QPSB951_1 (ALPHA-GLUCANPHOSPHORYLASE 2,CYTOSOLIC) | 6acg | SPIKE GLYCOPROTEIN (SARSr-CoV) | 4 / 8 | ARG A1001GLU B 999GLU A 999ARG C1001 | 1.77A | 20.88 | None | ||
![]() | 6GNG_B_QPSB601_2 (-) | 6acg | SPIKE GLYCOPROTEIN (SARSr-CoV) | 5 / 12 | GLY C 873LEU C 876GLY C 890ASN A1090PRO A1051 | 1.40A | 19.90 | None | ||
![]() | 2X2I_D_QPSD1060_1 (ALPHA-1,4-GLUCANLYASE ISOZYME 1) | 6acg | SPIKE GLYCOPROTEIN (SARSr-CoV) | 5 / 10 | THR B 92VAL B 205SER B 211SER B 36VAL B 66 | 1.55A | 21.88 | None | ||
![]() | 2X2I_A_QPSA1060_1 (ALPHA-1,4-GLUCANLYASE ISOZYME 1) | 6acg | SPIKE GLYCOPROTEIN (SARSr-CoV) | 5 / 12 | VAL A 382THR A 372ASN A 375GLY A 512ALA A 350 | 1.22A | 21.88 | None | ||
![]() | 2X2I_D_QPSD1050_1 (ALPHA-1,4-GLUCANLYASE ISOZYME 1) | 6acg | SPIKE GLYCOPROTEIN (SARSr-CoV) | 5 / 12 | PHE A 305ASN A 304ASP C 719MET C 722ASP C 727 | 1.70A | 21.88 | None | ||
![]() | 6GNG_B_QPSB601_3 (-) | 6acj | SPIKE GLYCOPROTEIN (SARSr-CoV) | 3 / 3 | ASP B 23ASP B 134ASN B 155 | 1.07A | 19.90 | None | ||
![]() | 2X2I_B_QPSB1060_1 (ALPHA-1,4-GLUCANLYASE ISOZYME 1) | 6acj | SPIKE GLYCOPROTEIN (SARSr-CoV) | 5 / 10 | VAL B1015PHE B1034SER B 798GLY B 862ALA B 864 | 1.48A | 21.88 | None | ||
![]() | 6GNF_C_QPSC602_2 (-) | 6acj | SPIKE GLYCOPROTEIN (SARSr-CoV) | 5 / 12 | VAL A 934ASN A 937ARG C 758GLU C 762GLU A 999 | 1.52A | 19.88 | None | ||
![]() | 6GNG_B_QPSB601_3 (-) | 6acj | ACE2 (Homosapiens) | 3 / 3 | ASP D 509ASP D 206ASN D 210 | 1.10A | 20.18 | None | ||
![]() | 6GNF_A_QPSA602_2 (-) | 6acj | ACE2SPIKE GLYCOPROTEIN (Homosapiens;SARSr-CoV) | 5 / 9 | THR C 487GLY C 488GLY C 490VAL C 394GLU D 37 | 1.59A | 19.88 | None | ||
![]() | 6GNG_A_QPSA601_1 (-) | 6acj | SPIKE GLYCOPROTEIN (SARSr-CoV) | 5 / 12 | VAL B 581THR B 535GLY B 534ASP A 719ASN A 721 | 1.32A | 19.90 | None | ||
![]() | 1DED_B_QPSB1501_1 (CYCLODEXTRINGLUCANOTRANSFERASE) | 6acj | ACE2 (Homosapiens) | 5 / 12 | TYR D 183LEU D 179ARG D 460ALA D 501PHE D 504 | 1.12A | 22.01 | None | ||
![]() | 1DED_A_QPSA1001_1 (CYCLODEXTRINGLUCANOTRANSFERASE) | 6acj | SPIKE GLYCOPROTEIN (SARSr-CoV) | 5 / 12 | LEU C 978LEU C 959ALA C 954ASP A 557ARG A 553 | 1.56A | 20.51 | None | ||
![]() | 6GNF_A_QPSA602_1 (-) | 6ack | SPIKE GLYCOPROTEIN (SARSr-CoV) | 5 / 12 | VAL A 97ASP A 154ASN A 135ARG A 232GLY A 77 | 1.58A | 19.88 | None | ||
![]() | 2XFF_A_QPSA600_1 (BETA-AMYLASE) | 6ack | ACE2 (Homosapiens) | 5 / 12 | ALA D 533PHE D 315SER D 411HIS D 373THR D 414 | 1.64A | 19.76 | None | ||
![]() | 1DED_B_QPSB1501_1 (CYCLODEXTRINGLUCANOTRANSFERASE) | 6ack | SPIKE GLYCOPROTEIN (SARSr-CoV) | 5 / 12 | LEU B 959ARG C 306ASP B 727PHE C 578ASP B 719 | 1.64A | 20.51 | None | ||
![]() | 6GNG_A_QPSA601_1 (-) | 6ack | ACE2 (Homosapiens) | 5 / 12 | THR D 453THR D 517GLY D 399HIS D 505ASN D 277 | 1.46A | 20.18 | None | ||
![]() | 2X2I_A_QPSA1060_1 (ALPHA-1,4-GLUCANLYASE ISOZYME 1) | 6crv | SPIKEGLYCOPROTEIN,FIBRITIN (SARSr-CoV) | 5 / 12 | SER C 607THR C 608VAL C 307ALA C 577GLN A 835 | 1.49A | 23.16 | None | ||
![]() | 6GNG_B_QPSB601_2 (-) | 6crv | SPIKEGLYCOPROTEIN,FIBRITIN (SARSr-CoV) | 5 / 12 | GLY C 580GLY C 579GLY C 298PRO C 586PRO C 617 | 1.63A | 18.39 | None | ||
![]() | 6GNF_C_QPSC602_2 (-) | 6crv | SPIKEGLYCOPROTEIN,FIBRITIN (SARSr-CoV) | 5 / 12 | VAL C 313ASP A 961ASN C 530GLN C 550PRO C 565 | 1.80A | 19.07 | None | ||
![]() | 6GNF_A_QPSA602_1 (-) | 6crv | SPIKEGLYCOPROTEIN,FIBRITIN (SARSr-CoV) | 5 / 12 | HIS C 33ASN C 29GLN C 26PRO C 28GLY C 77 | 1.76A | 19.07 | None | ||
![]() | 2X2I_B_QPSB1060_1 (ALPHA-1,4-GLUCANLYASE ISOZYME 1) | 6crv | SPIKEGLYCOPROTEIN,FIBRITIN (SARSr-CoV) | 5 / 10 | VAL B1015PHE B1034SER B 798GLY B 862ALA B 864 | 1.58A | 23.16 | None | ||
![]() | 6GNG_A_QPSA601_1 (-) | 6crv | SPIKEGLYCOPROTEIN,FIBRITIN (SARSr-CoV) | 5 / 12 | GLY B 634VAL B 628THR C 841GLY C 839ASP C 719 | 1.32A | 18.39 | None | ||
![]() | 2X2I_B_QPSB1060_1 (ALPHA-1,4-GLUCANLYASE ISOZYME 1) | 6crw | SPIKEGLYCOPROTEIN,FIBRITIN (SARSr-CoV) | 5 / 10 | VAL B1015PHE B1034SER B 798GLY B 862ALA B 864 | 1.40A | 23.33 | None | ||
![]() | 2X2I_D_QPSD1060_1 (ALPHA-1,4-GLUCANLYASE ISOZYME 1) | 6crw | SPIKEGLYCOPROTEIN,FIBRITIN (SARSr-CoV) | 5 / 10 | VAL C 328PHE C 329SER C 500ASN C 381VAL C 510 | 1.66A | 23.33 | None | ||
![]() | 6GNG_A_QPSA601_1 (-) | 6crx | SPIKEGLYCOPROTEIN,FIBRITIN (SARSr-CoV) | 5 / 12 | GLY C 634VAL C 628THR A 841GLY A 839ASP A 719 | 1.21A | 19.80 | None | ||
![]() | 6GNG_B_QPSB601_2 (-) | 6crx | SPIKEGLYCOPROTEIN,FIBRITIN (SARSr-CoV) | 5 / 12 | GLY A 580GLY A 579GLY A 298PRO A 586PRO A 617 | 1.57A | 19.80 | None | ||
![]() | 6GNF_C_QPSC602_1 (-) | 6crx | SPIKEGLYCOPROTEIN,FIBRITIN (SARSr-CoV) | 5 / 10 | THR C 716GLY C 820LEU C 840TYR C 989VAL B 555 | 1.65A | 19.72 | None | ||
![]() | 6GNF_C_QPSC602_2 (-) | 6cs0 | SPIKEGLYCOPROTEIN,FIBRITIN (SARSr-CoV) | 5 / 12 | HIS B 149ASN B 155ASN B 109ARG B 126GLU B 162 | 1.37A | 19.72 | None | ||
![]() | 2X2I_A_QPSA1060_1 (ALPHA-1,4-GLUCANLYASE ISOZYME 1) | 6cs1 | SPIKEGLYCOPROTEIN,FIBRITIN (SARSr-CoV) | 5 / 12 | VAL B1111THR B1058ASN B 692ALA C 881GLN C 902 | 1.23A | 23.33 | None | ||
![]() | 2X2I_A_QPSA1050_1 (ALPHA-1,4-GLUCANLYASE ISOZYME 1) | 6cs1 | SPIKEGLYCOPROTEIN,FIBRITIN (SARSr-CoV) | 5 / 12 | GLN C 614PHE C 578ASP A 719ASN A 721PHE C 305 | 1.42A | 23.33 | None | ||
![]() | 6GNF_A_QPSA602_2 (-) | 6cs2 | ACE2SPIKEGLYCOPROTEIN,FIBRITIN (Homosapiens;SARSr-CoV) | 5 / 9 | THR B 487GLY B 488GLY B 490VAL B 394GLU D 37 | 1.68A | 19.72 | None | ||
![]() | 6GNG_B_QPSB601_1 (-) | 6cs2 | SPIKEGLYCOPROTEIN,FIBRITIN (SARSr-CoV) | 5 / 12 | THR B 809VAL B 934HIS B1040PRO B 789GLY B 928 | 1.67A | 19.80 | None | ||
![]() | 1DED_A_QPSA1001_1 (CYCLODEXTRINGLUCANOTRANSFERASE) | 6cs2 | ACE2 (Homosapiens) | 5 / 12 | LEU D 418LEU D 423ASP D 292ASP D 367ASP D 368 | 1.43A | 22.22 | None | ||
![]() | 2X2I_D_QPSD1050_1 (ALPHA-1,4-GLUCANLYASE ISOZYME 1) | 6cs2 | SPIKEGLYCOPROTEIN,FIBRITIN (SARSr-CoV) | 5 / 12 | GLN B1124ASN B1101ASP B1100ASP B1121HIS B1065 | 1.61A | 23.33 | None | ||
![]() | 1DED_A_QPSA2001_1 (CYCLODEXTRINGLUCANOTRANSFERASE) | 6cs2 | ACE2 (Homosapiens) | 4 / 6 | TRP D 163GLY D 147ASN D 134PRO D 146 | 1.36A | 22.22 | None | ||
![]() | 2X2I_C_QPSC1050_1 (ALPHA-1,4-GLUCANLYASE ISOZYME 1) | 6cs2 | SPIKEGLYCOPROTEIN,FIBRITIN (SARSr-CoV) | 5 / 12 | GLN B1124ASN B1101ASP B1100ASP B1121HIS B1065 | 1.60A | 23.33 | None | ||
![]() | 6GNF_A_QPSA602_1 (-) | 6cs2 | SPIKEGLYCOPROTEIN,FIBRITIN (SARSr-CoV) | 5 / 12 | VAL C 525ASP C 600PHE C 578ASN C 526GLY C 534 | 1.66A | 19.72 | None | ||
![]() | 2XFF_A_QPSA600_1 (BETA-AMYLASE) | 6cs2 | ACE2 (Homosapiens) | 5 / 12 | ALA D 533PHE D 315SER D 411HIS D 373THR D 414 | 1.58A | 19.82 | None | ||
![]() | 6GNG_B_QPSB601_3 (-) | 6cs2 | SPIKEGLYCOPROTEIN,FIBRITIN (SARSr-CoV) | 3 / 3 | ASP B 850ASP B 790ASN B 783 | 0.79A | 19.80 | NoneNoneNAG B1316 (-1.8A) | ||
![]() | 6GNG_A_QPSA601_2 (-) | 6cs2 | SPIKEGLYCOPROTEIN,FIBRITIN (SARSr-CoV) | 5 / 12 | GLY C 892TYR A 886TRP A 868PRO A 879PRO C1051 | 1.58A | 19.80 | None | ||
![]() | 2X2I_B_QPSB1050_1 (ALPHA-1,4-GLUCANLYASE ISOZYME 1) | 6cs2 | SPIKEGLYCOPROTEIN,FIBRITIN (SARSr-CoV) | 5 / 12 | GLN B1124ASN B1101ASP B1100ASP B1121HIS B1065 | 1.70A | 23.33 | None | ||
![]() | 2QPU_B_QPSB3000_1 (ALPHA-AMYLASE TYPE AISOZYME) | 6jyt | HELICASE (SARSr-CoV) | 5 / 9 | ASP A 113THR B 137ASP B 105ALA B 134TRP B 114 | 1.69A | 21.21 | None | ||
![]() | 6GNG_A_QPSA601_1 (-) | 6jyt | HELICASE (SARSr-CoV) | 5 / 12 | VAL A 544THR A 440GLY A 439ASN A 562GLN A 404 | 1.44A | 20.71 | None | ||
![]() | 2X2I_D_QPSD1050_1 (ALPHA-1,4-GLUCANLYASE ISOZYME 1) | 6jyt | HELICASE (SARSr-CoV) | 5 / 12 | GLN B 270ASP B 435MET B 436HIS B 245HIS B 395 | 1.78A | 20.06 | None | ||
![]() | 6GNG_B_QPSB601_1 (-) | 6jyt | HELICASE (SARSr-CoV) | 5 / 12 | VAL A 449THR A 532TYR A 541PRO A 529GLY A 285 | 1.59A | 20.71 | None | ||
![]() | 2X2I_B_QPSB1050_1 (ALPHA-1,4-GLUCANLYASE ISOZYME 1) | 6jyt | HELICASE (SARSr-CoV) | 5 / 12 | GLN B 270ASP B 435MET B 436HIS B 245HIS B 395 | 1.73A | 20.06 | None | ||
![]() | 2X2I_D_QPSD1060_1 (ALPHA-1,4-GLUCANLYASE ISOZYME 1) | 6jyt | HELICASE (SARSr-CoV) | 5 / 10 | VAL B 521PHE B 511VAL B 496GLY B 494GLN B 518 | 1.80A | 20.06 | None | ||
![]() | 6GNF_C_QPSC602_2 (-) | 6lu7 | MAIN PROTEASE (SARS-CoV-2) | 5 / 12 | VAL A 261ASP A 197ASN A 203GLN A 110PRO A 293 | 1.80A | 21.52 | None | ||
![]() | 6GNF_C_QPSC602_1 (-) | 6lxt | SPIKE PROTEIN S2 (SARS-CoV-2) | 5 / 10 | THR F 941GLY F 946LEU F 945SER E 939VAL F 952 | 1.57A | 13.46 | None | ||
![]() | 6GNG_B_QPSB601_3 (-) | 6lxt | SPIKE PROTEIN S2 (SARS-CoV-2) | 3 / 3 | ASP D 950ASP D1184ASN D1192 | 0.92A | 10.59 | None | ||
![]() | 6GNG_B_QPSB601_1 (-) | 6lze | VIRAL PROTEASE (SARS-CoV-2) | 5 / 12 | VAL A 157TYR A 182TYR A 161VAL A 13CYH A 16 | 1.77A | 19.09 | None | ||
![]() | 6GNG_A_QPSA601_1 (-) | 6lze | VIRAL PROTEASE (SARS-CoV-2) | 5 / 12 | GLY A 143LEU A 27VAL A 20GLY A 170HIS A 41 | 1.62A | 19.09 | ELL D 3 (-3.6A)NoneNoneNoneALC D 2 ( 4.1A) | ||
![]() | 1DED_A_QPSA1001_1 (CYCLODEXTRINGLUCANOTRANSFERASE) | 6m0j | ACE2 (Homosapiens) | 5 / 12 | LEU A 418LEU A 423ASP A 292ASP A 367ASP A 368 | 1.50A | 22.01 | None | ||
![]() | 6GNG_A_QPSA601_1 (-) | 6m0k | VIRAL PROTEASE (SARS-CoV-2) | 5 / 12 | GLY A 143LEU A 27VAL A 20GLY A 170HIS A 41 | 1.67A | 19.66 | ELL D 3 (-3.6A)NoneNoneNoneN0A D 2 ( 4.0A) | ||
![]() | 6GNG_B_QPSB601_1 (-) | 6m0k | VIRAL PROTEASE (SARS-CoV-2) | 5 / 12 | VAL A 157TYR A 182TYR A 161VAL A 13CYH A 16 | 1.78A | 19.66 | None | ||
![]() | 6GNF_A_QPSA602_1 (-) | 6m17 | RECEPTOR BINDINGDOMAIN (SARS-CoV-2) | 5 / 12 | VAL E 510ASN E 439GLN E 506PRO E 507GLY E 404 | 1.73A | 18.63 | None | ||
![]() | 6GNF_C_QPSC602_2 (-) | 6m17 | RECEPTOR BINDINGDOMAIN (SARS-CoV-2) | 5 / 12 | VAL E 510ASN E 439GLN E 506PRO E 507GLY E 404 | 1.72A | 18.63 | None | ||
![]() | 6GNG_B_QPSB601_2 (-) | 6m17 | SODIUM-DEPENDENTNEUTRAL AMINO ACIDTRANSPORTER B(0)AT1 (Homosapiens) | 5 / 12 | GLU C 89GLY C 284GLY C 285LEU C 286GLY C 490 | 1.27A | 21.08 | None | ||
![]() | 4BQF_B_QPSB951_1 (ALPHA-GLUCANPHOSPHORYLASE 2,CYTOSOLIC) | 6m17 | ACE2 (Homosapiens) | 4 / 8 | MET B 123GLU B 181GLU B 182ARG B 115 | 1.57A | 22.87 | None | ||
![]() | 6GNG_B_QPSB601_3 (-) | 6m17 | SODIUM-DEPENDENTNEUTRAL AMINO ACIDTRANSPORTER B(0)AT1 (Homosapiens) | 3 / 3 | ASP A 564ASP A 164ASN A 158 | 1.04A | 21.08 | NoneNoneNAG A 701 (-2.5A) | ||
![]() | 1DED_A_QPSA1001_1 (CYCLODEXTRINGLUCANOTRANSFERASE) | 6m18 | ACE2 (Homosapiens) | 5 / 12 | LEU D 450TYR D 516GLU D 232HIS D 228ASP D 225 | 1.70A | 22.27 | None | ||
![]() | 6GNG_B_QPSB601_2 (-) | 6m18 | ACE2 (Homosapiens) | 5 / 12 | GLY D 575LEU D 570GLY D 551GLN D 531PRO D 583 | 1.61A | 21.07 | None | ||
![]() | 6GNG_A_QPSA601_2 (-) | 6m1d | ACE2 (Homosapiens) | 5 / 12 | GLU D 310GLY D 422HIS D 417PRO D 346PRO D 415 | 1.73A | 21.07 | None | ||
![]() | 2X2I_A_QPSA1060_1 (ALPHA-1,4-GLUCANLYASE ISOZYME 1) | 6m1d | ACE2 (Homosapiens) | 5 / 12 | SER D 128THR D 129VAL D 172GLY D 173ALA D 501 | 1.44A | 20.83 | None | ||
![]() | 4BQF_B_QPSB951_1 (ALPHA-GLUCANPHOSPHORYLASE 2,CYTOSOLIC) | 6m1d | SODIUM-DEPENDENTNEUTRAL AMINO ACIDTRANSPORTER B(0)AT1 (Homosapiens) | 4 / 8 | ARG A 97ARG A 32GLU A 28GLU A 27 | 1.65A | 20.81 | None | ||
![]() | 6GNG_A_QPSA601_1 (-) | 6m1d | SODIUM-DEPENDENTNEUTRAL AMINO ACIDTRANSPORTER B(0)AT1 (Homosapiens) | 5 / 12 | THR C 396GLY C 395VAL C 55GLY C 478ASN C 54 | 1.18A | 21.08 | None | ||
![]() | 6GNG_B_QPSB601_1 (-) | 6m1d | SODIUM-DEPENDENTNEUTRAL AMINO ACIDTRANSPORTER B(0)AT1 (Homosapiens) | 5 / 12 | THR C 180TYR C 139THR C 396TRP C 150VAL C 163 | 1.61A | 21.08 | None | ||
![]() | 2X2I_D_QPSD1060_1 (ALPHA-1,4-GLUCANLYASE ISOZYME 1) | 6m1d | SODIUM-DEPENDENTNEUTRAL AMINO ACIDTRANSPORTER B(0)AT1 (Homosapiens) | 5 / 10 | THR A 212VAL A 440SER A 288SER A 291TRP A 35 | 1.80A | 20.98 | None | ||
![]() | 2XFF_A_QPSA600_1 (BETA-AMYLASE) | 6m1d | SODIUM-DEPENDENTNEUTRAL AMINO ACIDTRANSPORTER B(0)AT1 (Homosapiens) | 5 / 12 | GLU A 217ARG A 214GLY A 215THR A 219MET A 436 | 1.79A | 22.11 | None | ||
![]() | 2X2I_A_QPSA1050_2 (ALPHA-1,4-GLUCANLYASE ISOZYME 1) | 6m1d | ACE2 (Homosapiens) | 4 / 6 | VAL B 485TRP B 275ARG B 273THR B 519 | 1.65A | 20.83 | None | ||
![]() | 6GNG_A_QPSA601_1 (-) | 6m2n | 3CL PROTEASE (SARS-CoV-2) | 5 / 12 | GLY C 146LEU C 27GLY C 15ASN C 119ASN C 142 | 1.75A | 18.86 | NoneNoneNoneNone3WL C 401 (-4.0A) | ||
![]() | 2X2I_A_QPSA1060_1 (ALPHA-1,4-GLUCANLYASE ISOZYME 1) | 6m2n | 3CL PROTEASE (SARS-CoV-2) | 5 / 12 | VAL C 114PHE C 150SER C 10VAL A 125ALA C 7 | 1.77A | 15.52 | None | ||
![]() | 6GNG_A_QPSA601_1 (-) | 6m2n | 3CL PROTEASE (SARS-CoV-2) | 5 / 12 | GLY D 143LEU D 27VAL D 20GLY D 170HIS D 41 | 1.62A | 18.86 | 3WL D 401 (-3.4A)NoneNoneNone3WL D 401 (-3.9A) | ||
![]() | 6GNG_A_QPSA601_1 (-) | 6m2n | 3CL PROTEASE (SARS-CoV-2) | 5 / 12 | GLY B 143LEU B 27VAL B 20GLY B 170HIS B 41 | 1.73A | 18.86 | 3WL B 401 (-3.4A)NoneNoneNone3WL B 401 (-3.7A) | ||
![]() | 6GNG_A_QPSA601_1 (-) | 6m2n | 3CL PROTEASE (SARS-CoV-2) | 5 / 12 | GLY C 143LEU C 27VAL C 20GLY C 170HIS C 41 | 1.65A | 18.86 | 3WL C 401 (-3.4A)NoneNoneNone3WL C 401 (-3.4A) | ||
![]() | 6GNG_A_QPSA601_1 (-) | 6m2n | 3CL PROTEASE (SARS-CoV-2) | 5 / 12 | THR B 135THR B 169HIS B 163ASN B 180GLN B 192 | 1.49A | 18.86 | None | ||
![]() | 6GNG_A_QPSA601_1 (-) | 6m2n | 3CL PROTEASE (SARS-CoV-2) | 5 / 12 | THR A 135THR A 169HIS A 163ASN A 180GLN A 192 | 1.50A | 18.86 | None | ||
![]() | 6GNG_A_QPSA601_1 (-) | 6m2n | 3CL PROTEASE (SARS-CoV-2) | 5 / 12 | GLY A 143LEU A 27VAL A 20GLY A 170HIS A 41 | 1.71A | 18.86 | 3WL A 401 (-3.3A)NoneNoneNone3WL A 401 (-3.7A) | ||
![]() | 6GNG_A_QPSA601_1 (-) | 6m2n | 3CL PROTEASE (SARS-CoV-2) | 5 / 12 | GLY A 146LEU A 27GLY A 15ASN A 119ASN A 142 | 1.77A | 18.86 | NoneNoneNoneNone3WL A 401 (-3.8A) | ||
![]() | 2X2I_A_QPSA1060_1 (ALPHA-1,4-GLUCANLYASE ISOZYME 1) | 6m2n | 3CL PROTEASE (SARS-CoV-2) | 5 / 12 | VAL D 114PHE D 150SER D 10VAL B 125ALA D 7 | 1.78A | 15.52 | None | ||
![]() | 6GNG_B_QPSB601_1 (-) | 6m2n | 3CL PROTEASE (SARS-CoV-2) | 5 / 12 | VAL B 157TYR B 182TYR B 161VAL B 13CYH B 16 | 1.80A | 18.86 | None | ||
![]() | 6GNG_A_QPSA601_1 (-) | 6m2n | 3CL PROTEASE (SARS-CoV-2) | 5 / 12 | GLY B 146LEU B 27GLY B 15ASN B 119ASN B 142 | 1.77A | 18.86 | NoneNoneNoneNone3WL B 401 (-4.0A) | ||
![]() | 6GNG_B_QPSB601_1 (-) | 6m2q | 3CL PROTEASE (SARS-CoV-2) | 5 / 12 | VAL A 157TYR A 182TYR A 161VAL A 13CYH A 16 | 1.79A | 18.86 | None | ||
![]() | 6GNG_A_QPSA601_1 (-) | 6m2q | 3CL PROTEASE (SARS-CoV-2) | 5 / 12 | GLY A 143LEU A 27VAL A 20GLY A 170HIS A 41 | 1.68A | 18.86 | None | ||
![]() | 6GNG_B_QPSB601_3 (-) | 6m3m | NUCLEOCAPSID PROTEIN (SARS-CoV-2) | 3 / 3 | ASP C 104ASP C 64ASN C 127 | 1.12A | 12.11 | None | ||
![]() | 2X2I_B_QPSB1060_1 (ALPHA-1,4-GLUCANLYASE ISOZYME 1) | 6m3m | NUCLEOCAPSID PROTEIN (SARS-CoV-2) | 5 / 10 | THR A 136VAL A 73ASN A 141GLY A 138GLN A 84 | 1.78A | 8.70 | None | ||
![]() | 2X2I_D_QPSD1060_1 (ALPHA-1,4-GLUCANLYASE ISOZYME 1) | 6m3m | NUCLEOCAPSID PROTEIN (SARS-CoV-2) | 5 / 10 | THR C 136VAL C 73ASN C 141GLY C 138GLN C 84 | 1.67A | 8.70 | None | ||
![]() | 6GNG_A_QPSA601_1 (-) | 6m71 | NSP12 (SARS-CoV-2) | 5 / 12 | THR A 148LEU A 212VAL A 182ASP A 211ASN A 213 | 1.79A | 20.04 | None | ||
![]() | 6GNF_C_QPSC602_1 (-) | 6m71 | NSP12 (SARS-CoV-2) | 5 / 10 | THR A 680GLY A 678LEU A 663PHE A 694VAL A 315 | 1.50A | 20.61 | None | ||
![]() | 2X2I_C_QPSC1060_1 (ALPHA-1,4-GLUCANLYASE ISOZYME 1) | 6m71 | NSP12NSP7 (SARS-CoV-2) | 5 / 12 | VAL A 424PHE A 429SER C 4THR C 45GLY A 432 | 1.77A | 21.79 | None | ||
![]() | 6GNG_A_QPSA601_1 (-) | 6m71 | NSP12 (SARS-CoV-2) | 5 / 12 | LEU A 758VAL A 588THR A 680ASP A 761ASN A 695 | 1.80A | 20.04 | None | ||
![]() | 6GNG_A_QPSA601_1 (-) | 6m71 | NSP12 (SARS-CoV-2) | 5 / 12 | LEU A 758VAL A 588GLY A 679ASP A 623ASN A 695 | 1.71A | 20.04 | None | ||
![]() | 2X2I_C_QPSC1060_1 (ALPHA-1,4-GLUCANLYASE ISOZYME 1) | 6m71 | NSP12 (SARS-CoV-2) | 5 / 12 | THR A 710PHE A 745ASN A 767VAL A 776GLY A 774 | 1.77A | 21.79 | None | ||
![]() | 2X2I_A_QPSA1060_1 (ALPHA-1,4-GLUCANLYASE ISOZYME 1) | 6m71 | NSP12 (SARS-CoV-2) | 5 / 12 | THR A 710PHE A 745ASN A 767VAL A 776GLY A 774 | 1.75A | 21.79 | None | ||
![]() | 1DED_A_QPSA1001_1 (CYCLODEXTRINGLUCANOTRANSFERASE) | 6m71 | NSP12NSP8 (SARS-CoV-2) | 5 / 12 | LEU A 387TYR B 149LEU B 122ALA A 399ASP A 390 | 1.76A | 21.74 | None | ||
![]() | 6GNG_A_QPSA601_1 (-) | 6m71 | NSP12 (SARS-CoV-2) | 5 / 12 | GLY A 179LEU A 178ASP A 170ASN A 150ASN A 213 | 1.61A | 20.04 | None | ||
![]() | 2X2I_D_QPSD1060_1 (ALPHA-1,4-GLUCANLYASE ISOZYME 1) | 6m71 | NSP12 (SARS-CoV-2) | 5 / 10 | THR A 710PHE A 745ASN A 767VAL A 776GLY A 774 | 1.73A | 21.79 | None | ||
![]() | 6GNG_B_QPSB601_1 (-) | 6nb6 | SPIKE GLYCOPROTEIN (SARSr-CoV) | 5 / 12 | THR B 616VAL B 606THR A 729VAL B 601GLY B 580 | 1.73A | 19.15 | None | ||
![]() | 6GNG_B_QPSB601_3 (-) | 6nb6 | SPIKE GLYCOPROTEIN (SARSr-CoV) | 3 / 3 | ASP C 312ASP B 727ASN C 304 | 1.28A | 19.15 | None | ||
![]() | 6GNF_C_QPSC602_2 (-) | 6nb6 | SPIKE GLYCOPROTEIN (SARSr-CoV) | 5 / 12 | ASP A 376ASP A 312ASN A 526GLU C 730PRO A 309 | 1.56A | 19.53 | None | ||
![]() | 6GNG_A_QPSA601_1 (-) | 6nb6 | SPIKE GLYCOPROTEIN (SARSr-CoV) | 5 / 12 | VAL A 581THR A 535GLY A 534ASP C 719ASN C 721 | 1.35A | 19.15 | None | ||
![]() | 4BQF_B_QPSB951_1 (ALPHA-GLUCANPHOSPHORYLASE 2,CYTOSOLIC) | 6nb6 | SPIKE GLYCOPROTEIN (SARSr-CoV) | 4 / 8 | ARG B 758ARG B1001GLU B 755LYS B 715 | 1.45A | 20.86 | None | ||
![]() | 6GNF_A_QPSA602_1 (-) | 6nb6 | SPIKE GLYCOPROTEIN (SARSr-CoV) | 5 / 12 | VAL C 990ASP C 727ASN C 746GLN A 301GLY C 751 | 1.59A | 19.53 | None | ||
![]() | 6GNG_B_QPSB601_2 (-) | 6nb7 | SPIKE GLYCOPROTEIN (SARSr-CoV) | 5 / 12 | GLY C 751LEU C 749PRO A 617GLU A 285ARG C 747 | 1.41A | 19.15 | None | ||
![]() | 2X2I_A_QPSA1060_1 (ALPHA-1,4-GLUCANLYASE ISOZYME 1) | 6nb7 | SPIKE GLYCOPROTEIN (SARSr-CoV) | 5 / 12 | VAL A1015PHE A1034SER A 798GLY A 862ALA A 864 | 1.52A | 22.96 | None | ||
![]() | 2X2I_B_QPSB1060_1 (ALPHA-1,4-GLUCANLYASE ISOZYME 1) | 6nb7 | SPIKE GLYCOPROTEIN (SARSr-CoV) | 5 / 10 | VAL A1015PHE A1034SER A 798GLY A 862ALA A 864 | 1.41A | 22.96 | None | ||
![]() | 2X2I_D_QPSD1060_1 (ALPHA-1,4-GLUCANLYASE ISOZYME 1) | 6nb8 | S230 ANTIGEN-BINDING(FAB) FRAGMENT,HEAVY CHAINS230 ANTIGEN-BINDING(FAB) FRAGMENT,LIGHT CHAIN (Homosapiens) | 5 / 10 | VAL H 166SER H 193SER L 181ASN L 142GLY H 176 | 1.73A | 13.17 | None | ||
![]() | 2X2I_B_QPSB1060_1 (ALPHA-1,4-GLUCANLYASE ISOZYME 1) | 6nb8 | S230 ANTIGEN-BINDING(FAB) FRAGMENT,HEAVY CHAINS230 ANTIGEN-BINDING(FAB) FRAGMENT,LIGHT CHAIN (Homosapiens) | 5 / 10 | VAL H 166SER H 193SER L 181ASN L 142GLY H 176 | 1.66A | 13.17 | None | ||
![]() | 6GNF_C_QPSC602_1 (-) | 6nb8 | S230 ANTIGEN-BINDING(FAB) FRAGMENT,LIGHT CHAIN (Homosapiens) | 5 / 10 | THR L 77GLY L 69LEU L 78SER L 25VAL L 63 | 1.66A | 17.82 | None | ||
![]() | 6GNG_B_QPSB601_1 (-) | 6nb8 | S230 ANTIGEN-BINDING(FAB) FRAGMENT,HEAVY CHAINS230 ANTIGEN-BINDING(FAB) FRAGMENT,LIGHT CHAIN (Homosapiens) | 5 / 12 | VAL H 221THR H 121PRO L 45VAL H 135GLY H 132 | 1.67A | 17.24 | None | ||
![]() | 2XFF_A_QPSA600_1 (BETA-AMYLASE) | 6nur | NSP12 (SARSr-CoV) | 5 / 12 | ALA A 253ARG A 183TYR A 286PHE A 287THR A 248 | 1.75A | 19.45 | None | ||
![]() | 6GNG_B_QPSB601_1 (-) | 6nur | NSP12 (SARSr-CoV) | 5 / 12 | THR A 611VAL A 605VAL A 763GLU A 802GLY A 808 | 1.55A | 20.43 | None | ||
![]() | 6GNF_C_QPSC602_1 (-) | 6nus | NSP12 (SARSr-CoV) | 5 / 10 | THR A 680GLY A 678LEU A 663PHE A 694VAL A 315 | 1.51A | 20.37 | None | ||
![]() | 6GNF_C_QPSC602_2 (-) | 6vsb | SPIKE GLYCOPROTEIN (SARS-CoV-2) | 5 / 12 | VAL B1068HIS B1064GLU C1031GLN C 784GLY C 889 | 1.77A | 18.54 | None | ||
![]() | 2X2I_A_QPSA1050_1 (ALPHA-1,4-GLUCANLYASE ISOZYME 1) | 6vsb | SPIKE GLYCOPROTEIN (SARS-CoV-2) | 5 / 12 | ASP B1139LEU B1141GLN B1142ASP C1139ASP C1118 | 1.75A | 22.69 | None | ||
![]() | 2X2I_A_QPSA1060_1 (ALPHA-1,4-GLUCANLYASE ISOZYME 1) | 6vsb | SPIKE GLYCOPROTEIN (SARS-CoV-2) | 5 / 12 | VAL B 130PHE B 168SER A 359THR A 393GLY B 199 | 1.39A | 22.69 | None | ||
![]() | 6GNG_A_QPSA601_1 (-) | 6vsb | SPIKE GLYCOPROTEIN (SARS-CoV-2) | 5 / 12 | GLY A 889LEU A1034VAL A 785GLY A 908GLN A 901 | 1.51A | 18.66 | None | ||
![]() | 6GNF_A_QPSA602_2 (-) | 6vsb | SPIKE GLYCOPROTEIN (SARS-CoV-2) | 5 / 9 | THR C 778GLY C1059HIS C1058VAL C 952GLU C 773 | 1.64A | 18.54 | None | ||
![]() | 6GNG_B_QPSB601_3 (-) | 6vw1 | ACE2SPIKE GLYCOPROTEIN (Homosapiens;SARS-CoV-2) | 3 / 3 | ASP F 406ASP B 30ASN B 90 | 1.28A | 15.28 | NoneNoneNAG B 701 (-1.9A) | ||
![]() | 4BQF_B_QPSB951_1 (ALPHA-GLUCANPHOSPHORYLASE 2,CYTOSOLIC) | 6vw1 | ACE2 (Homosapiens) | 4 / 8 | MET A 123GLU A 181GLU A 182ARG A 115 | 1.65A | 22.39 | None | ||
![]() | 2X2I_A_QPSA1050_2 (ALPHA-1,4-GLUCANLYASE ISOZYME 1) | 6vw1 | ACE2 (Homosapiens) | 4 / 6 | TRP B 349MET B 332TRP B 48THR B 55 | 1.72A | 20.00 | None | ||
![]() | 2X2I_A_QPSA1060_1 (ALPHA-1,4-GLUCANLYASE ISOZYME 1) | 6vw1 | SPIKE GLYCOPROTEIN (SARS-CoV-2) | 5 / 12 | VAL F 367PHE F 338ASN F 334VAL F 362ALA F 363 | 1.33A | 12.74 | NAG F 602 (-4.5A)NoneNoneNoneNone | ||
![]() | 1DED_A_QPSA1001_1 (CYCLODEXTRINGLUCANOTRANSFERASE) | 6vw1 | ACE2 (Homosapiens) | 5 / 12 | LEU A 418LEU A 423ASP A 292ASP A 367ASP A 368 | 1.47A | 22.19 | None | ||
![]() | 2X2I_A_QPSA1050_2 (ALPHA-1,4-GLUCANLYASE ISOZYME 1) | 6vww | URIDYLATE-SPECIFICENDORIBONUCLEASE (SARS-CoV-2) | 4 / 6 | VAL A 6TRP A 59TRP A 87THR A 84 | 1.79A | 16.78 | NoneGOL A 401 ( 4.6A)NoneNone | ||
![]() | 6GNG_B_QPSB601_2 (-) | 6vww | URIDYLATE-SPECIFICENDORIBONUCLEASE (SARS-CoV-2) | 5 / 12 | LEU A 298GLU A 203ARG A 207GLN A 160PRO A 158 | 1.43A | 21.59 | None | ||
![]() | 2X2I_C_QPSC1060_1 (ALPHA-1,4-GLUCANLYASE ISOZYME 1) | 6vxs | NSP3 (SARS-CoV-2) | 5 / 12 | PHE B 132SER B 128SER B 139VAL B 95GLY B 79 | 1.57A | None | |||
![]() | 6GNG_B_QPSB601_2 (-) | 6vxs | NSP3 (SARS-CoV-2) | 5 / 12 | GLY B 47GLY B 46HIS B 94ASN B 54PRO B 32 | 1.53A | None | |||
![]() | 6GNG_A_QPSA601_1 (-) | 6vxs | NSP3 (SARS-CoV-2) | 5 / 12 | GLY B 51LEU B 53VAL B 24THR A 71HIS B 94 | 1.79A | None | |||
![]() | 2X2I_D_QPSD1060_1 (ALPHA-1,4-GLUCANLYASE ISOZYME 1) | 6vxs | NSP3 (SARS-CoV-2) | 5 / 10 | PHE B 132SER B 128SER B 139VAL B 95GLY B 79 | 1.54A | None | |||
![]() | 2X2I_D_QPSD1060_1 (ALPHA-1,4-GLUCANLYASE ISOZYME 1) | 6vxs | NSP3 (SARS-CoV-2) | 5 / 10 | PHE A 132SER A 128SER A 139VAL A 95GLY A 79 | 1.57A | NoneNoneNoneNoneSO4 A 201 ( 4.8A) | |||
![]() | 2X2I_C_QPSC1060_1 (ALPHA-1,4-GLUCANLYASE ISOZYME 1) | 6vxs | NSP3 (SARS-CoV-2) | 5 / 12 | THR A 71SER B 65ASN B 59GLY B 46ALA B 50 | 1.66A | None | |||
![]() | 6GNG_B_QPSB601_2 (-) | 6vxs | NSP3 (SARS-CoV-2) | 5 / 12 | GLY A 47GLY A 46HIS A 94ASN A 54PRO A 32 | 1.49A | None | |||
![]() | 2X2I_A_QPSA1060_1 (ALPHA-1,4-GLUCANLYASE ISOZYME 1) | 6vxs | NSP3 (SARS-CoV-2) | 5 / 12 | PHE B 132SER B 128SER B 139VAL B 95GLY B 79 | 1.53A | None | |||
![]() | 2X2I_A_QPSA1060_1 (ALPHA-1,4-GLUCANLYASE ISOZYME 1) | 6vxs | NSP3 (SARS-CoV-2) | 5 / 12 | THR A 71SER B 65ASN B 59GLY B 46ALA B 50 | 1.64A | None | |||
![]() | 2X2I_A_QPSA1060_1 (ALPHA-1,4-GLUCANLYASE ISOZYME 1) | 6vxs | NSP3 (SARS-CoV-2) | 5 / 12 | PHE B 132SER B 128ASN B 115VAL B 95ALA B 39 | 1.78A | None | |||
![]() | 2X2I_A_QPSA1060_1 (ALPHA-1,4-GLUCANLYASE ISOZYME 1) | 6vxs | NSP3 (SARS-CoV-2) | 5 / 12 | THR B 146VAL B 142SER B 128VAL B 95ALA B 112 | 1.78A | None | |||
![]() | 6GNG_A_QPSA601_1 (-) | 6vxs | NSP3 (SARS-CoV-2) | 5 / 12 | LEU B 53VAL B 35THR A 71ASN B 54GLN B 62 | 1.70A | None | |||
![]() | 2X2I_A_QPSA1060_1 (ALPHA-1,4-GLUCANLYASE ISOZYME 1) | 6vxs | NSP3 (SARS-CoV-2) | 5 / 12 | PHE A 132SER A 128SER A 139VAL A 95GLY A 79 | 1.54A | NoneNoneNoneNoneSO4 A 201 ( 4.8A) | |||
![]() | 2X2I_B_QPSB1060_1 (ALPHA-1,4-GLUCANLYASE ISOZYME 1) | 6vxs | NSP3 (SARS-CoV-2) | 5 / 10 | THR A 71SER B 65ASN B 59GLY B 46ALA B 50 | 1.65A | None | |||
![]() | 2X2I_C_QPSC1060_1 (ALPHA-1,4-GLUCANLYASE ISOZYME 1) | 6vxs | NSP3 (SARS-CoV-2) | 5 / 12 | THR B 146VAL B 142SER B 128VAL B 95ALA B 112 | 1.78A | None | |||
![]() | 2X2I_C_QPSC1060_1 (ALPHA-1,4-GLUCANLYASE ISOZYME 1) | 6vxs | NSP3 (SARS-CoV-2) | 5 / 12 | PHE A 132SER A 128SER A 139VAL A 95GLY A 79 | 1.58A | NoneNoneNoneNoneSO4 A 201 ( 4.8A) | |||
![]() | 6GNG_B_QPSB601_3 (-) | 6vxx | SPIKE GLYCOPROTEIN (SARS-CoV-2) | 3 / 3 | ASP A 775ASP A 867ASN A 824 | 1.12A | 18.77 | None | ||
![]() | 2X2I_B_QPSB1050_1 (ALPHA-1,4-GLUCANLYASE ISOZYME 1) | 6vxx | SPIKE GLYCOPROTEIN (SARS-CoV-2) | 5 / 12 | ASP A1139LEU A1141GLN A1142ASP C1118ASP A1118 | 1.61A | 22.09 | None | ||
![]() | 2X2I_A_QPSA1050_1 (ALPHA-1,4-GLUCANLYASE ISOZYME 1) | 6vxx | SPIKE GLYCOPROTEIN (SARS-CoV-2) | 5 / 12 | ASP A1139LEU A1141GLN A1142ASP C1118ASP A1118 | 1.58A | 22.09 | None | ||
![]() | 6GNG_A_QPSA601_1 (-) | 6vxx | SPIKE GLYCOPROTEIN (SARS-CoV-2) | 5 / 12 | GLY A 889LEU A1034VAL A 785GLY A 908GLN A 901 | 1.46A | 18.77 | None | ||
![]() | 2X2I_A_QPSA1060_1 (ALPHA-1,4-GLUCANLYASE ISOZYME 1) | 6vxx | SPIKE GLYCOPROTEIN (SARS-CoV-2) | 5 / 12 | PHE C1095SER C1097THR C1076ASN C 710GLY C1131 | 1.55A | 22.09 | NoneNoneNoneNoneNAG C1311 (-3.3A) | ||
![]() | 6GNF_C_QPSC602_2 (-) | 6vxx | SPIKE GLYCOPROTEIN (SARS-CoV-2) | 5 / 12 | ASP B 405ASN C 439ASN C 448PRO C 499GLY C 496 | 1.73A | 18.68 | None | ||
![]() | 2X2I_B_QPSB1060_1 (ALPHA-1,4-GLUCANLYASE ISOZYME 1) | 6vxx | SPIKE GLYCOPROTEIN (SARS-CoV-2) | 5 / 10 | PHE C1095SER C1097ASN C 710GLY C1131ALA C1080 | 1.70A | 22.09 | NoneNoneNoneNAG C1311 (-3.3A)None | ||
![]() | 2X2I_B_QPSB1050_1 (ALPHA-1,4-GLUCANLYASE ISOZYME 1) | 6vyb | SPIKE GLYCOPROTEIN (SARS-CoV-2) | 5 / 12 | ASP C1139LEU C1141GLN C1142ASP B1118ASP C1118 | 1.43A | 22.11 | None | ||
![]() | 2X2I_B_QPSB1060_1 (ALPHA-1,4-GLUCANLYASE ISOZYME 1) | 6vyb | SPIKE GLYCOPROTEIN (SARS-CoV-2) | 5 / 10 | VAL C 576PHE C 565ASN A 978GLY C 545GLN C 564 | 1.71A | 22.11 | None | ||
![]() | 6GNG_B_QPSB601_1 (-) | 6vyb | SPIKE GLYCOPROTEIN (SARS-CoV-2) | 5 / 12 | VAL A1040THR A1105TYR B 904PRO A1079GLY B 891 | 1.70A | 18.77 | None | ||
![]() | 2X2I_D_QPSD1060_1 (ALPHA-1,4-GLUCANLYASE ISOZYME 1) | 6vyb | SPIKE GLYCOPROTEIN (SARS-CoV-2) | 5 / 10 | PHE A 592SER A 591ASN A 616VAL A 615GLY A 648 | 1.80A | 22.11 | NoneNoneNAG A1309 (-1.9A)NoneNone | ||
![]() | 6GNG_A_QPSA601_1 (-) | 6vyb | SPIKE GLYCOPROTEIN (SARS-CoV-2) | 5 / 12 | GLY C 889LEU C1034VAL C 785GLY C 908GLN C 901 | 1.48A | 18.77 | None | ||
![]() | 2X2I_A_QPSA1060_1 (ALPHA-1,4-GLUCANLYASE ISOZYME 1) | 6vyb | SPIKE GLYCOPROTEIN (SARS-CoV-2) | 5 / 12 | VAL B 610THR B 618ASN B 616VAL B 615GLY B 648 | 1.49A | 22.11 | NoneNAG B1308 (-3.5A)NAG B1308 (-2.0A)NoneNone | ||
![]() | 6GNG_B_QPSB601_3 (-) | 6vyb | SPIKE GLYCOPROTEIN (SARS-CoV-2) | 3 / 3 | ASP A 364ASP A 389ASN A 540 | 0.89A | 18.77 | None | ||
![]() | 2X2I_A_QPSA1050_1 (ALPHA-1,4-GLUCANLYASE ISOZYME 1) | 6vyb | SPIKE GLYCOPROTEIN (SARS-CoV-2) | 5 / 12 | ASP C1139LEU C1141GLN C1142ASP B1118ASP C1118 | 1.42A | 22.11 | None | ||
![]() | 6GNF_A_QPSA602_2 (-) | 6vyb | SPIKE GLYCOPROTEIN (SARS-CoV-2) | 5 / 9 | THR A 778GLY A1059HIS A1058VAL A 952GLU A 773 | 1.62A | 18.60 | None | ||
![]() | 2X2I_D_QPSD1060_1 (ALPHA-1,4-GLUCANLYASE ISOZYME 1) | 6vyo | NUCLEOPROTEIN (SARS-CoV-2) | 5 / 10 | THR D 135VAL D 72ASN D 140GLY D 137GLN D 83 | 1.76A | 8.68 | NoneNoneNoneNoneGOL D 204 (-3.3A) | ||
![]() | 6GNG_B_QPSB601_3 (-) | 6vyo | NUCLEOPROTEIN (SARS-CoV-2) | 3 / 3 | ASP D 103ASP D 63ASN D 126 | 1.01A | 11.62 | None | ||
![]() | 1DED_A_QPSA1001_1 (CYCLODEXTRINGLUCANOTRANSFERASE) | 6w02 | NSP3 (SARS-CoV-2) | 5 / 12 | LEU B 126LEU B 140ALA B 129ASP B 157ASP B 162 | 1.77A | 14.33 | APR B 201 (-4.8A)NoneAPR B 201 (-3.6A)NoneNone | ||
![]() | 2X2I_A_QPSA1060_1 (ALPHA-1,4-GLUCANLYASE ISOZYME 1) | 6w41 | CR3022 FAB HEAVYCHAINCR3022 FAB LIGHTCHAIN (Homosapiens) | 5 / 12 | VAL H 67PHE H 63SER H 60THR L 94GLY H 35 | 1.56A | 9.18 | None | ||
![]() | 2X2I_A_QPSA1060_1 (ALPHA-1,4-GLUCANLYASE ISOZYME 1) | 6w41 | CR3022 FAB HEAVYCHAINCR3022 FAB LIGHTCHAIN (Homosapiens) | 5 / 12 | PHE L 116SER L 174VAL H 182GLY H 139ALA H 137 | 1.77A | 9.38 | None | ||
![]() | 2X2I_C_QPSC1060_1 (ALPHA-1,4-GLUCANLYASE ISOZYME 1) | 6w41 | CR3022 FAB HEAVYCHAINCR3022 FAB LIGHTCHAIN (Homosapiens) | 5 / 12 | PHE L 116SER L 174VAL H 181GLY H 139ALA H 137 | 1.76A | 9.38 | None | ||
![]() | 2X2I_C_QPSC1060_1 (ALPHA-1,4-GLUCANLYASE ISOZYME 1) | 6w41 | CR3022 FAB HEAVYCHAINCR3022 FAB LIGHTCHAIN (Homosapiens) | 5 / 12 | VAL H 67PHE H 63SER H 60THR L 94GLY H 35 | 1.47A | 9.18 | None | ||
![]() | 2X2I_C_QPSC1060_1 (ALPHA-1,4-GLUCANLYASE ISOZYME 1) | 6w41 | SPIKE PROTEIN S1 (SARS-CoV-2) | 5 / 12 | VAL C 401SER C 443THR C 500ASN C 501GLY C 504 | 1.78A | 10.44 | None | ||
![]() | 2X2I_C_QPSC1060_1 (ALPHA-1,4-GLUCANLYASE ISOZYME 1) | 6w41 | CR3022 FAB HEAVYCHAINCR3022 FAB LIGHTCHAIN (Homosapiens) | 5 / 12 | PHE L 116SER L 174VAL H 182GLY H 139ALA H 137 | 1.80A | 9.38 | None | ||
![]() | 6GNG_A_QPSA601_1 (-) | 6w41 | CR3022 FAB HEAVYCHAINSPIKE PROTEIN S1 (Homosapiens;SARS-CoV-2) | 5 / 12 | LEU C 390GLY H 95ASP H 101ASP C 389ASN C 388 | 1.77A | 15.77 | None | ||
![]() | 2X2I_C_QPSC1060_1 (ALPHA-1,4-GLUCANLYASE ISOZYME 1) | 6w41 | CR3022 FAB HEAVYCHAIN (Homosapiens) | 5 / 12 | THR H 116VAL H 11THR H 151ASN H 199GLY H 118 | 1.63A | 9.18 | None | ||
![]() | 6GNG_A_QPSA601_2 (-) | 6w41 | CR3022 FAB LIGHTCHAIN (Homosapiens) | 5 / 12 | TYR L 173PRO L 40VAL L 196PRO L 113GLY L 200 | 1.77A | 14.43 | None | ||
![]() | 2X2I_A_QPSA1060_1 (ALPHA-1,4-GLUCANLYASE ISOZYME 1) | 6w41 | CR3022 FAB HEAVYCHAIN (Homosapiens) | 5 / 12 | THR H 116VAL H 11THR H 151ASN H 199GLY H 118 | 1.64A | 9.18 | None | ||
![]() | 6GNF_C_QPSC602_1 (-) | 6w41 | CR3022 FAB LIGHTCHAIN (Homosapiens) | 5 / 10 | THR L 72GLY L 64LEU L 73SER L 25VAL L 58 | 1.69A | 17.67 | None | ||
![]() | 2X2I_A_QPSA1060_1 (ALPHA-1,4-GLUCANLYASE ISOZYME 1) | 6w41 | CR3022 FAB LIGHTCHAIN (Homosapiens) | 5 / 12 | VAL L 163PHE L 139SER L 114VAL L 196ALA L 144 | 1.74A | 9.38 | None | ||
![]() | 6GNG_A_QPSA601_2 (-) | 6w4h | NSP10NSP16 (SARS-CoV-2) | 5 / 12 | TRP A6886PRO A6860GLU B4313PRO B4312GLY B4303 | 1.77A | 18.40 | None | ||
![]() | 6GNG_A_QPSA601_1 (-) | 6w61 | 2'-O-METHYLTRANSFERASENSP10 (SARS-CoV-2) | 5 / 12 | GLY B4322VAL A6876THR A6889GLY A6890ASP A6895 | 1.60A | None | |||
![]() | 6GNG_A_QPSA601_2 (-) | 6w61 | 2'-O-METHYLTRANSFERASENSP10 (SARS-CoV-2) | 5 / 12 | TRP A6886PRO A6860GLU B4313PRO B4312GLY B4303 | 1.78A | None | |||
![]() | 6GNG_B_QPSB601_2 (-) | 6w61 | NSP10 (SARS-CoV-2) | 5 / 12 | GLY B4322GLY B4323LEU B4345GLY B4303PRO B4360 | 1.73A | None | |||
![]() | 6GNG_A_QPSA601_1 (-) | 6w61 | 2'-O-METHYLTRANSFERASE (SARS-CoV-2) | 5 / 12 | GLY A6879THR A6891GLY A6890ASP A6906GLN A6885 | 1.77A | SAM A7104 (-3.6A)NoneNoneNoneNone | |||
![]() | 6GNG_B_QPSB601_2 (-) | 6w61 | 2'-O-METHYLTRANSFERASENSP10 (SARS-CoV-2) | 5 / 12 | GLY B4323GLY B4347GLY A6837PRO A6835GLN B4351 | 1.76A | None | |||
![]() | 6GNG_A_QPSA601_1 (-) | 6w63 | 3C-LIKE PROTEINASE (SARS-CoV-2) | 5 / 12 | GLY A 143LEU A 27VAL A 20GLY A 170HIS A 41 | 1.73A | X77 A 401 (-3.6A)X77 A 401 ( 3.9A)NoneNoneX77 A 401 (-3.2A) | |||
![]() | 2X2I_D_QPSD1060_1 (ALPHA-1,4-GLUCANLYASE ISOZYME 1) | 6w6y | NSP3 (SARS-CoV-2) | 5 / 10 | PHE A 132SER A 128SER A 139VAL A 95GLY A 79 | 1.57A | AMP A 201 ( 4.3A)NoneNoneNoneNone | |||
![]() | 2X2I_C_QPSC1060_1 (ALPHA-1,4-GLUCANLYASE ISOZYME 1) | 6w6y | NSP3 (SARS-CoV-2) | 5 / 12 | THR A 146VAL A 142SER A 128VAL A 95ALA A 112 | 1.79A | None | |||
![]() | 2X2I_C_QPSC1060_1 (ALPHA-1,4-GLUCANLYASE ISOZYME 1) | 6w6y | NSP3 (SARS-CoV-2) | 5 / 12 | THR B 146VAL B 142SER B 128VAL B 95ALA B 112 | 1.78A | NoneNoneMES B 201 ( 4.5A)NoneNone | |||
![]() | 2X2I_A_QPSA1060_1 (ALPHA-1,4-GLUCANLYASE ISOZYME 1) | 6w6y | NSP3 (SARS-CoV-2) | 5 / 12 | PHE A 132SER A 128ASN A 115VAL A 95ALA A 39 | 1.76A | AMP A 201 ( 4.3A)NoneNoneNoneNone | |||
![]() | 2X2I_A_QPSA1060_1 (ALPHA-1,4-GLUCANLYASE ISOZYME 1) | 6w6y | NSP3 (SARS-CoV-2) | 5 / 12 | PHE A 132SER A 128SER A 139VAL A 95ALA A 39 | 1.78A | AMP A 201 ( 4.3A)NoneNoneNoneNone | |||
![]() | 2X2I_A_QPSA1060_1 (ALPHA-1,4-GLUCANLYASE ISOZYME 1) | 6w6y | NSP3 (SARS-CoV-2) | 5 / 12 | THR B 146VAL B 142SER B 128VAL B 95ALA B 112 | 1.78A | NoneNoneMES B 201 ( 4.5A)NoneNone | |||
![]() | 2X2I_A_QPSA1060_1 (ALPHA-1,4-GLUCANLYASE ISOZYME 1) | 6w6y | NSP3 (SARS-CoV-2) | 5 / 12 | PHE B 132SER B 128SER B 139VAL B 95GLY B 79 | 1.72A | MES B 201 ( 3.4A)MES B 201 ( 4.5A)NoneNoneNone | |||
![]() | 2X2I_D_QPSD1060_1 (ALPHA-1,4-GLUCANLYASE ISOZYME 1) | 6w6y | NSP3 (SARS-CoV-2) | 5 / 10 | PHE B 132SER B 128SER B 139VAL B 95GLY B 79 | 1.73A | MES B 201 ( 3.4A)MES B 201 ( 4.5A)NoneNoneNone | |||
![]() | 2X2I_C_QPSC1060_1 (ALPHA-1,4-GLUCANLYASE ISOZYME 1) | 6w6y | NSP3 (SARS-CoV-2) | 5 / 12 | PHE A 132SER A 128SER A 139VAL A 95ALA A 39 | 1.80A | AMP A 201 ( 4.3A)NoneNoneNoneNone | |||
![]() | 6GNG_B_QPSB601_2 (-) | 6w6y | NSP3 (SARS-CoV-2) | 5 / 12 | GLY A 47GLY A 46HIS A 94ASN A 54PRO A 32 | 1.59A | None | |||
![]() | 2X2I_C_QPSC1060_1 (ALPHA-1,4-GLUCANLYASE ISOZYME 1) | 6w6y | NSP3 (SARS-CoV-2) | 5 / 12 | PHE B 132SER B 128SER B 139VAL B 95GLY B 79 | 1.73A | MES B 201 ( 3.4A)MES B 201 ( 4.5A)NoneNoneNone | |||
![]() | 2X2I_A_QPSA1060_1 (ALPHA-1,4-GLUCANLYASE ISOZYME 1) | 6w6y | NSP3 (SARS-CoV-2) | 5 / 12 | PHE A 132SER A 128SER A 139VAL A 95GLY A 79 | 1.57A | AMP A 201 ( 4.3A)NoneNoneNoneNone | |||
![]() | 6GNG_B_QPSB601_2 (-) | 6w6y | NSP3 (SARS-CoV-2) | 5 / 12 | GLY B 47GLY B 46HIS B 94ASN B 54PRO B 32 | 1.55A | None | |||
![]() | 2X2I_A_QPSA1060_1 (ALPHA-1,4-GLUCANLYASE ISOZYME 1) | 6w6y | NSP3 (SARS-CoV-2) | 5 / 12 | THR A 146VAL A 142SER A 128VAL A 95ALA A 112 | 1.78A | None | |||
![]() | 1DED_A_QPSA1001_1 (CYCLODEXTRINGLUCANOTRANSFERASE) | 6w6y | NSP3 (SARS-CoV-2) | 5 / 12 | LEU B 126LEU B 140ALA B 129ASP B 157ASP B 162 | 1.78A | None | |||
![]() | 2X2I_C_QPSC1060_1 (ALPHA-1,4-GLUCANLYASE ISOZYME 1) | 6w6y | NSP3 (SARS-CoV-2) | 5 / 12 | PHE A 132SER A 128SER A 139VAL A 95GLY A 79 | 1.61A | AMP A 201 ( 4.3A)NoneNoneNoneNone | |||
![]() | 6GNG_A_QPSA601_1 (-) | 6w75 | NSP16 (SARS-CoV-2) | 5 / 12 | THR A6915LEU A7093VAL C7086GLY A6946ASN C6920 | 1.78A | 12.77 | NoneNoneNoneFMT A7108 ( 4.8A)FMT C7106 ( 4.1A) | ||
![]() | 6GNG_A_QPSA601_1 (-) | 6w75 | NSP16 (SARS-CoV-2) | 5 / 12 | THR C6915LEU C7093VAL A7086GLY C6946ASN A6920 | 1.66A | 12.77 | NoneNoneNoneFMT C7115 ( 3.0A)FMT A7106 ( 4.0A) | ||
![]() | 6GNG_A_QPSA601_1 (-) | 6w75 | NSP10NSP16 (SARS-CoV-2) | 5 / 12 | GLY D4322VAL C6876THR C6889GLY C6890ASP C6895 | 1.47A | 12.42 | None | ||
![]() | 6GNG_A_QPSA601_1 (-) | 6w75 | NSP10NSP16 (SARS-CoV-2) | 5 / 12 | GLY B4322VAL A6876THR A6889GLY A6890ASP A6895 | 1.54A | 12.42 | None | ||
![]() | 6GNG_A_QPSA601_1 (-) | 6w75 | NSP16 (SARS-CoV-2) | 5 / 12 | GLY C6879THR C6891GLY C6890ASP C6906GLN C6885 | 1.78A | 12.77 | SAM C7105 ( 3.4A)NoneNoneNoneNone | ||
![]() | 6GNG_A_QPSA601_1 (-) | 6w75 | NSP10NSP16 (SARS-CoV-2) | 5 / 12 | GLY D4323VAL C6876THR C6889GLY C6890ASP C6895 | 1.75A | 12.42 | None | ||
![]() | 6GNG_A_QPSA601_2 (-) | 6w75 | NSP10NSP16 (SARS-CoV-2) | 5 / 12 | TRP C6886PRO C6860GLU D4313PRO D4312GLY D4303 | 1.74A | 12.77 | None | ||
![]() | 2X2I_A_QPSA1060_1 (ALPHA-1,4-GLUCANLYASE ISOZYME 1) | 6w75 | NSP10 (SARS-CoV-2) | 5 / 12 | THR B4364VAL B4350SER B4325THR B4292GLY B4362 | 1.72A | 9.15 | None | ||
![]() | 6GNG_B_QPSB601_2 (-) | 6w75 | NSP10NSP16 (SARS-CoV-2) | 5 / 12 | GLY B4323GLY B4347GLY A6837PRO A6835GLN B4351 | 1.76A | 12.42 | None | ||
![]() | 6GNG_B_QPSB601_2 (-) | 6w75 | NSP10NSP16 (SARS-CoV-2) | 5 / 12 | GLY D4323GLY D4347GLY C6837PRO C6835GLN D4351 | 1.77A | 12.42 | NoneNoneFMT D4404 ( 3.7A)NoneNone | ||
![]() | 6GNG_A_QPSA601_2 (-) | 6w75 | NSP10NSP16 (SARS-CoV-2) | 5 / 12 | TRP A6886PRO A6860GLU B4313PRO B4312GLY B4303 | 1.77A | 12.77 | None | ||
![]() | 6GNG_A_QPSA601_1 (-) | 6w75 | NSP16 (SARS-CoV-2) | 5 / 12 | THR C6908LEU C6893GLY C6875HIS C6867ASN A7096 | 1.44A | 12.77 | None | ||
![]() | 6GNG_A_QPSA601_1 (-) | 6w75 | NSP16 (SARS-CoV-2) | 5 / 12 | GLY A6879THR A6891GLY A6890ASP A6906GLN A6885 | 1.76A | 12.77 | SAM A7102 ( 3.4A)NoneNoneNoneNone | ||
![]() | 6GNG_A_QPSA601_1 (-) | 6w75 | NSP10NSP16 (SARS-CoV-2) | 5 / 12 | THR A6908THR A6880ASP A6900HIS B4333ASN A6899 | 1.62A | 12.77 | NoneNoneNoneNoneSAM A7102 ( 4.1A) | ||
![]() | 6GNG_A_QPSA601_1 (-) | 6w75 | NSP16 (SARS-CoV-2) | 5 / 12 | GLY C6879VAL C6876THR C6891GLY C6890GLN C6885 | 1.76A | 12.77 | SAM C7105 ( 3.4A)NoneNoneNoneNone | ||
![]() | 2X2I_D_QPSD1050_1 (ALPHA-1,4-GLUCANLYASE ISOZYME 1) | 6w9c | PAPAIN-LIKEPROTEINASE (SARS-CoV-2) | 5 / 12 | ASP B 164PHE B 173VAL B 202ASP B 302PHE B 304 | 1.64A | 15.39 | None | ||
![]() | 1DED_A_QPSA1001_1 (CYCLODEXTRINGLUCANOTRANSFERASE) | 6w9c | PAPAIN-LIKEPROTEINASE (SARS-CoV-2) | 5 / 12 | LEU A 80TYR A 56ALA A 68GLU A 67HIS A 17 | 1.35A | None | |||
![]() | 6GNG_A_QPSA601_1 (-) | 6w9c | PAPAIN-LIKEPROTEINASE (SARS-CoV-2) | 5 / 12 | LEU A 64VAL A 66THR A 42ASP A 61ASN A 60 | 1.79A | None | |||
![]() | 1DED_A_QPSA1001_1 (CYCLODEXTRINGLUCANOTRANSFERASE) | 6w9c | PAPAIN-LIKEPROTEINASE (SARS-CoV-2) | 5 / 12 | LEU B 80LEU B 58ALA B 68GLU B 67HIS B 17 | 1.35A | None | |||
![]() | 1DED_B_QPSB1501_1 (CYCLODEXTRINGLUCANOTRANSFERASE) | 6w9c | PAPAIN-LIKEPROTEINASE (SARS-CoV-2) | 5 / 12 | TYR A 56LEU A 80ALA A 68GLU A 67HIS A 17 | 1.60A | 19.33 | None | ||
![]() | 6GNG_A_QPSA601_1 (-) | 6w9c | PAPAIN-LIKEPROTEINASE (SARS-CoV-2) | 5 / 12 | LEU C 64VAL C 66THR C 42GLY C 28ASP C 61 | 1.71A | None | |||
![]() | 1DED_A_QPSA1001_1 (CYCLODEXTRINGLUCANOTRANSFERASE) | 6w9c | PAPAIN-LIKEPROTEINASE (SARS-CoV-2) | 5 / 12 | LEU B 150TYR B 83ALA B 135GLU B 143ASP B 37 | 1.71A | None | |||
![]() | 1DED_A_QPSA1001_1 (CYCLODEXTRINGLUCANOTRANSFERASE) | 6w9c | PAPAIN-LIKEPROTEINASE (SARS-CoV-2) | 5 / 12 | LEU C 80LEU C 58ALA C 68GLU C 67HIS C 17 | 1.46A | None | |||
![]() | 6GNG_A_QPSA601_2 (-) | 6w9c | PAPAIN-LIKEPROTEINASE (SARS-CoV-2) | 5 / 12 | GLU B 167GLY B 163TYR B 171PRO B 129GLY B 160 | 1.77A | None | |||
![]() | 6GNG_B_QPSB601_2 (-) | 6w9c | PAPAIN-LIKEPROTEINASE (SARS-CoV-2) | 5 / 12 | GLY B 163GLY A 271HIS B 272ASN B 110PRO A 248 | 1.64A | None | |||
![]() | 1DED_A_QPSA1001_1 (CYCLODEXTRINGLUCANOTRANSFERASE) | 6w9c | PAPAIN-LIKEPROTEINASE (SARS-CoV-2) | 5 / 12 | LEU C 87TYR C 83ALA C 145GLU C 143ASP C 134 | 1.68A | None | |||
![]() | 6GNG_B_QPSB601_3 (-) | 6w9c | PAPAIN-LIKEPROTEINASE (SARS-CoV-2) | 3 / 3 | ASP B 61ASP B 12ASN B 146 | 1.51A | 19.54 | None | ||
![]() | 6GNG_A_QPSA601_1 (-) | 6w9c | PAPAIN-LIKEPROTEINASE (SARS-CoV-2) | 5 / 12 | THR A 265GLY A 266ASP A 286ASN C 267ASN A 109 | 1.68A | None | |||
![]() | 1DED_A_QPSA1001_1 (CYCLODEXTRINGLUCANOTRANSFERASE) | 6w9c | PAPAIN-LIKEPROTEINASE (SARS-CoV-2) | 5 / 12 | LEU B 80TYR B 56ALA B 68GLU B 67HIS B 17 | 1.41A | None | |||
![]() | 1DED_A_QPSA1001_1 (CYCLODEXTRINGLUCANOTRANSFERASE) | 6w9c | PAPAIN-LIKEPROTEINASE (SARS-CoV-2) | 5 / 12 | LEU A 80LEU A 58ALA A 68GLU A 67HIS A 17 | 1.35A | None | |||
![]() | 2X2I_D_QPSD1050_1 (ALPHA-1,4-GLUCANLYASE ISOZYME 1) | 6w9c | PAPAIN-LIKEPROTEINASE (SARS-CoV-2) | 5 / 12 | ASP A 164PHE A 173VAL A 202ASP A 302PHE A 304 | 1.66A | 15.39 | None | ||
![]() | 2X2I_D_QPSD1050_1 (ALPHA-1,4-GLUCANLYASE ISOZYME 1) | 6w9c | PAPAIN-LIKEPROTEINASE (SARS-CoV-2) | 5 / 12 | ASP C 164PHE C 173VAL C 202ASP C 302PHE C 304 | 1.62A | 15.39 | None | ||
![]() | 6GNG_B_QPSB601_3 (-) | 6w9c | PAPAIN-LIKEPROTEINASE (SARS-CoV-2) | 3 / 3 | ASP A 61ASP A 12ASN A 146 | 1.60A | 19.54 | None | ||
![]() | 1DED_A_QPSA1001_1 (CYCLODEXTRINGLUCANOTRANSFERASE) | 6w9c | PAPAIN-LIKEPROTEINASE (SARS-CoV-2) | 5 / 12 | LEU A 150TYR A 83ALA A 135GLU A 143ASP A 37 | 1.72A | None | |||
![]() | 1DED_A_QPSA1001_1 (CYCLODEXTRINGLUCANOTRANSFERASE) | 6w9c | PAPAIN-LIKEPROTEINASE (SARS-CoV-2) | 5 / 12 | LEU A 150TYR A 83ASP A 134ALA A 135GLU A 143 | 1.76A | None | |||
![]() | 1DED_A_QPSA1001_1 (CYCLODEXTRINGLUCANOTRANSFERASE) | 6w9c | PAPAIN-LIKEPROTEINASE (SARS-CoV-2) | 5 / 12 | LEU C 150TYR C 83ALA C 135GLU C 143ASP C 37 | 1.55A | None | |||
![]() | 2X2I_A_QPSA1060_1 (ALPHA-1,4-GLUCANLYASE ISOZYME 1) | 6wcf | NSP3 (SARS-CoV-2) | 5 / 12 | PHE A 132SER A 128SER A 139VAL A 95GLY A 79 | 1.73A | MES A 201 (-2.5A)MES A 201 (-4.4A)NoneNoneNone | |||
![]() | 2X2I_C_QPSC1060_1 (ALPHA-1,4-GLUCANLYASE ISOZYME 1) | 6wcf | NSP3 (SARS-CoV-2) | 5 / 12 | PHE A 132SER A 128SER A 139VAL A 95GLY A 79 | 1.74A | MES A 201 (-2.5A)MES A 201 (-4.4A)NoneNoneNone | |||
![]() | 2X2I_A_QPSA1060_1 (ALPHA-1,4-GLUCANLYASE ISOZYME 1) | 6wcf | NSP3 (SARS-CoV-2) | 5 / 12 | THR A 146VAL A 142SER A 128VAL A 95ALA A 112 | 1.78A | NoneNoneMES A 201 (-4.4A)NoneNone | |||
![]() | 2X2I_D_QPSD1060_1 (ALPHA-1,4-GLUCANLYASE ISOZYME 1) | 6wcf | NSP3 (SARS-CoV-2) | 5 / 10 | PHE A 132SER A 128SER A 139VAL A 95GLY A 79 | 1.75A | MES A 201 (-2.5A)MES A 201 (-4.4A)NoneNoneNone | |||
![]() | 2X2I_C_QPSC1060_1 (ALPHA-1,4-GLUCANLYASE ISOZYME 1) | 6wcf | NSP3 (SARS-CoV-2) | 5 / 12 | THR A 146VAL A 142SER A 128VAL A 95ALA A 112 | 1.78A | NoneNoneMES A 201 (-4.4A)NoneNone | |||
![]() | 6GNG_B_QPSB601_2 (-) | 6wcf | NSP3 (SARS-CoV-2) | 5 / 12 | GLY A 47GLY A 46HIS A 94ASN A 54PRO A 32 | 1.57A | MES A 202 (-3.4A)MES A 202 (-4.7A)NoneNoneNone | |||
![]() | 2X2I_D_QPSD1060_1 (ALPHA-1,4-GLUCANLYASE ISOZYME 1) | 6wen | NSP3 (SARS-CoV-2) | 5 / 10 | PHE A 132SER A 128SER A 139VAL A 95GLY A 79 | 1.58A | None | |||
![]() | 2X2I_C_QPSC1060_1 (ALPHA-1,4-GLUCANLYASE ISOZYME 1) | 6wen | NSP3 (SARS-CoV-2) | 5 / 12 | PHE A 132SER A 128SER A 139VAL A 95GLY A 79 | 1.60A | None | |||
![]() | 2X2I_C_QPSC1060_1 (ALPHA-1,4-GLUCANLYASE ISOZYME 1) | 6wen | NSP3 (SARS-CoV-2) | 5 / 12 | THR A 146VAL A 142SER A 128VAL A 95ALA A 112 | 1.78A | None | |||
![]() | 2X2I_A_QPSA1060_1 (ALPHA-1,4-GLUCANLYASE ISOZYME 1) | 6wen | NSP3 (SARS-CoV-2) | 5 / 12 | PHE A 132SER A 128SER A 139VAL A 95GLY A 79 | 1.56A | None | |||
![]() | 6GNG_B_QPSB601_2 (-) | 6wen | NSP3 (SARS-CoV-2) | 5 / 12 | GLY A 48GLY A 47HIS A 94ASN A 54PRO A 32 | 1.74A | None | |||
![]() | 2X2I_C_QPSC1060_1 (ALPHA-1,4-GLUCANLYASE ISOZYME 1) | 6wen | NSP3 (SARS-CoV-2) | 5 / 12 | PHE A 132SER A 128ASN A 115VAL A 95ALA A 39 | 1.80A | None | |||
![]() | 2X2I_A_QPSA1060_1 (ALPHA-1,4-GLUCANLYASE ISOZYME 1) | 6wen | NSP3 (SARS-CoV-2) | 5 / 12 | PHE A 132SER A 128ASN A 115VAL A 95ALA A 39 | 1.77A | None | |||
![]() | 1DED_A_QPSA1001_1 (CYCLODEXTRINGLUCANOTRANSFERASE) | 6wen | NSP3 (SARS-CoV-2) | 5 / 12 | LEU A 126LEU A 140ALA A 129ASP A 157ASP A 162 | 1.80A | None | |||
![]() | 2X2I_A_QPSA1060_1 (ALPHA-1,4-GLUCANLYASE ISOZYME 1) | 6wen | NSP3 (SARS-CoV-2) | 5 / 12 | THR A 146VAL A 142SER A 128VAL A 95ALA A 112 | 1.77A | None | |||
![]() | 2X2I_C_QPSC1060_1 (ALPHA-1,4-GLUCANLYASE ISOZYME 1) | 6wen | NSP3 (SARS-CoV-2) | 5 / 12 | PHE A 132SER A 128SER A 139VAL A 95ALA A 39 | 1.80A | None | |||
![]() | 6GNG_B_QPSB601_2 (-) | 6wen | NSP3 (SARS-CoV-2) | 5 / 12 | GLY A 47GLY A 46HIS A 94ASN A 54PRO A 32 | 1.55A | None | |||
![]() | 2X2I_D_QPSD1060_1 (ALPHA-1,4-GLUCANLYASE ISOZYME 1) | 6wey | NSP3 (SARS-CoV-2) | 5 / 10 | PHE A 336SER A 332SER A 343VAL A 299GLY A 283 | 1.59A | None | |||
![]() | 2X2I_C_QPSC1060_1 (ALPHA-1,4-GLUCANLYASE ISOZYME 1) | 6wey | NSP3 (SARS-CoV-2) | 5 / 12 | THR A 350VAL A 346SER A 332VAL A 299ALA A 316 | 1.75A | None | |||
![]() | 6GNG_B_QPSB601_2 (-) | 6wey | NSP3 (SARS-CoV-2) | 5 / 12 | GLY A 251GLY A 250HIS A 298ASN A 258PRO A 236 | 1.66A | None | |||
![]() | 2X2I_C_QPSC1060_1 (ALPHA-1,4-GLUCANLYASE ISOZYME 1) | 6wey | NSP3 (SARS-CoV-2) | 5 / 12 | PHE A 336SER A 332SER A 343VAL A 299GLY A 283 | 1.62A | None | |||
![]() | 2X2I_A_QPSA1060_1 (ALPHA-1,4-GLUCANLYASE ISOZYME 1) | 6wey | NSP3 (SARS-CoV-2) | 5 / 12 | THR A 350VAL A 346SER A 332VAL A 299ALA A 316 | 1.75A | None | |||
![]() | 2X2I_A_QPSA1060_1 (ALPHA-1,4-GLUCANLYASE ISOZYME 1) | 6wey | NSP3 (SARS-CoV-2) | 5 / 12 | PHE A 336SER A 332SER A 343VAL A 299GLY A 283 | 1.58A | None | |||
![]() | 1DED_B_QPSB1501_1 (CYCLODEXTRINGLUCANOTRANSFERASE) | 6wji | NUCLEOCAPSID PROTEIN (SARS-CoV-2) | 5 / 12 | HIS B 300TYR B 298PHE B 363HIS B 356ASP B 288 | 1.71A | 10.44 | None | ||
![]() | 6GNG_A_QPSA601_1 (-) | 6wji | NUCLEOCAPSID PROTEIN (SARS-CoV-2) | 5 / 12 | THR F 332GLY F 321THR F 325GLY F 328ASN E 354 | 1.79A | None | |||
![]() | 1DED_B_QPSB1501_1 (CYCLODEXTRINGLUCANOTRANSFERASE) | 6wji | NUCLEOCAPSID PROTEIN (SARS-CoV-2) | 5 / 12 | HIS D 300TYR D 298PHE D 363HIS D 356ASP D 288 | 1.79A | 10.44 | None | ||
![]() | 1DED_B_QPSB1501_1 (CYCLODEXTRINGLUCANOTRANSFERASE) | 6wji | NUCLEOCAPSID PROTEIN (SARS-CoV-2) | 5 / 12 | HIS E 300TYR E 298PHE E 363HIS E 356ASP E 288 | 1.78A | 10.44 | None | ||
![]() | 6GNG_A_QPSA601_1 (-) | 6wji | NUCLEOCAPSID PROTEIN (SARS-CoV-2) | 5 / 12 | THR A 332GLY A 321THR A 325GLY A 328ASN B 354 | 1.77A | None | |||
![]() | 6GNG_A_QPSA601_1 (-) | 6wji | NUCLEOCAPSID PROTEIN (SARS-CoV-2) | 5 / 12 | THR B 332GLY B 321THR B 325GLY B 328ASN A 354 | 1.78A | None | |||
![]() | 1DED_B_QPSB1501_1 (CYCLODEXTRINGLUCANOTRANSFERASE) | 6wji | NUCLEOCAPSID PROTEIN (SARS-CoV-2) | 5 / 12 | HIS A 300TYR A 298PHE A 363HIS A 356ASP A 288 | 1.70A | 10.44 | None | ||
![]() | 6GNG_A_QPSA601_1 (-) | 6wji | NUCLEOCAPSID PROTEIN (SARS-CoV-2) | 5 / 12 | GLY A 321LEU B 353THR A 325ASP B 341ASN B 354 | 1.53A | None | |||
![]() | 1DED_B_QPSB1501_1 (CYCLODEXTRINGLUCANOTRANSFERASE) | 6wji | NUCLEOCAPSID PROTEIN (SARS-CoV-2) | 5 / 12 | HIS C 300TYR C 298PHE C 363HIS C 356ASP C 288 | 1.70A | 10.44 | None | ||
![]() | 6GNG_A_QPSA601_1 (-) | 6wji | NUCLEOCAPSID PROTEIN (SARS-CoV-2) | 5 / 12 | GLY C 321LEU D 353THR C 325ASP D 341ASN D 354 | 1.74A | None | |||
![]() | 6GNG_A_QPSA601_1 (-) | 6wji | NUCLEOCAPSID PROTEIN (SARS-CoV-2) | 5 / 12 | THR C 332GLY C 321THR C 325GLY C 328ASN D 354 | 1.78A | None | |||
![]() | 6GNG_A_QPSA601_1 (-) | 6wjt | 2'-O-METHYLTRANSFERASE (SARS-CoV-2) | 5 / 12 | THR C6908LEU C6893GLY C6875HIS C6867ASN A7096 | 1.49A | None | |||
![]() | 6GNG_B_QPSB601_2 (-) | 6wjt | 2'-O-METHYLTRANSFERASENSP10 (SARS-CoV-2) | 5 / 12 | GLY B4323GLY B4347GLY A6837PRO A6835GLN B4351 | 1.76A | None | |||
![]() | 6GNG_A_QPSA601_1 (-) | 6wjt | 2'-O-METHYLTRANSFERASE (SARS-CoV-2) | 5 / 12 | GLY C6879THR C6891GLY C6890ASP C6906GLN C6885 | 1.76A | SAH C7102 (-3.5A)NoneNoneNoneNone | |||
![]() | 6GNG_A_QPSA601_1 (-) | 6wjt | 2'-O-METHYLTRANSFERASENSP10 (SARS-CoV-2) | 5 / 12 | GLY D4323VAL C6876THR C6889GLY C6890ASP C6895 | 1.76A | None | |||
![]() | 6GNG_A_QPSA601_2 (-) | 6wjt | 2'-O-METHYLTRANSFERASENSP10 (SARS-CoV-2) | 5 / 12 | TRP C6886PRO C6860GLU D4313PRO D4312GLY D4303 | 1.74A | None | |||
![]() | 6GNG_A_QPSA601_1 (-) | 6wjt | 2'-O-METHYLTRANSFERASE (SARS-CoV-2) | 5 / 12 | THR A6908LEU A6893GLY A6875HIS A6867ASN C7096 | 1.48A | None | |||
![]() | 6GNG_A_QPSA601_1 (-) | 6wjt | 2'-O-METHYLTRANSFERASE (SARS-CoV-2) | 5 / 12 | GLY C6879VAL C6876THR C6891GLY C6890GLN C6885 | 1.79A | SAH C7102 (-3.5A)NoneNoneNoneNone | |||
![]() | 6GNG_A_QPSA601_1 (-) | 6wjt | 2'-O-METHYLTRANSFERASENSP10 (SARS-CoV-2) | 5 / 12 | THR A6908THR A6880ASP A6900HIS B4333ASN A6899 | 1.46A | NoneNoneNoneNoneSAH A7102 (-4.0A) | |||
![]() | 6GNG_A_QPSA601_1 (-) | 6wjt | 2'-O-METHYLTRANSFERASE (SARS-CoV-2) | 5 / 12 | THR C6915LEU C7093VAL A7086GLY C6946ASN A6920 | 1.64A | FMT C7107 (-3.7A)NoneNoneNoneFMT A7106 (-3.8A) | |||
![]() | 6GNG_A_QPSA601_1 (-) | 6wjt | 2'-O-METHYLTRANSFERASE (SARS-CoV-2) | 5 / 12 | THR A6908THR A6880GLY A6879ASP A6900ASN A6899 | 1.51A | NoneNoneSAH A7102 (-3.5A)NoneSAH A7102 (-4.0A) | |||
![]() | 6GNG_A_QPSA601_1 (-) | 6wjt | 2'-O-METHYLTRANSFERASENSP10 (SARS-CoV-2) | 5 / 12 | GLY B4322VAL A6876THR A6889GLY A6890ASP A6895 | 1.55A | NoneNone NA A7101 ( 4.8A)NoneNone | |||
![]() | 6GNG_A_QPSA601_2 (-) | 6wjt | 2'-O-METHYLTRANSFERASENSP10 (SARS-CoV-2) | 5 / 12 | TRP A6886PRO A6860GLU B4313PRO B4312GLY B4303 | 1.78A | None | |||
![]() | 6GNG_A_QPSA601_1 (-) | 6wjt | 2'-O-METHYLTRANSFERASENSP10 (SARS-CoV-2) | 5 / 12 | GLY A6875GLY D4341ASP A6897ASN A6899ASN A6841 | 1.77A | NoneNoneSAH A7102 (-2.6A)SAH A7102 (-4.0A)SAH A7102 (-3.6A) | |||
![]() | 6GNG_A_QPSA601_1 (-) | 6wjt | 2'-O-METHYLTRANSFERASENSP10 (SARS-CoV-2) | 5 / 12 | GLY D4322VAL C6876THR C6889GLY C6890ASP C6895 | 1.49A | None | |||
![]() | 6GNG_A_QPSA601_1 (-) | 6wjt | 2'-O-METHYLTRANSFERASE (SARS-CoV-2) | 5 / 12 | GLY A6879THR A6891GLY A6890ASP A6906GLN A6885 | 1.75A | SAH A7102 (-3.5A)NoneNoneNoneNone | |||
![]() | 6GNG_A_QPSA601_1 (-) | 6wkp | NUCLEOCAPSID PROTEIN (SARS-CoV-2) | 5 / 12 | THR D 115GLY D 147THR D 141ASN D 75ASN D 154 | 1.73A | NoneNoneNoneMES D 201 (-3.0A)MES D 201 (-3.8A) | |||
![]() | 6GNG_B_QPSB601_2 (-) | 6wkp | NUCLEOCAPSID PROTEIN (SARS-CoV-2) | 5 / 12 | GLU D 62GLY D 60GLY D 71PRO D 162PRO A 80 | 1.79A | None | |||
![]() | 2X2I_A_QPSA1060_1 (ALPHA-1,4-GLUCANLYASE ISOZYME 1) | 6wkp | NUCLEOCAPSID PROTEIN (SARS-CoV-2) | 5 / 12 | THR B 135VAL B 72ASN B 140GLY B 137GLN B 83 | 1.72A | None | |||
![]() | 6GNG_A_QPSA601_1 (-) | 6wkp | NUCLEOCAPSID PROTEIN (SARS-CoV-2) | 5 / 12 | LEU D 121THR D 148GLY D 147ASP D 144ASN D 126 | 1.76A | None | |||
![]() | 6GNG_A_QPSA601_1 (-) | 6wkp | NUCLEOCAPSID PROTEIN (SARS-CoV-2) | 5 / 12 | THR A 141LEU A 139THR A 115GLY A 147HIS D 59 | 1.63A | NoneNoneNoneNone ZN A 201 (-4.1A) | |||
![]() | 6GNG_A_QPSA601_1 (-) | 6wkp | NUCLEOCAPSID PROTEIN (SARS-CoV-2) | 5 / 12 | LEU C 121THR C 148GLY C 147ASP C 144ASN C 126 | 1.70A | None | |||
![]() | 2X2I_D_QPSD1060_1 (ALPHA-1,4-GLUCANLYASE ISOZYME 1) | 6wkp | NUCLEOCAPSID PROTEIN (SARS-CoV-2) | 5 / 10 | THR C 135VAL C 72ASN C 140GLY C 137GLN C 83 | 1.75A | None | |||
![]() | 6GNG_B_QPSB601_3 (-) | 6wkp | NUCLEOCAPSID PROTEIN (SARS-CoV-2) | 3 / 3 | ASP B 103ASP B 63ASN B 126 | 1.30A | 11.60 | None | ||
![]() | 2X2I_A_QPSA1060_1 (ALPHA-1,4-GLUCANLYASE ISOZYME 1) | 6wkp | NUCLEOCAPSID PROTEIN (SARS-CoV-2) | 5 / 12 | THR A 135VAL A 72ASN A 140GLY A 137GLN A 83 | 1.75A | None | |||
![]() | 2X2I_D_QPSD1060_1 (ALPHA-1,4-GLUCANLYASE ISOZYME 1) | 6wkp | NUCLEOCAPSID PROTEIN (SARS-CoV-2) | 5 / 10 | THR B 135VAL B 72ASN B 140GLY B 137GLN B 83 | 1.75A | None | |||
![]() | 2X2I_C_QPSC1060_1 (ALPHA-1,4-GLUCANLYASE ISOZYME 1) | 6wkp | NUCLEOCAPSID PROTEIN (SARS-CoV-2) | 5 / 12 | THR C 135VAL C 72ASN C 140GLY C 137GLN C 83 | 1.80A | None | |||
![]() | 6GNG_A_QPSA601_1 (-) | 6wkp | NUCLEOCAPSID PROTEIN (SARS-CoV-2) | 5 / 12 | THR B 115GLY B 147THR B 141ASN B 75ASN B 154 | 1.69A | NoneNoneNoneMES B 201 (-3.1A)MES B 201 (-3.2A) | |||
![]() | 2X2I_D_QPSD1060_1 (ALPHA-1,4-GLUCANLYASE ISOZYME 1) | 6wkp | NUCLEOCAPSID PROTEIN (SARS-CoV-2) | 5 / 10 | THR A 135VAL A 72ASN A 140GLY A 137GLN A 83 | 1.77A | None | |||
![]() | 6GNG_A_QPSA601_2 (-) | 6wkq | NSP10NSP16 (SARS-CoV-2) | 5 / 12 | TRP C6886PRO C6860GLU D4313PRO D4312GLY D4303 | 1.73A | None | |||
![]() | 6GNG_B_QPSB601_2 (-) | 6wkq | NSP10NSP16 (SARS-CoV-2) | 5 / 12 | GLY D4323GLY D4347GLY C6837PRO C6835GLN D4351 | 1.79A | None | |||
![]() | 6GNG_A_QPSA601_1 (-) | 6wkq | NSP16 (SARS-CoV-2) | 5 / 12 | GLY C6879VAL C6876THR C6891GLY C6890GLN C6885 | 1.77A | SFG C7103 ( 3.5A)NoneNoneNoneNone | |||
![]() | 6GNG_A_QPSA601_1 (-) | 6wkq | NSP10NSP16 (SARS-CoV-2) | 5 / 12 | GLY D4322VAL C6876THR C6889GLY C6890ASP C6895 | 1.47A | None | |||
![]() | 6GNG_B_QPSB601_2 (-) | 6wkq | NSP10NSP16 (SARS-CoV-2) | 5 / 12 | GLY B4323GLY B4347GLY A6837PRO A6835GLN B4351 | 1.77A | None | |||
![]() | 6GNG_A_QPSA601_1 (-) | 6wkq | NSP16 (SARS-CoV-2) | 5 / 12 | THR C6908LEU C6893GLY C6875HIS C6867ASN A7096 | 1.44A | None | |||
![]() | 6GNG_A_QPSA601_1 (-) | 6wkq | NSP16 (SARS-CoV-2) | 5 / 12 | GLY C6879THR C6891GLY C6890ASP C6906GLN C6885 | 1.75A | SFG C7103 ( 3.5A)NoneNoneNoneNone | |||
![]() | 6GNG_A_QPSA601_1 (-) | 6wkq | NSP10NSP16 (SARS-CoV-2) | 5 / 12 | THR A6908THR A6880ASP A6900HIS B4333ASN A6899 | 1.52A | NoneNoneNoneNoneSFG A7103 ( 4.1A) | |||
![]() | 6GNG_A_QPSA601_1 (-) | 6wkq | NSP16 (SARS-CoV-2) | 5 / 12 | THR C6915LEU C7093VAL A7086GLY C6946ASN A6920 | 1.66A | NoneNoneNoneFMT C7105 ( 2.9A)FMT A7109 ( 3.9A) | |||
![]() | 6GNG_A_QPSA601_1 (-) | 6wkq | NSP16 (SARS-CoV-2) | 5 / 12 | GLY A6879THR A6891GLY A6890ASP A6906GLN A6885 | 1.73A | SFG A7103 ( 3.5A)NoneNoneNoneNone | |||
![]() | 6GNG_A_QPSA601_1 (-) | 6wkq | NSP16 (SARS-CoV-2) | 5 / 12 | THR A6908LEU A6893GLY A6875HIS A6867ASN C7096 | 1.49A | None | |||
![]() | 6GNG_A_QPSA601_1 (-) | 6wkq | NSP16 (SARS-CoV-2) | 5 / 12 | THR A6915LEU A7093VAL C7086GLY A6946ASN C6920 | 1.77A | NoneNoneNoneNoneFMT C7106 ( 4.1A) | |||
![]() | 6GNG_A_QPSA601_1 (-) | 6wkq | NSP10NSP16 (SARS-CoV-2) | 5 / 12 | GLY B4322VAL A6876THR A6889GLY A6890ASP A6895 | 1.52A | None | |||
![]() | 6GNG_A_QPSA601_1 (-) | 6wkq | NSP10NSP16 (SARS-CoV-2) | 5 / 12 | GLY B4323VAL A6876THR A6889GLY A6890ASP A6895 | 1.80A | None | |||
![]() | 6GNG_A_QPSA601_2 (-) | 6wkq | NSP10NSP16 (SARS-CoV-2) | 5 / 12 | TRP A6886PRO A6860GLU B4313PRO B4312GLY B4303 | 1.77A | None | |||
![]() | 6GNG_A_QPSA601_1 (-) | 6wkq | NSP10NSP16 (SARS-CoV-2) | 5 / 12 | GLY D4323VAL C6876THR C6889GLY C6890ASP C6895 | 1.75A | None | |||
![]() | 2X2I_A_QPSA1050_2 (ALPHA-1,4-GLUCANLYASE ISOZYME 1) | 6wlc | URIDYLATE-SPECIFICENDORIBONUCLEASE (SARS-CoV-2) | 4 / 6 | VAL B 6TRP B 59TRP B 87THR B 84 | 1.75A | 16.80 | NoneTRS B 402 (-4.1A)NoneNone | ||
![]() | 6GNG_B_QPSB601_2 (-) | 6wlc | URIDYLATE-SPECIFICENDORIBONUCLEASE (SARS-CoV-2) | 5 / 12 | LEU A 298GLU A 203ARG A 207GLN A 160PRO A 158 | 1.63A | None | |||
![]() | 2X2I_A_QPSA1050_2 (ALPHA-1,4-GLUCANLYASE ISOZYME 1) | 6wlc | URIDYLATE-SPECIFICENDORIBONUCLEASE (SARS-CoV-2) | 4 / 6 | VAL A 6TRP A 59TRP A 87THR A 84 | 1.75A | 16.80 | NoneTRS A 402 ( 4.5A)NoneNone | ||
![]() | 6GNG_B_QPSB601_2 (-) | 6wlc | URIDYLATE-SPECIFICENDORIBONUCLEASE (SARS-CoV-2) | 5 / 12 | LEU B 298GLU B 203ARG B 207GLN B 160PRO B 158 | 1.61A | None | |||
![]() | 6GNG_B_QPSB601_1 (-) | 6wnp | 3C-LIKE PROTEINASE (SARS-CoV-2) | 5 / 12 | VAL A 157TYR A 182TYR A 161VAL A 13CYH A 16 | 1.78A | 18.86 | None | ||
![]() | 6GNG_A_QPSA601_1 (-) | 6wnp | 3C-LIKE PROTEINASE (SARS-CoV-2) | 5 / 12 | GLY A 143LEU A 27VAL A 20GLY A 170HIS A 41 | 1.63A | U5G A 401 (-3.0A)U5G A 401 ( 4.0A)NoneNoneU5G A 401 (-3.3A) | |||
![]() | 6GNG_A_QPSA601_1 (-) | 6wnp | 3C-LIKE PROTEINASE (SARS-CoV-2) | 5 / 12 | THR A 135THR A 169HIS A 163ASN A 180GLN A 192 | 1.42A | NoneNoneNoneNoneU5G A 401 (-3.5A) | |||
![]() | 6GNG_B_QPSB601_2 (-) | 6woj | REPLICASEPOLYPROTEIN 1AB (SARS-CoV-2) | 5 / 12 | GLY C 47GLY C 46HIS C 94ASN C 54PRO C 32 | 1.71A | APR C 201 (-4.1A)APR C 201 (-3.9A)NoneNoneNone | |||
![]() | 2X2I_A_QPSA1060_1 (ALPHA-1,4-GLUCANLYASE ISOZYME 1) | 6woj | REPLICASEPOLYPROTEIN 1AB (SARS-CoV-2) | 5 / 12 | PHE A 132SER A 128SER A 139VAL A 95GLY A 79 | 1.71A | APR A 201 (-3.1A)APR A 201 (-4.4A)NoneNoneNone | |||
![]() | 2X2I_C_QPSC1060_1 (ALPHA-1,4-GLUCANLYASE ISOZYME 1) | 6woj | REPLICASEPOLYPROTEIN 1AB (SARS-CoV-2) | 5 / 12 | THR B 146VAL B 142SER B 128VAL B 95ALA B 112 | 1.78A | NoneNoneAPR B 201 (-4.5A)NoneNone | |||
![]() | 6GNG_B_QPSB601_2 (-) | 6woj | REPLICASEPOLYPROTEIN 1AB (SARS-CoV-2) | 5 / 12 | GLY B 47GLY B 46HIS B 94ASN B 54PRO B 32 | 1.74A | APR B 201 (-4.0A)APR B 201 (-3.7A)NoneNoneNone | |||
![]() | 2X2I_C_QPSC1060_1 (ALPHA-1,4-GLUCANLYASE ISOZYME 1) | 6woj | REPLICASEPOLYPROTEIN 1AB (SARS-CoV-2) | 5 / 12 | PHE D 132SER D 128SER D 139VAL D 95GLY D 79 | 1.77A | APR D 201 (-3.5A)APR D 201 (-4.3A)NoneNoneNone | |||
![]() | 2X2I_D_QPSD1060_1 (ALPHA-1,4-GLUCANLYASE ISOZYME 1) | 6woj | REPLICASEPOLYPROTEIN 1AB (SARS-CoV-2) | 5 / 10 | PHE B 132SER B 128SER B 139VAL B 95GLY B 79 | 1.76A | APR B 201 (-3.6A)APR B 201 (-4.5A)NoneNoneNone | |||
![]() | 6GNG_A_QPSA601_1 (-) | 6woj | REPLICASEPOLYPROTEIN 1AB (SARS-CoV-2) | 5 / 12 | GLY D 79LEU D 75VAL D 41ASP A 162ASN D 40 | 1.70A | NoneNoneNoneNoneAPR D 201 (-3.6A) | |||
![]() | 2X2I_A_QPSA1060_1 (ALPHA-1,4-GLUCANLYASE ISOZYME 1) | 6woj | REPLICASEPOLYPROTEIN 1AB (SARS-CoV-2) | 5 / 12 | PHE B 132SER B 128SER B 139VAL B 95GLY B 79 | 1.74A | APR B 201 (-3.6A)APR B 201 (-4.5A)NoneNoneNone | |||
![]() | 2X2I_C_QPSC1060_1 (ALPHA-1,4-GLUCANLYASE ISOZYME 1) | 6woj | REPLICASEPOLYPROTEIN 1AB (SARS-CoV-2) | 5 / 12 | THR A 146VAL A 142SER A 128VAL A 95ALA A 112 | 1.79A | NoneNoneAPR A 201 (-4.4A)NoneNone | |||
![]() | 2X2I_A_QPSA1060_1 (ALPHA-1,4-GLUCANLYASE ISOZYME 1) | 6woj | REPLICASEPOLYPROTEIN 1AB (SARS-CoV-2) | 5 / 12 | THR D 146VAL D 142SER D 128VAL D 95ALA D 112 | 1.78A | NoneNoneAPR D 201 (-4.3A)NoneNone | |||
![]() | 6GNG_A_QPSA601_1 (-) | 6woj | REPLICASEPOLYPROTEIN 1AB (SARS-CoV-2) | 5 / 12 | LEU D 122VAL D 34THR D 13ASN D 117ASN A 159 | 1.71A | None | |||
![]() | 2X2I_A_QPSA1060_1 (ALPHA-1,4-GLUCANLYASE ISOZYME 1) | 6woj | REPLICASEPOLYPROTEIN 1AB (SARS-CoV-2) | 5 / 12 | THR A 146VAL A 142SER A 128VAL A 95ALA A 112 | 1.79A | NoneNoneAPR A 201 (-4.4A)NoneNone | |||
![]() | 6GNG_A_QPSA601_1 (-) | 6woj | REPLICASEPOLYPROTEIN 1AB (SARS-CoV-2) | 5 / 12 | GLY B 79LEU B 75VAL B 41ASP C 162ASN B 40 | 1.67A | NoneNoneNoneNoneAPR B 201 (-3.6A) | |||
![]() | 6GNG_B_QPSB601_3 (-) | 6woj | REPLICASEPOLYPROTEIN 1AB (SARS-CoV-2) | 3 / 3 | ASP A 145ASP A 135ASN A 101 | 1.78A | 16.67 | None | ||
![]() | 2X2I_A_QPSA1060_1 (ALPHA-1,4-GLUCANLYASE ISOZYME 1) | 6woj | REPLICASEPOLYPROTEIN 1AB (SARS-CoV-2) | 5 / 12 | THR B 146VAL B 142SER B 128VAL B 95ALA B 112 | 1.77A | NoneNoneAPR B 201 (-4.5A)NoneNone | |||
![]() | 2X2I_C_QPSC1060_1 (ALPHA-1,4-GLUCANLYASE ISOZYME 1) | 6woj | REPLICASEPOLYPROTEIN 1AB (SARS-CoV-2) | 5 / 12 | PHE C 132SER C 128SER C 139VAL C 95GLY C 79 | 1.75A | APR C 201 (-3.5A)APR C 201 (-4.4A)NoneNoneNone | |||
![]() | 2X2I_C_QPSC1060_1 (ALPHA-1,4-GLUCANLYASE ISOZYME 1) | 6woj | REPLICASEPOLYPROTEIN 1AB (SARS-CoV-2) | 5 / 12 | PHE A 132SER A 128SER A 139VAL A 95GLY A 79 | 1.72A | APR A 201 (-3.1A)APR A 201 (-4.4A)NoneNoneNone | |||
![]() | 2X2I_A_QPSA1060_1 (ALPHA-1,4-GLUCANLYASE ISOZYME 1) | 6woj | REPLICASEPOLYPROTEIN 1AB (SARS-CoV-2) | 5 / 12 | PHE D 132SER D 128SER D 139VAL D 95GLY D 79 | 1.77A | APR D 201 (-3.5A)APR D 201 (-4.3A)NoneNoneNone | |||
![]() | 6GNG_B_QPSB601_2 (-) | 6woj | REPLICASEPOLYPROTEIN 1AB (SARS-CoV-2) | 5 / 12 | GLY A 47GLY A 46HIS A 94ASN A 54PRO A 32 | 1.71A | APR A 201 (-4.1A)APR A 201 (-3.9A)NoneNoneNone | |||
![]() | 2X2I_C_QPSC1060_1 (ALPHA-1,4-GLUCANLYASE ISOZYME 1) | 6woj | REPLICASEPOLYPROTEIN 1AB (SARS-CoV-2) | 5 / 12 | PHE B 132SER B 128SER B 139VAL B 95GLY B 79 | 1.74A | APR B 201 (-3.6A)APR B 201 (-4.5A)NoneNoneNone | |||
![]() | 2X2I_A_QPSA1060_1 (ALPHA-1,4-GLUCANLYASE ISOZYME 1) | 6woj | REPLICASEPOLYPROTEIN 1AB (SARS-CoV-2) | 5 / 12 | PHE C 132SER C 128SER C 139VAL C 95GLY C 79 | 1.74A | APR C 201 (-3.5A)APR C 201 (-4.4A)NoneNoneNone | |||
![]() | 6GNG_A_QPSA601_1 (-) | 6woj | REPLICASEPOLYPROTEIN 1AB (SARS-CoV-2) | 5 / 12 | LEU B 122VAL B 34THR B 13ASN B 117ASN C 159 | 1.71A | None | |||
![]() | 6GNG_B_QPSB601_2 (-) | 6woj | REPLICASEPOLYPROTEIN 1AB (SARS-CoV-2) | 5 / 12 | GLY D 47GLY D 46HIS D 94ASN D 54PRO D 32 | 1.73A | APR D 201 (-4.2A)APR D 201 (-3.8A)NoneNoneNone | |||
![]() | 6GNG_A_QPSA601_1 (-) | 6wq3 | 2'-O-METHYLTRANSFERASE (SARS-CoV-2) | 5 / 12 | GLY A6879THR A6891GLY A6890ASP A6906GLN A6885 | 1.73A | SAH A7101 (-3.5A)NoneNoneNoneNone | |||
![]() | 6GNG_A_QPSA601_1 (-) | 6wq3 | 2'-O-METHYLTRANSFERASENSP10 (SARS-CoV-2) | 5 / 12 | GLY B4322VAL A6842THR B4364ASP B4359GLN B4351 | 1.76A | None | |||
![]() | 6GNG_A_QPSA601_1 (-) | 6wq3 | 2'-O-METHYLTRANSFERASENSP10 (SARS-CoV-2) | 5 / 12 | GLY B4322VAL A6876THR A6889GLY A6890ASP A6895 | 1.59A | None | |||
![]() | 6GNG_A_QPSA601_2 (-) | 6wq3 | 2'-O-METHYLTRANSFERASENSP10 (SARS-CoV-2) | 5 / 12 | TRP A6886PRO A6860GLU B4313PRO B4312GLY B4303 | 1.78A | NoneNoneSO4 B4403 ( 4.5A)NoneSO4 B4403 (-3.7A) | |||
![]() | 6GNG_A_QPSA601_1 (-) | 6wqf | 3C-LIKE PROTEINASE (SARS-CoV-2) | 5 / 12 | THR A 135THR A 169HIS A 163ASN A 180GLN A 192 | 1.58A | None | |||
![]() | 6GNG_A_QPSA601_1 (-) | 6wqf | 3C-LIKE PROTEINASE (SARS-CoV-2) | 5 / 12 | GLY A 146LEU A 27GLY A 15ASN A 119ASN A 142 | 1.77A | None | |||
![]() | 6GNG_A_QPSA601_1 (-) | 6wqf | 3C-LIKE PROTEINASE (SARS-CoV-2) | 5 / 12 | GLY A 143LEU A 27VAL A 20GLY A 170HIS A 41 | 1.66A | None | |||
![]() | 2X2I_D_QPSD1050_1 (ALPHA-1,4-GLUCANLYASE ISOZYME 1) | 6wrh | PEPTIDASE C16 (SARS-CoV-2) | 5 / 12 | ASP A 164PHE A 173VAL A 202ASP A 302PHE A 304 | 1.70A | 14.93 | GOL A 508 (-3.4A)NoneNoneNoneNone | ||
![]() | 6GNG_A_QPSA601_1 (-) | 6y2g | REPLICASEPOLYPROTEIN 1AB (SARS-CoV-2) | 5 / 12 | THR A 135THR A 169HIS A 163ASN A 180GLN A 192 | 1.47A | 18.86 | NoneNoneO6K A 402 ( 3.7A)NoneNone | ||
![]() | 6GNG_A_QPSA601_1 (-) | 6yb7 | REPLICASEPOLYPROTEIN 1AB (SARS-CoV-2) | 5 / 12 | GLY A 143LEU A 27VAL A 20GLY A 170HIS A 41 | 1.58A | 13.74 | None | ||
![]() | 6GNG_B_QPSB601_1 (-) | 6yb7 | REPLICASEPOLYPROTEIN 1AB (SARS-CoV-2) | 5 / 12 | VAL A 157TYR A 182TYR A 161VAL A 13CYH A 16 | 1.77A | 13.74 | None | ||
![]() | 2X2I_D_QPSD1060_1 (ALPHA-1,4-GLUCANLYASE ISOZYME 1) | 6yhu | REPLICASEPOLYPROTEIN 1A (SARS-CoV-2) | 5 / 10 | VAL A 16PHE B 92SER A 57GLY A 64GLN B 88 | 1.76A | None | |||
![]() | 2X2I_A_QPSA1060_1 (ALPHA-1,4-GLUCANLYASE ISOZYME 1) | 6yla | HEAVY CHAINLIGHT CHAIN (Homosapiens) | 5 / 12 | VAL B 68PHE B 64SER B 61THR C 100GLY B 35 | 1.59A | None | |||
![]() | 2X2I_A_QPSA1060_1 (ALPHA-1,4-GLUCANLYASE ISOZYME 1) | 6yla | HEAVY CHAINLIGHT CHAIN (Homosapiens) | 5 / 12 | VAL H 68PHE H 64SER H 61THR L 100GLY H 35 | 1.60A | None | |||
![]() | 2X2I_D_QPSD1060_1 (ALPHA-1,4-GLUCANLYASE ISOZYME 1) | 6yla | HEAVY CHAIN (Homosapiens) | 5 / 10 | THR H 169VAL H 167SER H 160ASN H 203VAL H 202 | 1.72A | None | |||
![]() | 2X2I_A_QPSA1060_1 (ALPHA-1,4-GLUCANLYASE ISOZYME 1) | 6yla | HEAVY CHAINLIGHT CHAIN (Homosapiens) | 5 / 12 | PHE C 122SER C 180VAL B 186GLY B 143ALA B 141 | 1.78A | None | |||
![]() | 2X2I_D_QPSD1060_1 (ALPHA-1,4-GLUCANLYASE ISOZYME 1) | 6yla | SPIKE GLYCOPROTEIN (SARS-CoV-2) | 5 / 10 | VAL A 341PHE A 338SER A 514ASN A 394VAL A 524 | 1.78A | None | |||
![]() | 6GNG_B_QPSB601_2 (-) | 6yla | HEAVY CHAINLIGHT CHAIN (Homosapiens) | 5 / 12 | LEU C 53GLY B 44GLU B 46GLN C 95PRO B 105 | 1.78A | None1PE C 301 ( 4.4A)NoneNoneNone | |||
![]() | 2X2I_A_QPSA1060_1 (ALPHA-1,4-GLUCANLYASE ISOZYME 1) | 6yla | SPIKE GLYCOPROTEIN (SARS-CoV-2) | 5 / 12 | VAL E 395PHE E 338THR E 385GLY E 526ALA E 363 | 1.47A | None | |||
![]() | 6GNG_B_QPSB601_2 (-) | 6yla | HEAVY CHAINLIGHT CHAIN (Homosapiens) | 5 / 12 | LEU L 53GLY H 44GLU H 46GLN L 95PRO H 105 | 1.78A | None1PE L1603 ( 4.3A)NoneNoneNone | |||
![]() | 6GNG_B_QPSB601_3 (-) | 6yla | LIGHT CHAINSPIKE GLYCOPROTEIN (Homosapiens;SARS-CoV-2) | 3 / 3 | ASP C 88ASP C 66ASN E 331 | 1.61A | 15.65 | NoneNoneNAG E 906 (-1.9A) | ||
![]() | 2X2I_A_QPSA1060_1 (ALPHA-1,4-GLUCANLYASE ISOZYME 1) | 6yla | SPIKE GLYCOPROTEIN (SARS-CoV-2) | 6 / 12 | VAL E 367PHE E 338THR E 333VAL E 362GLY E 526ALA E 363 | 1.78A | None | |||
![]() | 6GNG_B_QPSB601_2 (-) | 6yla | LIGHT CHAIN (Homosapiens) | 5 / 12 | GLY C 105GLY C 107GLY C 74ASN C 22PRO C 8 | 1.72A | None1PE C 301 (-3.7A)NoneNoneNone | |||
![]() | 2X2I_A_QPSA1060_1 (ALPHA-1,4-GLUCANLYASE ISOZYME 1) | 6yla | SPIKE GLYCOPROTEIN (SARS-CoV-2) | 5 / 12 | VAL A 395PHE A 338THR A 385GLY A 526ALA A 363 | 1.47A | None | |||
![]() | 2X2I_A_QPSA1060_1 (ALPHA-1,4-GLUCANLYASE ISOZYME 1) | 6yla | SPIKE GLYCOPROTEIN (SARS-CoV-2) | 5 / 12 | PHE E 338SER E 514ASN E 394VAL E 524ALA E 363 | 1.47A | None | |||
![]() | 2X2I_C_QPSC1060_1 (ALPHA-1,4-GLUCANLYASE ISOZYME 1) | 6yla | LIGHT CHAIN (Homosapiens) | 5 / 12 | THR L 212VAL L 121SER L 183SER L 165TRP L 154 | 1.76A | None | |||
![]() | 2X2I_A_QPSA1060_1 (ALPHA-1,4-GLUCANLYASE ISOZYME 1) | 6yla | HEAVY CHAINLIGHT CHAIN (Homosapiens) | 5 / 12 | PHE C 122SER C 180VAL B 185GLY B 143ALA B 141 | 1.76A | None | |||
![]() | 2X2I_C_QPSC1060_1 (ALPHA-1,4-GLUCANLYASE ISOZYME 1) | 6yla | LIGHT CHAIN (Homosapiens) | 5 / 12 | THR L 212VAL L 121SER L 183SER L 165ALA L 199 | 1.76A | None | |||
![]() | 2X2I_C_QPSC1060_1 (ALPHA-1,4-GLUCANLYASE ISOZYME 1) | 6yla | HEAVY CHAINLIGHT CHAIN (Homosapiens) | 5 / 12 | VAL H 68PHE H 64SER H 61THR L 100GLY H 35 | 1.53A | None | |||
![]() | 2X2I_C_QPSC1060_1 (ALPHA-1,4-GLUCANLYASE ISOZYME 1) | 6yla | HEAVY CHAINLIGHT CHAIN (Homosapiens) | 5 / 12 | PHE L 122SER L 180VAL H 185GLY H 143ALA H 141 | 1.68A | None | |||
![]() | 2X2I_C_QPSC1060_1 (ALPHA-1,4-GLUCANLYASE ISOZYME 1) | 6yla | SPIKE GLYCOPROTEIN (SARS-CoV-2) | 6 / 12 | VAL A 367PHE A 338THR A 333VAL A 362GLY A 526ALA A 363 | 1.79A | NAG A 904 (-4.5A)NoneNoneNoneNoneNone | |||
![]() | 2X2I_C_QPSC1060_1 (ALPHA-1,4-GLUCANLYASE ISOZYME 1) | 6yla | SPIKE GLYCOPROTEIN (SARS-CoV-2) | 5 / 12 | VAL A 401SER A 443THR A 500ASN A 501GLY A 504 | 1.74A | NoneNoneNoneNoneDMS A 903 ( 4.0A) | |||
![]() | 6GNG_A_QPSA601_1 (-) | 6yla | HEAVY CHAINSPIKE GLYCOPROTEIN (Homosapiens;SARS-CoV-2) | 5 / 12 | LEU A 390GLY B 99ASP B 107ASP A 389ASN A 388 | 1.54A | DMS A 905 (-4.9A)NoneNoneNoneNone | |||
![]() | 2X2I_C_QPSC1060_1 (ALPHA-1,4-GLUCANLYASE ISOZYME 1) | 6yla | SPIKE GLYCOPROTEIN (SARS-CoV-2) | 6 / 12 | VAL E 367PHE E 338THR E 333VAL E 362GLY E 526ALA E 363 | 1.77A | None | |||
![]() | 2X2I_A_QPSA1060_1 (ALPHA-1,4-GLUCANLYASE ISOZYME 1) | 6yla | HEAVY CHAINLIGHT CHAIN (Homosapiens) | 5 / 12 | PHE L 122SER L 180VAL H 185GLY H 143ALA H 141 | 1.74A | None | |||
![]() | 6GNF_C_QPSC602_1 (-) | 6yla | LIGHT CHAIN (Homosapiens) | 5 / 10 | THR C 78GLY C 70LEU C 79SER C 25VAL C 64 | 1.68A | 17.77 | None | ||
![]() | 6GNG_B_QPSB601_2 (-) | 6yla | LIGHT CHAIN (Homosapiens) | 5 / 12 | GLY L 105GLY L 107GLY L 74ASN L 22PRO L 8 | 1.78A | None1PE L1603 (-4.3A)NoneNoneNone | |||
![]() | 2X2I_C_QPSC1060_1 (ALPHA-1,4-GLUCANLYASE ISOZYME 1) | 6yla | SPIKE GLYCOPROTEIN (SARS-CoV-2) | 5 / 12 | VAL A 395PHE A 338THR A 385GLY A 526ALA A 363 | 1.51A | None | |||
![]() | 6GNG_A_QPSA601_1 (-) | 6yla | HEAVY CHAINSPIKE GLYCOPROTEIN (Homosapiens;SARS-CoV-2) | 5 / 12 | THR B 104GLY B 99ASP B 107ASP A 389ASN A 388 | 1.61A | None | |||
![]() | 2X2I_A_QPSA1060_1 (ALPHA-1,4-GLUCANLYASE ISOZYME 1) | 6yla | SPIKE GLYCOPROTEIN (SARS-CoV-2) | 5 / 12 | VAL E 524PHE E 392THR E 385VAL E 382GLY E 431 | 1.79A | NoneNoneNoneDMS L1601 (-4.2A)None | |||
![]() | 6GNG_A_QPSA601_1 (-) | 6yla | HEAVY CHAINSPIKE GLYCOPROTEIN (Homosapiens;SARS-CoV-2) | 5 / 12 | THR H 31GLY H 28THR H 104GLY E 381ASN E 388 | 1.78A | None | |||
![]() | 2X2I_C_QPSC1060_1 (ALPHA-1,4-GLUCANLYASE ISOZYME 1) | 6yla | HEAVY CHAINLIGHT CHAINSPIKE GLYCOPROTEIN (Homosapiens;SARS-CoV-2) | 5 / 12 | THR B 0VAL B 108SER B 100ASN A 370GLY L 63 | 1.79A | MLI B 303 (-4.2A)NoneNoneNoneNone | |||
![]() | 2X2I_A_QPSA1060_1 (ALPHA-1,4-GLUCANLYASE ISOZYME 1) | 6yla | HEAVY CHAINLIGHT CHAIN (Homosapiens) | 5 / 12 | PHE L 122SER L 180VAL H 186GLY H 143ALA H 141 | 1.78A | None | |||
![]() | 6GNG_A_QPSA601_1 (-) | 6yla | HEAVY CHAINSPIKE GLYCOPROTEIN (Homosapiens;SARS-CoV-2) | 5 / 12 | LEU E 390GLY H 99ASP H 107ASP E 389ASN E 388 | 1.50A | None | |||
![]() | 2X2I_C_QPSC1060_1 (ALPHA-1,4-GLUCANLYASE ISOZYME 1) | 6yla | SPIKE GLYCOPROTEIN (SARS-CoV-2) | 5 / 12 | VAL A 341PHE A 338SER A 514ASN A 394VAL A 524 | 1.69A | None | |||
![]() | 2X2I_A_QPSA1060_1 (ALPHA-1,4-GLUCANLYASE ISOZYME 1) | 6yla | SPIKE GLYCOPROTEIN (SARS-CoV-2) | 5 / 12 | VAL E 341PHE E 338SER E 514ASN E 394VAL E 524 | 1.64A | None | |||
![]() | 2X2I_C_QPSC1060_1 (ALPHA-1,4-GLUCANLYASE ISOZYME 1) | 6yla | HEAVY CHAINLIGHT CHAIN (Homosapiens) | 5 / 12 | VAL B 68PHE B 64SER B 61THR C 100GLY B 35 | 1.52A | None | |||
![]() | 2X2I_C_QPSC1060_1 (ALPHA-1,4-GLUCANLYASE ISOZYME 1) | 6yla | HEAVY CHAINLIGHT CHAIN (Homosapiens) | 5 / 12 | PHE C 122SER C 180VAL B 185GLY B 143ALA B 141 | 1.69A | None | |||
![]() | 2X2I_A_QPSA1060_1 (ALPHA-1,4-GLUCANLYASE ISOZYME 1) | 6yla | SPIKE GLYCOPROTEIN (SARS-CoV-2) | 5 / 12 | VAL A 341PHE A 338SER A 514ASN A 394VAL A 524 | 1.68A | None | |||
![]() | 2X2I_D_QPSD1060_1 (ALPHA-1,4-GLUCANLYASE ISOZYME 1) | 6yla | SPIKE GLYCOPROTEIN (SARS-CoV-2) | 5 / 10 | VAL E 341PHE E 338SER E 514ASN E 394VAL E 524 | 1.78A | None | |||
![]() | 2X2I_A_QPSA1060_1 (ALPHA-1,4-GLUCANLYASE ISOZYME 1) | 6yla | SPIKE GLYCOPROTEIN (SARS-CoV-2) | 5 / 12 | VAL A 401SER A 443THR A 500ASN A 501GLY A 504 | 1.73A | NoneNoneNoneNoneDMS A 903 ( 4.0A) | |||
![]() | 2X2I_C_QPSC1060_1 (ALPHA-1,4-GLUCANLYASE ISOZYME 1) | 6ym0 | LIGHT CHAIN (Homosapiens) | 5 / 12 | THR L 212VAL L 121SER L 183SER L 165TRP L 154 | 1.77A | None | |||
![]() | 2X2I_C_QPSC1060_1 (ALPHA-1,4-GLUCANLYASE ISOZYME 1) | 6ym0 | HEAVY CHAINLIGHT CHAIN (Homosapiens) | 5 / 12 | PHE L 122SER L 180VAL H 185GLY H 143ALA H 141 | 1.74A | None | |||
![]() | 2X2I_A_QPSA1060_1 (ALPHA-1,4-GLUCANLYASE ISOZYME 1) | 6ym0 | SPIKE GLYCOPROTEIN (SARS-CoV-2) | 6 / 12 | VAL E 367PHE E 338THR E 333VAL E 362GLY E 526ALA E 363 | 1.76A | None | |||
![]() | 2X2I_A_QPSA1060_1 (ALPHA-1,4-GLUCANLYASE ISOZYME 1) | 6ym0 | HEAVY CHAIN (Homosapiens) | 5 / 12 | THR H 169VAL H 167SER H 160ASN H 203VAL H 202 | 1.72A | None | |||
![]() | 2X2I_A_QPSA1060_1 (ALPHA-1,4-GLUCANLYASE ISOZYME 1) | 6ym0 | LIGHT CHAIN (Homosapiens) | 5 / 12 | VAL L 169PHE L 145SER L 120VAL L 202ALA L 150 | 1.74A | None | |||
![]() | 6GNF_C_QPSC602_1 (-) | 6ym0 | LIGHT CHAIN (Homosapiens) | 5 / 10 | THR L 78GLY L 70LEU L 79SER L 25VAL L 64 | 1.80A | 17.77 | None | ||
![]() | 2X2I_A_QPSA1060_1 (ALPHA-1,4-GLUCANLYASE ISOZYME 1) | 6ym0 | HEAVY CHAINLIGHT CHAIN (Homosapiens) | 5 / 12 | PHE L 122SER L 180VAL H 186GLY H 143ALA H 141 | 1.78A | None | |||
![]() | 2X2I_A_QPSA1060_1 (ALPHA-1,4-GLUCANLYASE ISOZYME 1) | 6ym0 | SPIKE GLYCOPROTEIN (SARS-CoV-2) | 5 / 12 | VAL E 341PHE E 338SER E 514ASN E 394VAL E 524 | 1.70A | None | |||
![]() | 2X2I_C_QPSC1060_1 (ALPHA-1,4-GLUCANLYASE ISOZYME 1) | 6ym0 | SPIKE GLYCOPROTEIN (SARS-CoV-2) | 5 / 12 | PHE E 338SER E 514ASN E 394VAL E 524ALA E 363 | 1.68A | None | |||
![]() | 2X2I_A_QPSA1060_1 (ALPHA-1,4-GLUCANLYASE ISOZYME 1) | 6ym0 | HEAVY CHAINLIGHT CHAIN (Homosapiens) | 5 / 12 | VAL H 68PHE H 64SER H 61THR L 100GLY H 35 | 1.64A | None | |||
![]() | 2X2I_C_QPSC1060_1 (ALPHA-1,4-GLUCANLYASE ISOZYME 1) | 6ym0 | HEAVY CHAINLIGHT CHAIN (Homosapiens) | 5 / 12 | VAL H 68PHE H 64SER H 61THR L 100GLY H 35 | 1.57A | None | |||
![]() | 2X2I_C_QPSC1060_1 (ALPHA-1,4-GLUCANLYASE ISOZYME 1) | 6ym0 | SPIKE GLYCOPROTEIN (SARS-CoV-2) | 6 / 12 | VAL E 367PHE E 338THR E 333VAL E 362GLY E 526ALA E 363 | 1.75A | None | |||
![]() | 6GNG_B_QPSB601_2 (-) | 6ym0 | HEAVY CHAINLIGHT CHAIN (Homosapiens) | 5 / 12 | LEU L 53GLY H 44GLU H 46GLN L 95PRO H 105 | 1.76A | None | |||
![]() | 6GNG_A_QPSA601_1 (-) | 6ym0 | HEAVY CHAINSPIKE GLYCOPROTEIN (Homosapiens;SARS-CoV-2) | 5 / 12 | LEU E 390GLY H 99ASP H 107ASP E 389ASN E 388 | 1.59A | None | |||
![]() | 2X2I_D_QPSD1060_1 (ALPHA-1,4-GLUCANLYASE ISOZYME 1) | 6ym0 | HEAVY CHAIN (Homosapiens) | 5 / 10 | THR H 169VAL H 167SER H 160ASN H 203VAL H 202 | 1.74A | None | |||
![]() | 2X2I_A_QPSA1060_1 (ALPHA-1,4-GLUCANLYASE ISOZYME 1) | 6ym0 | SPIKE GLYCOPROTEIN (SARS-CoV-2) | 5 / 12 | VAL E 395PHE E 338THR E 385GLY E 526ALA E 363 | 1.49A | None | |||
![]() | 2X2I_A_QPSA1060_1 (ALPHA-1,4-GLUCANLYASE ISOZYME 1) | 6ym0 | SPIKE GLYCOPROTEIN (SARS-CoV-2) | 5 / 12 | PHE E 338SER E 514ASN E 394VAL E 524ALA E 363 | 1.61A | None | |||
![]() | 2X2I_C_QPSC1060_1 (ALPHA-1,4-GLUCANLYASE ISOZYME 1) | 6ym0 | SPIKE GLYCOPROTEIN (SARS-CoV-2) | 5 / 12 | VAL E 341PHE E 338SER E 514ASN E 394VAL E 524 | 1.70A | None | |||
![]() | 6GNG_A_QPSA601_1 (-) | 6ynq | REPLICASEPOLYPROTEIN 1AB (SARS-CoV-2) | 5 / 12 | GLY A 143LEU A 27VAL A 20GLY A 170HIS A 41 | 1.64A | P6N A 502 ( 4.4A)NoneNoneNoneNone | |||
![]() | 6GNG_A_QPSA601_1 (-) | 6ynq | REPLICASEPOLYPROTEIN 1AB (SARS-CoV-2) | 5 / 12 | GLY A 146LEU A 27GLY A 15ASN A 119ASN A 142 | 1.79A | NoneNoneNoneNoneP6N A 502 (-3.4A) | |||
![]() | 2X2I_A_QPSA1060_1 (ALPHA-1,4-GLUCANLYASE ISOZYME 1) | 6yor | SPIKE GLYCOPROTEIN (SARS-CoV-2) | 5 / 12 | VAL E 367PHE E 338ASN E 334VAL E 362ALA E 363 | 1.72A | None | |||
![]() | 2X2I_C_QPSC1060_1 (ALPHA-1,4-GLUCANLYASE ISOZYME 1) | 6yor | SPIKE GLYCOPROTEIN (SARS-CoV-2) | 5 / 12 | VAL A 367PHE A 338VAL A 362GLY A 526ALA A 363 | 1.77A | None | |||
![]() | 2X2I_C_QPSC1060_1 (ALPHA-1,4-GLUCANLYASE ISOZYME 1) | 6yor | IGG L CHAIN (Homosapiens) | 5 / 12 | THR L 212VAL L 121SER L 183SER L 165ALA L 199 | 1.76A | None | |||
![]() | 2X2I_D_QPSD1060_1 (ALPHA-1,4-GLUCANLYASE ISOZYME 1) | 6yor | IGG H CHAIN (Homosapiens) | 5 / 10 | THR B 169VAL B 167SER B 160ASN B 203VAL B 202 | 1.71A | None | |||
![]() | 2X2I_C_QPSC1060_1 (ALPHA-1,4-GLUCANLYASE ISOZYME 1) | 6yor | IGG L CHAIN (Homosapiens) | 5 / 12 | THR C 212VAL C 121SER C 183SER C 165ALA C 199 | 1.77A | None | |||
![]() | 2X2I_A_QPSA1060_1 (ALPHA-1,4-GLUCANLYASE ISOZYME 1) | 6yor | IGG H CHAINIGG L CHAIN (Homosapiens) | 5 / 12 | VAL H 68PHE H 64SER H 61THR L 100GLY H 35 | 1.59A | None | |||
![]() | 2X2I_C_QPSC1060_1 (ALPHA-1,4-GLUCANLYASE ISOZYME 1) | 6yor | IGG H CHAINIGG L CHAIN (Homosapiens) | 5 / 12 | VAL B 68PHE B 64SER B 61THR C 100GLY B 35 | 1.54A | None | |||
![]() | 2X2I_C_QPSC1060_1 (ALPHA-1,4-GLUCANLYASE ISOZYME 1) | 6yor | IGG L CHAIN (Homosapiens) | 5 / 12 | THR L 212VAL L 121SER L 183SER L 165TRP L 154 | 1.76A | None | |||
![]() | 2XFF_A_QPSA600_1 (BETA-AMYLASE) | 6yor | IGG H CHAINSPIKE GLYCOPROTEIN (Homosapiens;SARS-CoV-2) | 5 / 12 | ALA B 118TYR E 489GLN E 493PHE E 490GLY E 485 | 1.44A | 18.81 | None | ||
![]() | 2XFF_A_QPSA600_1 (BETA-AMYLASE) | 6yor | IGG H CHAINSPIKE GLYCOPROTEIN (Homosapiens;SARS-CoV-2) | 5 / 12 | ALA H 118TYR A 489GLN A 493PHE A 490GLY A 485 | 1.42A | 18.81 | None | ||
![]() | 6GNG_B_QPSB601_2 (-) | 6yor | IGG H CHAINIGG L CHAIN (Homosapiens) | 5 / 12 | LEU L 53GLY H 44GLU H 46GLN L 95PRO H 105 | 1.77A | None | |||
![]() | 2X2I_A_QPSA1060_1 (ALPHA-1,4-GLUCANLYASE ISOZYME 1) | 6yor | IGG H CHAINIGG L CHAIN (Homosapiens) | 5 / 12 | PHE L 122SER L 180VAL H 186GLY H 143ALA H 141 | 1.78A | None | |||
![]() | 2X2I_A_QPSA1060_1 (ALPHA-1,4-GLUCANLYASE ISOZYME 1) | 6yor | SPIKE GLYCOPROTEIN (SARS-CoV-2) | 5 / 12 | VAL E 395PHE E 338THR E 385GLY E 526ALA E 363 | 1.47A | None | |||
![]() | 6GNG_A_QPSA601_1 (-) | 6yor | IGG H CHAINSPIKE GLYCOPROTEIN (Homosapiens;SARS-CoV-2) | 5 / 12 | THR H 31GLY H 28THR H 104GLY E 381ASN E 388 | 1.79A | None | |||
![]() | 2X2I_D_QPSD1060_1 (ALPHA-1,4-GLUCANLYASE ISOZYME 1) | 6yor | IGG H CHAIN (Homosapiens) | 5 / 10 | THR H 169VAL H 167SER H 160ASN H 203VAL H 202 | 1.72A | None | |||
![]() | 6GNG_A_QPSA601_1 (-) | 6yor | IGG H CHAINSPIKE GLYCOPROTEIN (Homosapiens;SARS-CoV-2) | 5 / 12 | THR B 31GLY B 28THR B 104GLY A 381ASN A 388 | 1.79A | None | |||
![]() | 2X2I_A_QPSA1060_1 (ALPHA-1,4-GLUCANLYASE ISOZYME 1) | 6yor | SPIKE GLYCOPROTEIN (SARS-CoV-2) | 5 / 12 | VAL A 524PHE A 392THR A 385VAL A 382GLY A 431 | 1.78A | None | |||
![]() | 2X2I_A_QPSA1060_1 (ALPHA-1,4-GLUCANLYASE ISOZYME 1) | 6yor | SPIKE GLYCOPROTEIN (SARS-CoV-2) | 5 / 12 | PHE E 338SER E 514ASN E 394VAL E 524ALA E 363 | 1.47A | None | |||
![]() | 2X2I_A_QPSA1060_1 (ALPHA-1,4-GLUCANLYASE ISOZYME 1) | 6yor | SPIKE GLYCOPROTEIN (SARS-CoV-2) | 5 / 12 | PHE A 338SER A 514ASN A 394VAL A 524ALA A 363 | 1.47A | None | |||
![]() | 2X2I_D_QPSD1060_1 (ALPHA-1,4-GLUCANLYASE ISOZYME 1) | 6yor | SPIKE GLYCOPROTEIN (SARS-CoV-2) | 5 / 10 | VAL A 341PHE A 338SER A 514ASN A 394VAL A 524 | 1.77A | None | |||
![]() | 2X2I_C_QPSC1060_1 (ALPHA-1,4-GLUCANLYASE ISOZYME 1) | 6yor | IGG H CHAINIGG L CHAIN (Homosapiens) | 5 / 12 | PHE L 122SER L 180VAL H 185GLY H 143ALA H 141 | 1.68A | None | |||
![]() | 6GNG_B_QPSB601_2 (-) | 6yor | IGG L CHAIN (Homosapiens) | 5 / 12 | GLY L 105GLY L 107GLY L 74ASN L 22PRO L 8 | 1.78A | None | |||
![]() | 2X2I_A_QPSA1060_1 (ALPHA-1,4-GLUCANLYASE ISOZYME 1) | 6yor | IGG H CHAINIGG L CHAIN (Homosapiens) | 5 / 12 | VAL B 68PHE B 64SER B 61THR C 100GLY B 35 | 1.61A | None | |||
![]() | 2X2I_C_QPSC1060_1 (ALPHA-1,4-GLUCANLYASE ISOZYME 1) | 6yor | IGG H CHAINIGG L CHAIN (Homosapiens) | 5 / 12 | PHE C 122SER C 180VAL B 185GLY B 143ALA B 141 | 1.68A | None | |||
![]() | 2X2I_A_QPSA1060_1 (ALPHA-1,4-GLUCANLYASE ISOZYME 1) | 6yor | SPIKE GLYCOPROTEIN (SARS-CoV-2) | 5 / 12 | VAL A 367PHE A 338ASN A 334VAL A 362ALA A 363 | 1.73A | None | |||
![]() | 6GNG_B_QPSB601_2 (-) | 6yor | IGG L CHAIN (Homosapiens) | 5 / 12 | GLY C 105GLY C 107GLY C 74ASN C 22PRO C 8 | 1.78A | None | |||
![]() | 6GNG_A_QPSA601_1 (-) | 6yor | IGG H CHAINSPIKE GLYCOPROTEIN (Homosapiens;SARS-CoV-2) | 5 / 12 | LEU E 390GLY H 99ASP H 107ASP E 389ASN E 388 | 1.49A | None | |||
![]() | 2X2I_A_QPSA1060_1 (ALPHA-1,4-GLUCANLYASE ISOZYME 1) | 6yor | IGG H CHAINIGG L CHAIN (Homosapiens) | 5 / 12 | PHE C 122SER C 180VAL B 185GLY B 143ALA B 141 | 1.73A | None | |||
![]() | 2X2I_C_QPSC1060_1 (ALPHA-1,4-GLUCANLYASE ISOZYME 1) | 6yor | SPIKE GLYCOPROTEIN (SARS-CoV-2) | 5 / 12 | VAL A 367PHE A 338ASN A 334VAL A 362ALA A 363 | 1.74A | None | |||
![]() | 2X2I_A_QPSA1060_1 (ALPHA-1,4-GLUCANLYASE ISOZYME 1) | 6yor | SPIKE GLYCOPROTEIN (SARS-CoV-2) | 5 / 12 | VAL E 341PHE E 338SER E 514ASN E 394VAL E 524 | 1.64A | None | |||
![]() | 6GNG_A_QPSA601_1 (-) | 6yor | IGG H CHAINSPIKE GLYCOPROTEIN (Homosapiens;SARS-CoV-2) | 5 / 12 | LEU A 390GLY B 99ASP B 107ASP A 389ASN A 388 | 1.49A | None | |||
![]() | 2X2I_A_QPSA1060_1 (ALPHA-1,4-GLUCANLYASE ISOZYME 1) | 6yor | SPIKE GLYCOPROTEIN (SARS-CoV-2) | 5 / 12 | VAL A 395PHE A 338THR A 385GLY A 526ALA A 363 | 1.46A | None | |||
![]() | 2X2I_A_QPSA1060_1 (ALPHA-1,4-GLUCANLYASE ISOZYME 1) | 6yor | SPIKE GLYCOPROTEIN (SARS-CoV-2) | 5 / 12 | VAL E 367PHE E 338VAL E 362GLY E 526ALA E 363 | 1.79A | None | |||
![]() | 2X2I_C_QPSC1060_1 (ALPHA-1,4-GLUCANLYASE ISOZYME 1) | 6yor | IGG H CHAINIGG L CHAIN (Homosapiens) | 5 / 12 | VAL H 68PHE H 64SER H 61THR L 100GLY H 35 | 1.51A | None | |||
![]() | 2X2I_C_QPSC1060_1 (ALPHA-1,4-GLUCANLYASE ISOZYME 1) | 6yor | SPIKE GLYCOPROTEIN (SARS-CoV-2) | 5 / 12 | VAL E 367PHE E 338ASN E 334VAL E 362ALA E 363 | 1.74A | None | |||
![]() | 6GNG_B_QPSB601_2 (-) | 6yor | IGG H CHAINIGG L CHAIN (Homosapiens) | 5 / 12 | LEU C 53GLY B 44GLU B 46GLN C 95PRO B 105 | 1.79A | None | |||
![]() | 2X2I_A_QPSA1060_1 (ALPHA-1,4-GLUCANLYASE ISOZYME 1) | 6yor | IGG H CHAINIGG L CHAIN (Homosapiens) | 5 / 12 | PHE C 122SER C 180VAL B 186GLY B 143ALA B 141 | 1.79A | None | |||
![]() | 2X2I_C_QPSC1060_1 (ALPHA-1,4-GLUCANLYASE ISOZYME 1) | 6yor | SPIKE GLYCOPROTEIN (SARS-CoV-2) | 5 / 12 | VAL E 367PHE E 338VAL E 362GLY E 526ALA E 363 | 1.77A | None | |||
![]() | 2X2I_D_QPSD1060_1 (ALPHA-1,4-GLUCANLYASE ISOZYME 1) | 6yor | SPIKE GLYCOPROTEIN (SARS-CoV-2) | 5 / 10 | VAL E 341PHE E 338SER E 514ASN E 394VAL E 524 | 1.78A | None | |||
![]() | 2X2I_A_QPSA1060_1 (ALPHA-1,4-GLUCANLYASE ISOZYME 1) | 6yor | SPIKE GLYCOPROTEIN (SARS-CoV-2) | 5 / 12 | VAL E 524PHE E 392THR E 385VAL E 382GLY E 431 | 1.78A | None | |||
![]() | 2X2I_A_QPSA1060_1 (ALPHA-1,4-GLUCANLYASE ISOZYME 1) | 6yor | IGG H CHAINIGG L CHAIN (Homosapiens) | 5 / 12 | PHE L 122SER L 180VAL H 185GLY H 143ALA H 141 | 1.75A | None | |||
![]() | 2X2I_C_QPSC1060_1 (ALPHA-1,4-GLUCANLYASE ISOZYME 1) | 6yor | IGG L CHAIN (Homosapiens) | 5 / 12 | THR C 212VAL C 121SER C 183SER C 165TRP C 154 | 1.76A | None | |||
![]() | 2X2I_A_QPSA1060_1 (ALPHA-1,4-GLUCANLYASE ISOZYME 1) | 6yor | SPIKE GLYCOPROTEIN (SARS-CoV-2) | 5 / 12 | VAL A 367PHE A 338VAL A 362GLY A 526ALA A 363 | 1.78A | None | |||
![]() | 2X2I_A_QPSA1060_1 (ALPHA-1,4-GLUCANLYASE ISOZYME 1) | 6yor | SPIKE GLYCOPROTEIN (SARS-CoV-2) | 5 / 12 | VAL A 341PHE A 338SER A 514ASN A 394VAL A 524 | 1.64A | None | |||
![]() | 6GNG_B_QPSB601_1 (-) | 6yt8 | REPLICASEPOLYPROTEIN 1AB (SARS-CoV-2) | 5 / 12 | VAL A 157TYR A 182TYR A 161VAL A 13CYH A 16 | 1.79A | 18.86 | None | ||
![]() | 6GNG_A_QPSA601_1 (-) | 6yt8 | REPLICASEPOLYPROTEIN 1AB (SARS-CoV-2) | 5 / 12 | THR A 135THR A 169HIS A 163ASN A 180GLN A 192 | 1.54A | NoneNoneDMS A 403 (-4.1A)NoneNone | |||
![]() | 6GNG_A_QPSA601_1 (-) | 6yt8 | REPLICASEPOLYPROTEIN 1AB (SARS-CoV-2) | 5 / 12 | GLY A 143LEU A 27VAL A 20GLY A 170HIS A 41 | 1.75A | PK8 A 401 ( 4.0A)PK8 A 401 ( 3.6A)NoneNonePK8 A 401 (-3.2A) | |||
![]() | 2X2I_C_QPSC1060_1 (ALPHA-1,4-GLUCANLYASE ISOZYME 1) | 6ywk | NSP3 MACRODOMAIN (SARS-CoV-2) | 5 / 12 | PHE D 132SER D 128SER D 139VAL D 95GLY D 79 | 1.71A | EDO D 205 ( 3.6A)NoneNoneNoneNone | |||
![]() | 2X2I_C_QPSC1060_1 (ALPHA-1,4-GLUCANLYASE ISOZYME 1) | 6ywk | NSP3 MACRODOMAIN (SARS-CoV-2) | 5 / 12 | THR E 146VAL E 142SER E 128VAL E 95ALA E 112 | 1.78A | NoneNoneEPE E 202 (-4.6A)NoneNone | |||
![]() | 2X2I_A_QPSA1060_1 (ALPHA-1,4-GLUCANLYASE ISOZYME 1) | 6ywk | NSP3 MACRODOMAIN (SARS-CoV-2) | 5 / 12 | PHE D 132SER D 128SER D 139VAL D 95GLY D 79 | 1.69A | EDO D 205 ( 3.6A)NoneNoneNoneNone | |||
![]() | 2X2I_C_QPSC1060_1 (ALPHA-1,4-GLUCANLYASE ISOZYME 1) | 6ywk | NSP3 MACRODOMAIN (SARS-CoV-2) | 5 / 12 | PHE E 132SER E 128SER E 139VAL E 95GLY E 79 | 1.73A | EPE E 202 (-3.2A)EPE E 202 (-4.6A)NoneNoneEPE E 203 (-3.3A) | |||
![]() | 2X2I_A_QPSA1060_1 (ALPHA-1,4-GLUCANLYASE ISOZYME 1) | 6ywk | NSP3 MACRODOMAIN (SARS-CoV-2) | 5 / 12 | THR C 146VAL C 142SER C 128VAL C 95ALA C 112 | 1.79A | None | |||
![]() | 6GNG_B_QPSB601_1 (-) | 6ywk | NSP3 MACRODOMAIN (SARS-CoV-2) | 5 / 12 | VAL D 165THR D 149TYR D 152PRO D 32GLY E 8 | 1.62A | 17.23 | NoneEDO D 203 ( 4.7A)NoneNoneNone | ||
![]() | 2X2I_C_QPSC1060_1 (ALPHA-1,4-GLUCANLYASE ISOZYME 1) | 6ywk | NSP3 MACRODOMAIN (SARS-CoV-2) | 5 / 12 | THR B 146VAL B 142SER B 128VAL B 95ALA B 112 | 1.77A | None | |||
![]() | 6GNG_B_QPSB601_2 (-) | 6ywk | NSP3 MACRODOMAIN (SARS-CoV-2) | 5 / 12 | GLY A 79GLY A 78GLY D 78ASN D 117PRO D 98 | 1.58A | None | |||
![]() | 2X2I_C_QPSC1060_1 (ALPHA-1,4-GLUCANLYASE ISOZYME 1) | 6ywk | NSP3 MACRODOMAIN (SARS-CoV-2) | 5 / 12 | THR C 146VAL C 142SER C 128VAL C 95ALA C 112 | 1.79A | None | |||
![]() | 6GNG_B_QPSB601_3 (-) | 6ywk | NSP3 MACRODOMAIN (SARS-CoV-2) | 3 / 3 | ASP C 145ASP C 135ASN C 101 | 1.70A | 17.23 | None | ||
![]() | 6GNG_B_QPSB601_3 (-) | 6ywk | NSP3 MACRODOMAIN (SARS-CoV-2) | 3 / 3 | ASP B 145ASP B 135ASN B 101 | 1.76A | 17.23 | None | ||
![]() | 6GNG_B_QPSB601_2 (-) | 6ywk | NSP3 MACRODOMAIN (SARS-CoV-2) | 5 / 12 | GLU B 64GLY B 85LEU B 83ASN B 37PRO E 136 | 1.28A | None | |||
![]() | 6GNG_B_QPSB601_2 (-) | 6ywk | NSP3 MACRODOMAIN (SARS-CoV-2) | 5 / 12 | GLY E 47GLY E 46HIS E 94ASN E 54PRO E 32 | 1.54A | EPE E 202 (-4.3A)EPE E 202 (-3.9A)NoneNoneNone | |||
![]() | 2X2I_C_QPSC1060_1 (ALPHA-1,4-GLUCANLYASE ISOZYME 1) | 6ywk | NSP3 MACRODOMAIN (SARS-CoV-2) | 5 / 12 | PHE B 132SER B 128SER B 139VAL B 95GLY B 79 | 1.63A | None | |||
![]() | 6GNG_B_QPSB601_1 (-) | 6ywk | NSP3 MACRODOMAIN (SARS-CoV-2) | 5 / 12 | VAL E 165THR E 149TYR E 152PRO E 32GLY D 8 | 1.74A | 17.23 | None | ||
![]() | 2X2I_A_QPSA1060_1 (ALPHA-1,4-GLUCANLYASE ISOZYME 1) | 6ywk | NSP3 MACRODOMAIN (SARS-CoV-2) | 5 / 12 | PHE B 132SER B 128SER B 139VAL B 95GLY B 79 | 1.59A | None | |||
![]() | 6GNG_A_QPSA601_1 (-) | 6ywk | NSP3 MACRODOMAIN (SARS-CoV-2) | 5 / 12 | GLY D 97LEU D 127VAL D 142ASN D 115GLN A 118 | 1.77A | NoneNoneNoneEDO D 201 (-3.6A)EDO D 201 ( 4.5A) | |||
![]() | 1DED_A_QPSA1001_1 (CYCLODEXTRINGLUCANOTRANSFERASE) | 6ywk | NSP3 MACRODOMAIN (SARS-CoV-2) | 5 / 12 | LEU D 126LEU D 140ALA D 129ASP D 157ASP D 162 | 1.79A | NoneNoneEDO D 205 (-4.5A)NoneNone | |||
![]() | 6GNG_B_QPSB601_2 (-) | 6ywk | NSP3 MACRODOMAIN (SARS-CoV-2) | 5 / 12 | GLY D 79GLY D 78GLY A 78ASN A 117PRO A 98 | 1.59A | None | |||
![]() | 6GNG_B_QPSB601_2 (-) | 6ywk | NSP3 MACRODOMAIN (SARS-CoV-2) | 5 / 12 | GLY A 47GLY A 46HIS A 94ASN A 54PRO A 32 | 1.54A | None | |||
![]() | 2X2I_D_QPSD1060_1 (ALPHA-1,4-GLUCANLYASE ISOZYME 1) | 6ywk | NSP3 MACRODOMAIN (SARS-CoV-2) | 5 / 10 | PHE B 132SER B 128SER B 139VAL B 95GLY B 79 | 1.59A | None | |||
![]() | 6GNG_A_QPSA601_1 (-) | 6ywk | NSP3 MACRODOMAIN (SARS-CoV-2) | 5 / 12 | GLY A 97LEU A 127VAL A 142ASN A 115GLN D 118 | 1.77A | EDO A 202 ( 4.9A)EDO A 202 ( 4.8A)NoneEDO D 201 (-3.4A)EDO D 201 ( 4.4A) | |||
![]() | 6GNG_B_QPSB601_2 (-) | 6ywk | NSP3 MACRODOMAIN (SARS-CoV-2) | 5 / 12 | GLY C 47GLY C 46HIS C 94ASN C 54PRO C 32 | 1.53A | None | |||
![]() | 6GNG_B_QPSB601_2 (-) | 6ywk | NSP3 MACRODOMAIN (SARS-CoV-2) | 5 / 12 | GLY D 47GLY D 46HIS D 94ASN D 54PRO D 32 | 1.55A | EDO D 206 (-4.5A)EDO D 206 ( 4.6A)NoneNoneNone | |||
![]() | 6GNF_C_QPSC602_2 (-) | 6ywk | NSP3 MACRODOMAIN (SARS-CoV-2) | 5 / 12 | VAL B 41ASP E 145ASP E 135HIS E 138GLY B 73 | 1.61A | 16.18 | None | ||
![]() | 6GNF_A_QPSA602_1 (-) | 6ywk | NSP3 MACRODOMAIN (SARS-CoV-2) | 5 / 12 | VAL B 41ASP E 145ASP E 135HIS E 138GLY B 73 | 1.62A | 16.18 | None | ||
![]() | 2X2I_A_QPSA1060_1 (ALPHA-1,4-GLUCANLYASE ISOZYME 1) | 6ywk | NSP3 MACRODOMAIN (SARS-CoV-2) | 5 / 12 | PHE E 132SER E 128SER E 139VAL E 95GLY E 79 | 1.71A | EPE E 202 (-3.2A)EPE E 202 (-4.6A)NoneNoneEPE E 203 (-3.3A) | |||
![]() | 2X2I_A_QPSA1060_1 (ALPHA-1,4-GLUCANLYASE ISOZYME 1) | 6ywk | NSP3 MACRODOMAIN (SARS-CoV-2) | 5 / 12 | THR B 146VAL B 142SER B 128VAL B 95ALA B 112 | 1.76A | None | |||
![]() | 2X2I_A_QPSA1060_1 (ALPHA-1,4-GLUCANLYASE ISOZYME 1) | 6ywk | NSP3 MACRODOMAIN (SARS-CoV-2) | 5 / 12 | PHE C 132SER C 128SER C 139VAL C 95GLY C 79 | 1.56A | NoneNoneNoneNoneEPE C 202 (-3.4A) | |||
![]() | 6GNG_B_QPSB601_2 (-) | 6ywk | NSP3 MACRODOMAIN (SARS-CoV-2) | 5 / 12 | GLY B 47GLY B 46HIS B 94ASN B 54PRO B 32 | 1.53A | None | |||
![]() | 2X2I_D_QPSD1060_1 (ALPHA-1,4-GLUCANLYASE ISOZYME 1) | 6ywk | NSP3 MACRODOMAIN (SARS-CoV-2) | 5 / 10 | PHE C 132SER C 128SER C 139VAL C 95GLY C 79 | 1.57A | NoneNoneNoneNoneEPE C 202 (-3.4A) | |||
![]() | 2X2I_A_QPSA1060_1 (ALPHA-1,4-GLUCANLYASE ISOZYME 1) | 6ywk | NSP3 MACRODOMAIN (SARS-CoV-2) | 5 / 12 | PHE B 132SER B 128ASN B 115VAL B 95ALA B 39 | 1.77A | None | |||
![]() | 2X2I_C_QPSC1060_1 (ALPHA-1,4-GLUCANLYASE ISOZYME 1) | 6ywk | NSP3 MACRODOMAIN (SARS-CoV-2) | 5 / 12 | PHE C 132SER C 128SER C 139VAL C 95GLY C 79 | 1.60A | NoneNoneNoneNoneEPE C 202 (-3.4A) | |||
![]() | 2X2I_A_QPSA1060_1 (ALPHA-1,4-GLUCANLYASE ISOZYME 1) | 6ywk | NSP3 MACRODOMAIN (SARS-CoV-2) | 5 / 12 | THR E 146VAL E 142SER E 128VAL E 95ALA E 112 | 1.77A | NoneNoneEPE E 202 (-4.6A)NoneNone | |||
![]() | 2X2I_A_QPSA1060_1 (ALPHA-1,4-GLUCANLYASE ISOZYME 1) | 6ywk | NSP3 MACRODOMAIN (SARS-CoV-2) | 5 / 12 | PHE A 132SER A 128SER A 139VAL A 95GLY A 79 | 1.70A | EDO A 202 (-3.9A)EDO A 202 (-4.3A)NoneNoneNone | |||
![]() | 2X2I_A_QPSA1060_1 (ALPHA-1,4-GLUCANLYASE ISOZYME 1) | 6ywk | NSP3 MACRODOMAIN (SARS-CoV-2) | 5 / 12 | THR A 146VAL A 142SER A 128VAL A 95ALA A 112 | 1.77A | NoneNoneEDO A 202 (-4.3A)NoneNone | |||
![]() | 2X2I_C_QPSC1060_1 (ALPHA-1,4-GLUCANLYASE ISOZYME 1) | 6ywk | NSP3 MACRODOMAIN (SARS-CoV-2) | 5 / 12 | THR A 146VAL A 142SER A 128VAL A 95ALA A 112 | 1.77A | NoneNoneEDO A 202 (-4.3A)NoneNone | |||
![]() | 2X2I_C_QPSC1060_1 (ALPHA-1,4-GLUCANLYASE ISOZYME 1) | 6ywk | NSP3 MACRODOMAIN (SARS-CoV-2) | 5 / 12 | PHE A 132SER A 128SER A 139VAL A 95GLY A 79 | 1.72A | EDO A 202 (-3.9A)EDO A 202 (-4.3A)NoneNoneNone | |||
![]() | 2X2I_A_QPSA1060_1 (ALPHA-1,4-GLUCANLYASE ISOZYME 1) | 6ywk | NSP3 MACRODOMAIN (SARS-CoV-2) | 5 / 12 | THR D 146VAL D 142SER D 128VAL D 95ALA D 112 | 1.79A | None | |||
![]() | 2X2I_A_QPSA1060_1 (ALPHA-1,4-GLUCANLYASE ISOZYME 1) | 6ywl | NSP3 MACRODOMAIN (SARS-CoV-2) | 5 / 12 | PHE B 132SER B 128SER B 139VAL B 95GLY B 79 | 1.73A | APR B 201 (-3.5A)APR B 201 (-4.3A)NoneNoneNone | |||
![]() | 2X2I_A_QPSA1060_1 (ALPHA-1,4-GLUCANLYASE ISOZYME 1) | 6ywl | NSP3 MACRODOMAIN (SARS-CoV-2) | 5 / 12 | THR E 146VAL E 142SER E 128VAL E 95ALA E 112 | 1.78A | NoneNoneAPR E 201 (-4.4A)NoneNone | |||
![]() | 6GNG_B_QPSB601_2 (-) | 6ywl | NSP3 MACRODOMAIN (SARS-CoV-2) | 5 / 12 | GLY D 47GLY D 46HIS D 94ASN D 54PRO D 32 | 1.73A | APR D 201 ( 4.3A)APR D 201 (-3.8A)NoneNoneNone | |||
![]() | 2X2I_C_QPSC1060_1 (ALPHA-1,4-GLUCANLYASE ISOZYME 1) | 6ywl | NSP3 MACRODOMAIN (SARS-CoV-2) | 5 / 12 | PHE A 132SER A 128SER A 139VAL A 95GLY A 79 | 1.72A | APR A 201 (-3.7A)APR A 201 (-4.4A)NoneNoneNone | |||
![]() | 2X2I_A_QPSA1060_1 (ALPHA-1,4-GLUCANLYASE ISOZYME 1) | 6ywl | NSP3 MACRODOMAIN (SARS-CoV-2) | 5 / 12 | THR D 146VAL D 142SER D 128VAL D 95ALA D 112 | 1.79A | NoneNoneAPR D 201 (-4.3A)NoneNone | |||
![]() | 6GNG_B_QPSB601_2 (-) | 6ywl | NSP3 MACRODOMAIN (SARS-CoV-2) | 5 / 12 | GLY C 47GLY C 46HIS C 94ASN C 54PRO C 32 | 1.69A | APR C 201 (-4.3A)APR C 201 (-4.3A)NoneNoneNone | |||
![]() | 2X2I_C_QPSC1060_1 (ALPHA-1,4-GLUCANLYASE ISOZYME 1) | 6ywl | NSP3 MACRODOMAIN (SARS-CoV-2) | 5 / 12 | THR C 146VAL C 142SER C 128VAL C 95ALA C 112 | 1.80A | NoneNoneAPR C 201 (-4.4A)NoneNone | |||
![]() | 6GNG_A_QPSA601_1 (-) | 6ywl | NSP3 MACRODOMAIN (SARS-CoV-2) | 5 / 12 | GLY A 97LEU A 127VAL A 142ASN A 115GLN D 118 | 1.78A | NoneNoneNoneEDO A 207 (-3.9A)EDO A 207 ( 4.7A) | |||
![]() | 6GNG_B_QPSB601_2 (-) | 6ywl | NSP3 MACRODOMAIN (SARS-CoV-2) | 5 / 12 | GLU B 64GLY B 85LEU B 83ASN B 37PRO E 136 | 1.29A | NoneNoneNoneNoneEDO B 202 (-4.7A) | |||
![]() | 2X2I_C_QPSC1060_1 (ALPHA-1,4-GLUCANLYASE ISOZYME 1) | 6ywl | NSP3 MACRODOMAIN (SARS-CoV-2) | 5 / 12 | PHE E 132SER E 128SER E 139VAL E 95GLY E 79 | 1.72A | APR E 201 (-3.5A)APR E 201 (-4.4A)NoneNoneNone | |||
![]() | 2X2I_A_QPSA1060_1 (ALPHA-1,4-GLUCANLYASE ISOZYME 1) | 6ywl | NSP3 MACRODOMAIN (SARS-CoV-2) | 5 / 12 | PHE A 132SER A 128SER A 139VAL A 95GLY A 79 | 1.72A | APR A 201 (-3.7A)APR A 201 (-4.4A)NoneNoneNone | |||
![]() | 2X2I_A_QPSA1060_1 (ALPHA-1,4-GLUCANLYASE ISOZYME 1) | 6ywl | NSP3 MACRODOMAIN (SARS-CoV-2) | 5 / 12 | PHE E 132SER E 128SER E 139VAL E 95GLY E 79 | 1.71A | APR E 201 (-3.5A)APR E 201 (-4.4A)NoneNoneNone | |||
![]() | 2X2I_C_QPSC1060_1 (ALPHA-1,4-GLUCANLYASE ISOZYME 1) | 6ywl | NSP3 MACRODOMAIN (SARS-CoV-2) | 5 / 12 | PHE C 132SER C 128SER C 139VAL C 95GLY C 79 | 1.72A | APR C 201 (-3.5A)APR C 201 (-4.4A)NoneNoneNone | |||
![]() | 6GNG_A_QPSA601_1 (-) | 6ywl | NSP3 MACRODOMAIN (SARS-CoV-2) | 5 / 12 | GLY B 97LEU B 127GLY E 133ASN B 37ASN B 115 | 1.79A | None | |||
![]() | 2X2I_C_QPSC1060_1 (ALPHA-1,4-GLUCANLYASE ISOZYME 1) | 6ywl | NSP3 MACRODOMAIN (SARS-CoV-2) | 5 / 12 | PHE B 132SER B 128SER B 139VAL B 95GLY B 79 | 1.74A | APR B 201 (-3.5A)APR B 201 (-4.3A)NoneNoneNone | |||
![]() | 2X2I_C_QPSC1060_1 (ALPHA-1,4-GLUCANLYASE ISOZYME 1) | 6ywl | NSP3 MACRODOMAIN (SARS-CoV-2) | 5 / 12 | THR D 146VAL D 142SER D 128VAL D 95ALA D 112 | 1.79A | NoneNoneAPR D 201 (-4.3A)NoneNone | |||
![]() | 6GNG_B_QPSB601_1 (-) | 6ywl | NSP3 MACRODOMAIN (SARS-CoV-2) | 5 / 12 | VAL D 165THR D 149TYR D 152PRO D 32GLY E 8 | 1.66A | 17.23 | NoneNoneNoneNoneEDO E 203 (-4.8A) | ||
![]() | 2X2I_C_QPSC1060_1 (ALPHA-1,4-GLUCANLYASE ISOZYME 1) | 6ywl | NSP3 MACRODOMAIN (SARS-CoV-2) | 5 / 12 | THR E 146VAL E 142SER E 128VAL E 95ALA E 112 | 1.78A | NoneNoneAPR E 201 (-4.4A)NoneNone | |||
![]() | 2X2I_A_QPSA1060_1 (ALPHA-1,4-GLUCANLYASE ISOZYME 1) | 6ywl | NSP3 MACRODOMAIN (SARS-CoV-2) | 5 / 12 | PHE C 132SER C 128SER C 139VAL C 95GLY C 79 | 1.71A | APR C 201 (-3.5A)APR C 201 (-4.4A)NoneNoneNone | |||
![]() | 6GNF_C_QPSC602_2 (-) | 6ywl | NSP3 MACRODOMAIN (SARS-CoV-2) | 5 / 12 | VAL B 41ASP E 145ASP E 135HIS E 138GLY B 73 | 1.58A | 16.18 | NoneNoneEDO B 202 (-4.8A)NoneNone | ||
![]() | 2X2I_A_QPSA1060_1 (ALPHA-1,4-GLUCANLYASE ISOZYME 1) | 6ywl | NSP3 MACRODOMAIN (SARS-CoV-2) | 5 / 12 | PHE D 132SER D 128SER D 139VAL D 95GLY D 79 | 1.73A | APR D 201 (-3.3A)APR D 201 (-4.3A)NoneNoneEDO D 203 (-3.1A) | |||
![]() | 2X2I_C_QPSC1060_1 (ALPHA-1,4-GLUCANLYASE ISOZYME 1) | 6ywl | NSP3 MACRODOMAIN (SARS-CoV-2) | 5 / 12 | THR A 146VAL A 142SER A 128VAL A 95ALA A 112 | 1.78A | NoneNoneAPR A 201 (-4.4A)NoneNone | |||
![]() | 6GNG_B_QPSB601_2 (-) | 6ywl | NSP3 MACRODOMAIN (SARS-CoV-2) | 5 / 12 | GLY A 47GLY A 46HIS A 94ASN A 54PRO A 32 | 1.60A | APR A 201 (-4.1A)APR A 201 (-4.2A)NoneNoneNone | |||
![]() | 2X2I_C_QPSC1060_1 (ALPHA-1,4-GLUCANLYASE ISOZYME 1) | 6ywl | NSP3 MACRODOMAIN (SARS-CoV-2) | 5 / 12 | PHE D 132SER D 128SER D 139VAL D 95GLY D 79 | 1.74A | APR D 201 (-3.3A)APR D 201 (-4.3A)NoneNoneEDO D 203 (-3.1A) | |||
![]() | 2X2I_A_QPSA1060_1 (ALPHA-1,4-GLUCANLYASE ISOZYME 1) | 6ywl | NSP3 MACRODOMAIN (SARS-CoV-2) | 5 / 12 | THR A 146VAL A 142SER A 128VAL A 95ALA A 112 | 1.78A | NoneNoneAPR A 201 (-4.4A)NoneNone | |||
![]() | 6GNG_B_QPSB601_2 (-) | 6ywl | NSP3 MACRODOMAIN (SARS-CoV-2) | 5 / 12 | GLY A 79GLY A 78GLY D 78ASN D 117PRO D 98 | 1.58A | None | |||
![]() | 6GNF_A_QPSA602_1 (-) | 6ywl | NSP3 MACRODOMAIN (SARS-CoV-2) | 5 / 12 | VAL B 41ASP E 145ASP E 135HIS E 138GLY B 73 | 1.59A | 16.18 | NoneNoneEDO B 202 (-4.8A)NoneNone | ||
![]() | 6GNG_B_QPSB601_2 (-) | 6ywl | NSP3 MACRODOMAIN (SARS-CoV-2) | 5 / 12 | GLY D 79GLY D 78GLY A 78ASN A 117PRO A 98 | 1.61A | EDO D 203 (-3.1A)NoneNoneNoneNone | |||
![]() | 6GNG_B_QPSB601_2 (-) | 6ywl | NSP3 MACRODOMAIN (SARS-CoV-2) | 5 / 12 | GLY E 47GLY E 46HIS E 94ASN E 54PRO E 32 | 1.71A | APR E 201 (-4.4A)APR E 201 (-3.9A)NoneNoneNone | |||
![]() | 2X2I_C_QPSC1060_1 (ALPHA-1,4-GLUCANLYASE ISOZYME 1) | 6ywl | NSP3 MACRODOMAIN (SARS-CoV-2) | 5 / 12 | THR B 146VAL B 142SER B 128VAL B 95ALA B 112 | 1.78A | NoneNoneAPR B 201 (-4.3A)NoneNone | |||
![]() | 6GNG_A_QPSA601_1 (-) | 6ywl | NSP3 MACRODOMAIN (SARS-CoV-2) | 5 / 12 | GLY D 97LEU D 127VAL D 142ASN D 115GLN A 118 | 1.75A | NoneNoneNoneEDO A 207 ( 3.7A)EDO D 203 (-3.7A) | |||
![]() | 6GNG_B_QPSB601_1 (-) | 6ywl | NSP3 MACRODOMAIN (SARS-CoV-2) | 5 / 12 | VAL E 165THR E 149TYR E 152PRO E 32GLY D 8 | 1.74A | 17.23 | None | ||
![]() | 6GNG_B_QPSB601_2 (-) | 6ywl | NSP3 MACRODOMAIN (SARS-CoV-2) | 5 / 12 | GLY B 47GLY B 46HIS B 94ASN B 54PRO B 32 | 1.61A | APR B 201 (-3.6A)EDO B 202 (-3.9A)NoneNoneNone | |||
![]() | 2X2I_A_QPSA1060_1 (ALPHA-1,4-GLUCANLYASE ISOZYME 1) | 6ywl | NSP3 MACRODOMAIN (SARS-CoV-2) | 5 / 12 | THR B 146VAL B 142SER B 128VAL B 95ALA B 112 | 1.78A | NoneNoneAPR B 201 (-4.3A)NoneNone | |||
![]() | 6GNG_A_QPSA601_1 (-) | 6ywl | NSP3 MACRODOMAIN (SARS-CoV-2) | 5 / 12 | GLY D 48VAL D 24ASP C 67HIS C 86ASN C 59 | 1.65A | EDO D 204 ( 3.4A)NoneNoneNoneNone | |||
![]() | 1DED_A_QPSA1001_1 (CYCLODEXTRINGLUCANOTRANSFERASE) | 6ywm | NSP3 MACRODOMAIN (SARS-CoV-2) | 5 / 12 | LEU B 126LEU B 140ALA B 129ASP B 157ASP B 162 | 1.79A | None | |||
![]() | 2X2I_C_QPSC1060_1 (ALPHA-1,4-GLUCANLYASE ISOZYME 1) | 6ywm | NSP3 MACRODOMAIN (SARS-CoV-2) | 5 / 12 | THR A 146VAL A 142SER A 128VAL A 95ALA A 112 | 1.78A | NoneNoneMES A 201 (-4.4A)NoneNone | |||
![]() | 2X2I_C_QPSC1060_1 (ALPHA-1,4-GLUCANLYASE ISOZYME 1) | 6ywm | NSP3 MACRODOMAIN (SARS-CoV-2) | 5 / 12 | PHE A 132SER A 128SER A 139VAL A 95GLY A 79 | 1.72A | MES A 201 (-3.5A)MES A 201 (-4.4A)NoneNoneEDO A 204 (-3.6A) | |||
![]() | 2X2I_A_QPSA1060_1 (ALPHA-1,4-GLUCANLYASE ISOZYME 1) | 6ywm | NSP3 MACRODOMAIN (SARS-CoV-2) | 5 / 12 | PHE C 132SER C 128SER C 139VAL C 95GLY C 79 | 1.72A | MES C 201 (-3.6A)MES C 201 (-4.6A)NoneNoneNone | |||
![]() | 6GNG_A_QPSA601_1 (-) | 6ywm | NSP3 MACRODOMAIN (SARS-CoV-2) | 5 / 12 | GLY A 97LEU A 127VAL A 142ASN A 115GLN C 118 | 1.74A | NoneNoneNoneEDO A 202 ( 3.5A)EDO A 204 (-4.1A) | |||
![]() | 6GNG_B_QPSB601_2 (-) | 6ywm | NSP3 MACRODOMAIN (SARS-CoV-2) | 5 / 12 | GLY A 47GLY A 46HIS A 94ASN A 54PRO A 32 | 1.53A | MES A 201 ( 4.8A)MES A 201 ( 4.9A)NoneNoneNone | |||
![]() | 6GNG_A_QPSA601_1 (-) | 6ywm | NSP3 MACRODOMAIN (SARS-CoV-2) | 5 / 12 | GLY C 97LEU C 127VAL C 142ASN C 115GLN A 118 | 1.78A | NoneNoneNoneEDO A 202 (-3.6A)EDO A 202 (-4.6A) | |||
![]() | 2X2I_D_QPSD1060_1 (ALPHA-1,4-GLUCANLYASE ISOZYME 1) | 6ywm | NSP3 MACRODOMAIN (SARS-CoV-2) | 5 / 10 | PHE B 132SER B 128SER B 139VAL B 95GLY B 79 | 1.70A | None | |||
![]() | 6GNG_B_QPSB601_2 (-) | 6ywm | NSP3 MACRODOMAIN (SARS-CoV-2) | 5 / 12 | GLY C 79GLY C 78GLY A 78ASN A 117PRO A 98 | 1.59A | None | |||
![]() | 6GNG_B_QPSB601_2 (-) | 6ywm | NSP3 MACRODOMAIN (SARS-CoV-2) | 5 / 12 | GLY C 97GLY C 73HIS C 94ASN C 115GLN A 118 | 1.65A | NoneNoneNoneEDO A 202 (-3.6A)EDO A 202 (-4.6A) | |||
![]() | 6GNG_B_QPSB601_2 (-) | 6ywm | NSP3 MACRODOMAIN (SARS-CoV-2) | 5 / 12 | GLY C 47GLY C 46HIS C 94ASN C 54PRO C 32 | 1.53A | MES C 201 ( 4.9A)NoneNoneNoneNone | |||
![]() | 2X2I_C_QPSC1060_1 (ALPHA-1,4-GLUCANLYASE ISOZYME 1) | 6ywm | NSP3 MACRODOMAIN (SARS-CoV-2) | 5 / 12 | PHE B 132SER B 128SER B 139VAL B 95GLY B 79 | 1.70A | None | |||
![]() | 2X2I_A_QPSA1060_1 (ALPHA-1,4-GLUCANLYASE ISOZYME 1) | 6ywm | NSP3 MACRODOMAIN (SARS-CoV-2) | 5 / 12 | PHE A 132SER A 128SER A 139VAL A 95GLY A 79 | 1.71A | MES A 201 (-3.5A)MES A 201 (-4.4A)NoneNoneEDO A 204 (-3.6A) | |||
![]() | 6GNG_B_QPSB601_3 (-) | 6ywm | NSP3 MACRODOMAIN (SARS-CoV-2) | 3 / 3 | ASP A 157ASP B 145ASN B 117 | 1.50A | 17.23 | None | ||
![]() | 2X2I_A_QPSA1060_1 (ALPHA-1,4-GLUCANLYASE ISOZYME 1) | 6ywm | NSP3 MACRODOMAIN (SARS-CoV-2) | 5 / 12 | THR C 146VAL C 142SER C 128VAL C 95ALA C 112 | 1.78A | NoneNoneMES C 201 (-4.6A)NoneNone | |||
![]() | 2X2I_A_QPSA1060_1 (ALPHA-1,4-GLUCANLYASE ISOZYME 1) | 6ywm | NSP3 MACRODOMAIN (SARS-CoV-2) | 5 / 12 | THR B 146VAL B 142SER B 128VAL B 95ALA B 112 | 1.76A | None | |||
![]() | 6GNG_B_QPSB601_2 (-) | 6ywm | NSP3 MACRODOMAIN (SARS-CoV-2) | 5 / 12 | GLY A 79GLY A 78GLY C 78ASN C 117PRO C 98 | 1.59A | EDO A 204 (-3.6A)NoneNoneNoneNone | |||
![]() | 2X2I_C_QPSC1060_1 (ALPHA-1,4-GLUCANLYASE ISOZYME 1) | 6ywm | NSP3 MACRODOMAIN (SARS-CoV-2) | 5 / 12 | PHE C 132SER C 128SER C 139VAL C 95GLY C 79 | 1.73A | MES C 201 (-3.6A)MES C 201 (-4.6A)NoneNoneNone | |||
![]() | 6GNG_B_QPSB601_2 (-) | 6ywm | NSP3 MACRODOMAIN (SARS-CoV-2) | 5 / 12 | GLY B 47GLY B 46HIS B 94ASN B 54PRO B 32 | 1.55A | None | |||
![]() | 2X2I_A_QPSA1060_1 (ALPHA-1,4-GLUCANLYASE ISOZYME 1) | 6ywm | NSP3 MACRODOMAIN (SARS-CoV-2) | 5 / 12 | PHE B 132SER B 128SER B 139VAL B 95GLY B 79 | 1.67A | None | |||
![]() | 2X2I_C_QPSC1060_1 (ALPHA-1,4-GLUCANLYASE ISOZYME 1) | 6ywm | NSP3 MACRODOMAIN (SARS-CoV-2) | 5 / 12 | THR C 146VAL C 142SER C 128VAL C 95ALA C 112 | 1.79A | NoneNoneMES C 201 (-4.6A)NoneNone | |||
![]() | 6GNG_A_QPSA601_1 (-) | 6ywm | NSP3 MACRODOMAIN (SARS-CoV-2) | 5 / 12 | GLY A 79LEU A 108GLY A 130ASP A 105ASN C 117 | 1.79A | EDO A 204 (-3.6A)EDO C 205 (-4.9A)MES A 201 (-3.1A)NoneNone | |||
![]() | 6GNG_B_QPSB601_2 (-) | 6ywm | NSP3 MACRODOMAIN (SARS-CoV-2) | 5 / 12 | GLY A 97GLY A 73HIS A 94ASN A 115GLN C 118 | 1.62A | NoneNoneNoneEDO A 202 ( 3.5A)EDO A 204 (-4.1A) | |||
![]() | 2X2I_C_QPSC1060_1 (ALPHA-1,4-GLUCANLYASE ISOZYME 1) | 6ywm | NSP3 MACRODOMAIN (SARS-CoV-2) | 5 / 12 | THR B 146VAL B 142SER B 128VAL B 95ALA B 112 | 1.77A | None | |||
![]() | 1DED_A_QPSA1001_1 (CYCLODEXTRINGLUCANOTRANSFERASE) | 6ywm | NSP3 MACRODOMAIN (SARS-CoV-2) | 5 / 12 | LEU C 126LEU C 140ALA C 129ASP C 157ASP C 162 | 1.77A | NoneNoneNone MG C 202 ( 2.6A)None | |||
![]() | 2X2I_A_QPSA1060_1 (ALPHA-1,4-GLUCANLYASE ISOZYME 1) | 6ywm | NSP3 MACRODOMAIN (SARS-CoV-2) | 5 / 12 | THR A 146VAL A 142SER A 128VAL A 95ALA A 112 | 1.77A | NoneNoneMES A 201 (-4.4A)NoneNone | |||
![]() | 6GNG_B_QPSB601_1 (-) | 7bqy | MAIN PROTEASE (SARS-CoV-2) | 5 / 12 | VAL A 157TYR A 182TYR A 161VAL A 13CYH A 16 | 1.80A | 18.86 | None | ||
![]() | 6GNG_A_QPSA601_1 (-) | 7btf | NSP12 (SARS-CoV-2) | 5 / 12 | THR A 538VAL A 398THR A 565ASP A 684GLN A 541 | 1.74A | None | |||
![]() | 6GNF_C_QPSC602_1 (-) | 7btf | NSP12 (SARS-CoV-2) | 5 / 10 | THR A 680GLY A 678LEU A 663PHE A 694VAL A 315 | 1.66A | 20.61 | None | ||
![]() | 2X2I_C_QPSC1060_1 (ALPHA-1,4-GLUCANLYASE ISOZYME 1) | 7btf | NSP12 (SARS-CoV-2) | 5 / 12 | PHE A 652SER A 649ASN A 534VAL A 535ALA A 656 | 1.60A | None | |||
![]() | 6GNG_A_QPSA601_1 (-) | 7btf | NSP12 (SARS-CoV-2) | 5 / 12 | LEU A 758VAL A 588GLY A 679ASP A 623ASN A 695 | 1.73A | None | |||
![]() | 2X2I_A_QPSA1050_1 (ALPHA-1,4-GLUCANLYASE ISOZYME 1) | 7btf | NSP12 (SARS-CoV-2) | 5 / 12 | GLN A 789PHE A 45ASP A 36ASP A 465HIS A 133 | 1.67A | 21.79 | None | ||
![]() | 6GNG_A_QPSA601_1 (-) | 7btf | NSP12NSP8 (SARS-CoV-2) | 5 / 12 | THR A 344GLY A 345VAL A 353ASP B 112ASN A 297 | 1.65A | None | |||
![]() | 2X2I_C_QPSC1060_1 (ALPHA-1,4-GLUCANLYASE ISOZYME 1) | 7btf | NSP12 (SARS-CoV-2) | 5 / 12 | THR A 710ASN A 767VAL A 776GLY A 774ALA A 706 | 1.71A | None | |||
![]() | 6GNG_A_QPSA601_1 (-) | 7btf | NSP12 (SARS-CoV-2) | 5 / 12 | THR A 148LEU A 212VAL A 182ASP A 211ASN A 213 | 1.79A | None | |||
![]() | 6GNG_A_QPSA601_1 (-) | 7btf | NSP12NSP7 (SARS-CoV-2) | 5 / 12 | LEU C 41GLY A 413ASP C 38ASN C 37GLN A 444 | 1.75A | None | |||
![]() | 2X2I_A_QPSA1060_1 (ALPHA-1,4-GLUCANLYASE ISOZYME 1) | 7btf | NSP12 (SARS-CoV-2) | 5 / 12 | THR A 710ASN A 767VAL A 776GLY A 774ALA A 706 | 1.76A | None | |||
![]() | 2X2I_D_QPSD1060_1 (ALPHA-1,4-GLUCANLYASE ISOZYME 1) | 7btf | NSP12 (SARS-CoV-2) | 5 / 10 | THR A 710PHE A 745ASN A 767VAL A 776GLY A 774 | 1.68A | None | |||
![]() | 6GNG_B_QPSB601_3 (-) | 7btf | NSP12 (SARS-CoV-2) | 3 / 3 | ASP A 390ASP A 452ASN A 552 | 1.58A | 20.04 | None | ||
![]() | 2X2I_A_QPSA1060_1 (ALPHA-1,4-GLUCANLYASE ISOZYME 1) | 7btf | NSP12 (SARS-CoV-2) | 5 / 12 | PHE A 652SER A 649ASN A 534VAL A 535ALA A 656 | 1.54A | None | |||
![]() | 2X2I_D_QPSD1050_1 (ALPHA-1,4-GLUCANLYASE ISOZYME 1) | 7btf | NSP12 (SARS-CoV-2) | 5 / 12 | GLN A 789PHE A 45ASP A 36ASP A 465HIS A 133 | 1.67A | 21.79 | None | ||
![]() | 6GNG_A_QPSA601_1 (-) | 7buy | VIRUS MAIN PROTEASE (SARS-CoV-2) | 5 / 12 | GLY A 143LEU A 27VAL A 20GLY A 170HIS A 41 | 1.74A | JRY A 401 (-3.3A)NoneNoneNoneJRY A 401 (-3.9A) | |||
![]() | 6GNG_B_QPSB601_1 (-) | 7buy | VIRUS MAIN PROTEASE (SARS-CoV-2) | 5 / 12 | VAL A 157TYR A 182TYR A 161VAL A 13CYH A 16 | 1.79A | 18.86 | None | ||
![]() | 2X2I_C_QPSC1060_1 (ALPHA-1,4-GLUCANLYASE ISOZYME 1) | 7bv1 | NSP12 (SARS-CoV-2) | 5 / 12 | THR A 687THR A 538VAL A 560GLY A 683ALA A 558 | 1.73A | None | |||
![]() | 6GNF_C_QPSC602_1 (-) | 7bv1 | NSP12 (SARS-CoV-2) | 5 / 10 | THR A 680GLY A 678LEU A 663PHE A 694VAL A 315 | 1.59A | 20.70 | None | ||
![]() | 2X2I_D_QPSD1050_1 (ALPHA-1,4-GLUCANLYASE ISOZYME 1) | 7bv1 | NSP12 (SARS-CoV-2) | 5 / 12 | GLN A 789PHE A 45ASP A 36ASP A 465HIS A 133 | 1.75A | 21.65 | None | ||
![]() | 2X2I_A_QPSA1060_1 (ALPHA-1,4-GLUCANLYASE ISOZYME 1) | 7bv1 | NSP12 (SARS-CoV-2) | 5 / 12 | THR A 687THR A 538VAL A 560GLY A 683ALA A 558 | 1.74A | None | |||
![]() | 2X2I_A_QPSA1050_1 (ALPHA-1,4-GLUCANLYASE ISOZYME 1) | 7bv1 | NSP12 (SARS-CoV-2) | 5 / 12 | GLN A 789PHE A 45ASP A 36ASP A 465HIS A 133 | 1.80A | 21.65 | None | ||
![]() | 6GNG_B_QPSB601_2 (-) | 7bv2 | NSP12 (SARS-CoV-2) | 5 / 12 | GLY A 839GLY A 841LEU A 838GLU A 811ARG A 836 | 1.61A | NoneNoneNoneNone U P 18 ( 2.9A) | |||
![]() | 2X2I_A_QPSA1060_1 (ALPHA-1,4-GLUCANLYASE ISOZYME 1) | 7bv2 | NSP12 (SARS-CoV-2) | 5 / 12 | THR A 687THR A 538VAL A 560GLY A 683ALA A 558 | 1.77A | F86 P 102 (-3.6A)None U T 10 ( 4.6A) U T 10 ( 3.1A)None | |||
![]() | 2X2I_C_QPSC1060_1 (ALPHA-1,4-GLUCANLYASE ISOZYME 1) | 7bv2 | NSP12 (SARS-CoV-2) | 5 / 12 | THR A 687THR A 538VAL A 560GLY A 683ALA A 558 | 1.75A | F86 P 102 (-3.6A)None U T 10 ( 4.6A) U T 10 ( 3.1A)None | |||
![]() | 6GNG_A_QPSA601_1 (-) | 7bv2 | NSP12NSP8 (SARS-CoV-2) | 5 / 12 | THR A 344GLY A 345VAL A 353ASP B 112ASN A 297 | 1.73A | None | |||
![]() | 6GNF_C_QPSC602_1 (-) | 7bv2 | NSP12 (SARS-CoV-2) | 5 / 10 | THR A 680GLY A 678LEU A 663PHE A 694VAL A 315 | 1.69A | 20.70 | F86 P 102 ( 4.9A)NoneNoneNoneNone | ||
![]() | 2X2I_D_QPSD1050_1 (ALPHA-1,4-GLUCANLYASE ISOZYME 1) | 7bv2 | NSP12 (SARS-CoV-2) | 5 / 12 | GLN A 789PHE A 45ASP A 36ASP A 465HIS A 133 | 1.77A | 21.65 | None |